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Abstract 
The scientific basis of xenobiotic safety is complicated because of the variance in 
predictability of the primary and secondary pharmacology of foreign chemical 
substances, as well as variability in individual susceptibility within the population [1]. 
Despite a wealth of research into this field, our understanding of the mechanisms 
underpinning the occurrence of adverse effects from xenobiotics remains limited [2]. 
Adverse drug reactions (ADRs) represent a major encumbrance to the development of 
new therapeutics with  approximately 21% of drug attrition attributed to toxicity during 
the development process [3].  
The  in vivo/ex vivo use of animals in science, and in particular drug development, is a 
global practice and the main purposes of animal experiments are; (i) to gain basic 
biological knowledge, (ii) for fundamental medical research, (iii) for the discovery and 
development of drugs, vaccines and medical devices, and (iv) for the toxicity testing of 
xenobiotics/drugs [4]. However, with there being species-species differences in 
mechanistic responses, it is difficult to assess results in animal trials and translate these 
findings in order to predict the in-vivo response in humans [5]. Current in vitro model 
systems developed to assess ADRs have a number of down falls including; (i) the isolating 
procedure of primary hepatocytes, (ii) their cost, (iii) inter-donor differences, (iv) limited 
availability, (v) as well as increasing ethical pressure to implement the 3R’s (Replacement, 
Reduction and Refinement) in research [6]. The emphasis on producing a relevant and 
representative in vitro model for hepatotoxicity has therefore expanded. 
The aim of this thesis is to characterise a novel 3D microtissue model that, in the future, 
aims to provide a better in vitro platform to assess liver toxicity after repeat-dose 
exposure to xenobiotics. This is particularly important because the processes of 
hepatotoxicity manifest themselves over several hours and even days, and therefore in 
vitro models need to be able to comprehensively assess toxic potential for repeat-dose 
scenarios as well as chronic exposures. Computational modelling is implemented to 
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allow translation of results and to better bridge the gap between in vitro and in vivo 
approaches and to exploit the knowledge gained from experimental work. 
Chapter 1 is a critical review of culture techniques and cell types that are used during the 
development stages of xenobiotic discovery. A number of in vitro models are evaluated 
with regards to the determination of hepatotoxic potential of compounds. This review 
has been previously published [7]. Chapter 1 also includes an introduction to 
mathematical modelling of hepatic clearance and other pharmacokinetic approaches.  
Chapter 2 describes the experimental characterisation of a primary rat hepatocyte (PRH) 
spheroid model. The application of the liquid-overlay technique (LOT) [8] with PRH 
results in the production of viable and reproducible microtissues, amenable for high-
throughput investigations. I show that our in vitro system mimics the in vivo cellular 
morphology, exhibiting both structural and functional polarisation, along with active and 
functional transporters.  
Chapter 3 describes the construction of a mathematical model of oxygen diffusion for 
my experimental in vitro spheroid system. This model is utilised to predict oxygen 
profiles within the spheroids and to propose optimised operating conditions in order to 
recapitulate healthy sinusoidal oxygen tensions. This optimisation is based on initial cell 
seeding densities and experimentally derived oxygen consumption rates (OCR).  
Chapter 4 describes the construction of a mathematical model to predict the diffusion of 
xenobiotics based on their inherent physicochemical properties. The in silico system 
incorporates specific parameters from the experimental spheroid system including 
paracellular transport features, namely tortuosity and pore fraction properties. The 
model describes how these spatiotemporal characteristics vary over the duration of the 
culture period and what effect these have on the transport of xenobiotics.  
 
 General Introduction 
  
15 
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1.1 Research motivation  
Syngenta are the world’s third largest seed company that specialise in the innovation and 
manufacture of novel seed and crop protection products including fungicides, herbicides 
and pesticides. The main ethos of the company stems from the challenge of how to feed 
an ever growing population in a sustainable way. This main principle drives the continual 
development of new technologies through the collaborative efforts of scientific research. 
These research collaborations enable Syngenta to critical evaluate all aspects of product 
safety and in turn ensures that these much-needed products reach the market.  
As new products are developed, a number of xenobiotics are examined and assessed not 
only with regards to their safety for eventual consumers, but also in terms of safety for 
users and the environment. These product safety analyses influence the design and 
selection of optimal new chemistry, traits and formulations for the development of novel 
products. This in combination with the use of sound scientific evidence ensures that 
these products and technologies are safe for both humans and the environment. As such, 
Syngenta outsource numerous research projects in order to strengthen their 
collaborative research efforts with leading academic experts, and also to facilitate the 
development of these required technologies.  
In order to be able to determine xenobiotic safety appropriately, it is vital that relevant 
and suitable means to test novel products are in place. In terms of novel xenobiotics, a 
key component of their intrinsic safety relies on the ability to elucidate the metabolism 
and physicochemical kinetics of the compounds, and also the toxic potential of 
subsequent metabolites. This is not only true for plant agrochemicals but also for other 
industries including pharmaceuticals, cosmetics and industrial chemicals.  
As product safety assessments of xenobiotics relies heavily on the ability to discern their 
metabolism and toxicity potential, our understanding of the liver plays a vital role in this 
process. As the liver is the organ responsible for the majority of metabolism of both 
endogenous and foreign substances, this project will focus on the characterisation of a 
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novel in vitro model that may aid in the elucidation of xenobiotic toxicity potential, as 
well as the development of in silico systems to facilitate the translatability of these results.  
As Syngenta are interested in the impact of xenobiotics on the environment as well as 
consumers and users, they have previously implemented the use of in vitro and in vivo 
rodent models. However, as the desire to implement the refinement, reduction and 
replacement of animals within scientific research is ever increasing, I will look at the 
utilisation of primary rat hepatocytes in a high-throughput platform as an in vitro model 
of choice in line with these principles.   
The main aim of the development of this in vitro model is to facilitate the reduction in 
the number of cycles and also the cycle time between test and analysis phases of 
Syngenta’s product development programme. The in vitro model may also potentially be 
used to reduce the number of initial/early stage compounds that reach later-stage testing 
by identifying xenobiotics that exhibit toxicity (see Figure 1-1).  In order to achieve this, 
a robust and in-depth characterisation of the model must first be undertaken. 
 
Figure 1-1- Schematic illustrating Sygnenta’s research and development cycle. An 
initiative is taken for a new product (Lead), where early chemicals are designed and 
synthesised and then tested and analysed at verious stages. One of the main aims of this 
research is to develop and characterise an in vitro model that can be implemented to 
reduce  the number of cycles, the overall cycle time and the number of chemicals that 
pass through cylces. 
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1.2 Introduction to the liver  
The liver is the largest solid organ in the body, and weighs between 1.8kg and 1.3kg (on 
average) in men and women respectively. The liver performs a number of vital roles 
within the body including; metabolism and detoxification of drugs, protein synthesis, as 
well as playing an important role in digestion, immunity and the control of blood glucose 
levels.  
1.3 Structure of the liver  
The entirety of the liver is made up of a number of functional units, often described as 
“classical lobules” which are anatomically hexagonal in microarchitecture. The human 
liver contains about one million of these lobules. There are two other ways to visualize 
the 2D microarchitecture of the liver which are, the portal lobule and liver acini (see 
Figure 1-2).  
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Figure 1-2  – A schematic diagram of the multiple functional units of the liver. The portal triad consists of the portal vein (blue oval), the 
hepatic artery (red) and the bile duct (green). The central veins are represented by the blue circles. The grey shaded areas show the functional 
units of the liver from multiple perspectives. 
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1.3.1 Parenchymal cells of the liver  
The major constituent cell type of the liver is the highly specialized hepatocyte, a 
parenchymal cell which makes up to 80% of the entire liver mass and performs the 
majority of the liver functions including synthetic activities, drug detoxification and 
metabolic functions [9]. Hepatocytes are unique in their proliferative capabilities in vivo 
and this inherent capacity allows the liver to regenerate following injury [10]. 
In vivo hepatocytes are functionally polarized and have a sinusoidal and a canalicular 
terminus. Hepatocytes are organized into plates which are one cell thick in mammals, 
and are separated via fenestrated capillaries called the sinusoids which allow blood to 
perfuse along the vascular channels. The inlet (periportal zone), which is made up from 
the portal triad, and the outlet (pericentral zone) of the hepatic lobule, are exposed to 
gradients of oxygen, nutrients, hormones, metabolites etc. which is caused by cellular 
uptake along the sinusoids. This variability of exposure to oxygen and hormones etc. gives 
rise to zonation whereby cells along the sinusoids have varying levels of gene and enzyme 
expression and also metabolic competence [11] (see Figure 1-3). 
The oxygen gradient within the sinusoid regulates the spatial expression of a number of 
specific genes [12]. For example, these genes encode specific carbohydrate metabolizing 
enzymes such as pyruvate carboxykinase 1, glucokinase and liver pyruvate kinase. These 
spatially expressed genes are mediated via oxygen-responsive transcription factors e.g. 
hypoxia-inducible factors (HIFs) [13].  
Hofman et al.  [14] described how hepatocytes take up substances such as bile salts via 
the basolateral membrane and subsequently excrete them across the canalicular 
membrane into the bile canaliculi where they move into the bile ductules. Protein and 
lipid components are specifically separated in the distinctive plasma membrane domains 
and thus, functional transport in hepatocytes is dependent on this highly polarized 
arrangement of the cells [15]. 
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Figure 1-3 – A diagram illustrating zonation of the liver acinus. Within the periportal 
zone (1), oxygen rich blood from the hepatic artery (red) mixes with nutrient rich blood 
from the portal vein (blue oval) and moves along the sinusoid towards the central vein 
(blue circle) in the pericentral zone (3). Bile moves in the opposite direction and drains 
into the bile duct (green). The expression of most genes appears to be determined by 
dynamic factors within the blood such as oxygen and hormone gradients which exist due 
to uptake along the sinusoid.   
 
1.3.2  Non-parenchymal cells of the liver  
The remaining liver mass of around 20% is made up of a number of non-parenchymal 
cells (NPCs) such as; Hepatic stellate cells (HSCs), Liver sinusoidal endothelial cells (LSECs), 
Kupffer cells (KCs) acting as in-situ macrophages, biliary epithelial cells (BECs), and 
immune cells such as lymphocytes and leukocytes [16]. (See Figure 1-4 for 
microarchitectural arrangement of parenchymal and non-parenchymal cells).  
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Figure 1-4 – A schematic representation of the spatial distribution of parenchymal and 
non-parenchymal cells within the liver acinus.   
 
1.3.3 Hepatic stellate cells (HSCs) 
HSCs are located in the perisinusoidal space of Dissé within the liver formed between the 
hepatocytes and the LSECs. These cells store up to 80% of retinoids in the whole body, 
and under normal conditions these quiescent cells play a vital role in retinoid 
homeostasis [17]. Under disease conditions (e.g. hepatic fibrosis) the inflammatory 
immune cells secrete cytokines and growth factors which in turn activates the HSCs. HSCs 
subsequently start to produce large amounts of extracellular matrix (ECM) components 
including collagen and adhesive glycoproteins such as fibronectin, as well as 
proteoglycans [18].  
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1.3.4  Liver sinusoidal endothelial cells (LSECs) 
In the 1970’s Wisse described LSECs as specialised endothelial cells with distinct features 
such as open fenestration as well as a lack of a basement membrane [19]. Wisse also 
described the atypically high amounts of endocytic vesicles and postulated that these 
cells were involved in protein uptake from the blood passing through the sinusoid. 
The literature has a number of conflicting opinions regarding the functions of these 
specific cells. However, it is accepted that LSECs play a scavenger role whereby they clear 
soluble macromolecules (e.g. hyaluronic acid and collagen α-chains) and colloids. This is 
in contrast to Kupffer cells, another identified type of scavenger cell, which is involved in 
the uptake of particulate matter [20]. 
1.3.5  Kupffer cells (KCs) 
KCs are bone marrow-derived monocyte cells acting as in-situ macrophages [21]. These 
cells act as a scavenger cell ingesting particulate matter, degraded red blood cells and 
endotoxins. When activated by liver damage, KCs synthesize and secrete the pro-
inflammatory cytokine, tumour necrosis factor α (TNFα) as well as interleukin-1β (IL-1β) 
[22]. Roberts and colleagues also demonstrated that TNFα from KCs activated LSECs 
leading to the deposition of fibrin in liver tissue [22]. Although the role of KCs has yet to 
be fully elucidated, it is thought that KCs may be the primary site of toxic response and 
also a secondary target responsive to toxic signals received by the parenchymal cells.  
1.3.6  Biliary epithelial cells (BECs) 
BECs line the biliary tracts and are often targets of liver damage (e.g. cholestatic liver 
disease), and are a subject of intense NPC research [15]. BECs constitute between 3-5% 
of the cells within the liver [23]. However, these cells are critical to the formation of the 
biliary components and the transport of bile into the duodenum. Although there is a 
relatively small percentage of BECs within the liver, they can account for up to 40% of 
total bile secretions in humans [24]. 
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1.4 Functions of the liver 
The liver has a number of vitally important functions which include metabolism and 
excretion. With regards to endogenous liver metabolism, there are a several main 
categories including carbohydrate, lipid and protein metabolism.  
1.4.1 Metabolism 
As well as endogenous metabolism, the liver is responsible for the metabolism and 
excretion of xenobiotics. The vast majority of molecules that enter the body are lipophilic 
and therefore, excretion of these substances is difficult. In this case, the liver converts 
these substances into more water-soluble substances by increasing the polarity of the 
compounds, thereby facilitating excretion.   
It is by no surprise that the main constituent cell of the liver, the parenchymal hepatocyte, 
carries out the majority of metabolism. The biotransformation of substances including 
xenobiotics is a multistep process.   
The liver breaks down lipids into their component parts and subsequently excretes them 
as lipoproteins. The liver also has the role of cholesterol production which is essential for 
plasma membrane fluidity and permeability.   
1.4.2 Synthesis  
The liver is responsible for synthesising a number of substances including; ECM proteins 
such as collagen, which are extremely important in liver function, acute phase proteins 
(APPs), clotting factors, and carrier proteins such as albumin etc. Albumin is the most 
abundant plasma protein and functions to bind to lipid-soluble toxins in order to excrete 
them, as well as playing an important role in maintaining oncotic pressure [25].   
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1.4.3  Biotransformation and Excretion 
1.4.3.1 Phase I Metabolism 
Phase I metabolism involves the metabolic modification of the xenobiotic via one of three 
modification processes. These include oxidation, reduction or hydrolysis but xenobiotics 
may also be modified via cyclization or decyclization. These reactions serve to introduce 
reactive and polar groups to the parent compound, thereby increasing the molecules 
polarity for subsequent modification. With most small drug molecules being relatively 
lipophilic, phase I modifications involve the conversion of these hydrophobic molecules 
into more water soluble compounds. Phase I metabolism mainly involves the oxidation 
of xenobiotics which are catalysed via the Cytochrome P450 monooxygneases (CYP450s). 
CYP450s are the most predominant drug metabolising enzyme present in the human 
body, and these enzymes account for up to 90% of all xenobiotic metabolism [26].  
1.4.3.2 Phase II Metabolism 
Phase II metabolism involves the conjugation of the phase I metabolites, i.e.  modification 
of the functional groups that were incorporated into the parent compound during phase 
I metabolism. In humans, glycine and glutamine are the most common amino acids 
involved in conjugation reactions. The most common phase II reactions are 
glucuronidation, which involves the addition of glucuronic acid via UDP-
glucuronosyltransferases (UGTs), and sulphation which involves combining with sulphate 
via sulphotransferases (SULTs) [27].  
1.4.3.3 Phase III Elimination 
Phase III metabolism encompasses the transporter mechanisms for xenobiotic 
metabolites. Interestingly, this process does not have to occur sequentially after phase I 
or phase II as the name implies. Recent studies have shown that a number of specific 
transporter proteins can mediate the transport of unmodified xenobiotics before they 
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are metabolised by phase I and II enzymes, as well as their subsequent phase I and II 
metabolites [28].  
This process involves the active transport of these unmodified parent compounds and 
metabolites via a number of membrane transporters such as, multidrug resistance-
associated proteins (MRPs), P-glycoprotein (P-gp), and organic anion transporting 
polypeptide 2 (OATP2) [27]. 
The above processes all contribute to the detoxification and subsequent elimination of 
many xenobiotic compounds.  
1.5  In vitro liver models utilised for hepatotoxicity prediction 
The main aim of an in vitro liver model is to be able to capture relevant and useful end 
points, such as assessing the toxicity potential of novel xenobiotics, identify possible 
ADRs and modifications in transporter functionality. For example, simple vesicle models 
can be used to investigate the uptake and efflux properties of specific transporters, 
demonstrating that in vitro models do not necessarily have to fully recapitulate the 
natural in vivo microenvironment in order to be utilised successfully [29]. 
Further to that, there are a number of in vitro liver models that differ depending on their 
culture conditions and conformations, cell types used and other additional culture 
parameters. These platforms include isolated primary hepatocytes, hepatic-derived cell 
lines and precision cut liver slices. Conventional cellular model systems such as simple 
monolayer cultures are easier to manipulate in the laboratory and are much more widely 
accepted ethically than the use of animal models. However, immortalised cell lines and 
2D hepatocyte cultures may be less representative of the in vivo liver. 
For certain compounds and other endpoint analyses, a more complex model that 
recapitulates the in vivo microenvironment more closely is required. As such, more 
complex approaches including 3D culture platforms, co-culture models and systems that 
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incorporate flow parameters such as bioreactor technologies, may prove to be better 
suited to capture these end points.  
The ongoing and continual development of 3D cell culture technology has meant that 
several technologies have been established to culture cells in these more complex 
environments. These include matrix-free systems for some cells, but also include the 
addition of hydrogels and scaffold technologies, and also the more recently established 
stem cell-derived hepatocyte-like cells and liver organoids [30-33]. Another degree of 
complexity in these systems has been introduced with the inclusion of fluid-flow to 
emulate sheer stress and nutrient exchange seen in vivo as a way to improve functionality 
and relevance [34, 35]. 
The use of animal models in research aids the development of our scientific 
understanding of basic and more complex cellular processes in both humans and animals. 
As a number of key cellular processes are conserved between species, animals provide 
an appropriate model by which to test and develop novel compounds across multiple 
industries. There are various ethical implications with regards to using animals in 
research, and to address these concerns the development of more representative in vitro 
and in silico models has accelerated. However, it is clear that in order to develop these 
alternative models accurate data and parameters are required, and thus the need for 
animal studies is apparent. (see Figure 1-5 for an overview of in vitro models utilised for 
hepatotoxicity investigations).  
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Figure 1-5- Schematic of commonly used liver models. These model can be ranked by 
their complexity and subsequent relevance to humans, and also by their ethical status. 
Some in vitro liver models are far more ethically accepted compared with others. 
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Figure 1-5 shows the multitude of liver models that differ in their translational relevance 
to humans. Systems vary from complex animal models that present significant ethical 
challenges alongside species variation, and primary human hepatocytes (PHH) that, 
although deemed more relevant, suffer from inter-donor variability, rapid 
dedifferentiation in vitro, along with sparse availability. On the other end of the spectrum 
are the more conventional cellular models that are easier to manipulate in the laboratory 
and are much more ethically accepted. However, these immortalised cell line models are 
less representative of the in vivo liver. Sandwich cultured hepatocytes retain more in vivo-
like properties, including polarised excretory function, enhanced morphology and 
viability of hepatocytes compared to monolayer cultures. However these models still lack 
complex cellular interactions and the 3D microenvironment. Cells can be grown in a 2D 
monolayer setting or the more complex 3D conformation, with 3D set-ups considered to 
be more representative of the native liver in vivo. The complexity of both 2D and 3D 
models can be further increased with the addition of NPCs, producing a more 
representative model via the adoption of a multicellular system, and the addition of flow 
with some systems incorporating highly complex microfluidic devices. 
1.5.1  Primary Human Hepatocytes (PHH) 
PHH in monolayer cultures are generally considered the gold standard in vitro model for 
drug metabolism and toxicity investigations [36, 37].  When isolated effectively, PHH 
demonstrate a number of favourable characteristics such as phase I and II metabolic 
enzyme activity, expression of liver-specific transporters, glucose metabolism, ammonia 
detoxification, as well as urea secretion and albumin production [38]. However, there are 
a number of problematic issues with this system; (i) loss of liver-specific 
function/dedifferentiation (PHHs lose their specific-liver function rapidly in vitro, 
including Cytochrome P450 (CYP) expression, and are therefore unsuitable for long-term 
and repeat-dose studies) [15, 39]; (ii) the isolation procedure of hepatocytes is technically 
difficult (with limited availability of tissue and considerable inter-donor variability that 
impacts on the reproducibility of end point measurements) [40]; (iii) classical 
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2D/monolayer cell culture does not recapitulate the complex 3D in vivo 
microenvironment. Despite this, PHH in vitro are still widely used despite the difficulties 
associated with culturing, isolating, cost, inter-donor variation, acquisition etc. Much 
research has therefore been conducted using cryopreserved hepatocytes, hepatic-
derived cell lines and other alternatives. 
Research has demonstrated that one way to improve and retain hepatocyte phenotype 
is to culture cells in a 3D conformation [41-43]. Mammalian cells in vivo grow in a 3D 
setting, therefore, 2D cell cultures are ineffectual at recreating a microenvironment that 
is representative of this native in vivo configuration [43]. 2D cultures fail to maintain 
phenotypic characteristics over the duration of the culture period [44]. Other strategies 
to improve PHH function and survival in vitro include the use of growth factors, cytokines 
and other supplementation within the growth media [45]. However, research has shown 
that one of the most successful techniques in retaining hepatocyte function has been 
their co-culture with other cell types including NPCs [46-48].   
Since many toxic responses in vivo are mediated by complex interplay amongst a 
multitude of cell types, the predictive capabilities of isolated hepatocytes are limited and 
therefore, there is a need to establish models that integrate NPCs within the culture 
platform [49].  Research has shown that intricate hepatocyte-NPC interactions affect the 
response after exposure to specific compounds. An example of this is vinyl chloride 
monomer (VCM), which is metabolically activated within hepatocytes causing 
hepatocellular cancer [50]. However, a long-term effect of VCM is that it gives rise to 
haemangiosarcoma, a rare tumour that arises from the LSECs [51]. Furthermore, toxic 
responses are not only mediated by the association of the cells within these multiplexes, 
but also by the complex 3D interaction involving NPCs and the extracellular matrix (ECM) 
which is believed to be crucial in regulating and maintaining hepatic function in vivo [52]. 
The differences between cells grown on flat culture surfaces versus novel 3D formats 
such as extracted ECM attachment surfaces, has been documented since the early 1970’s 
[53]. With decades of research being conducted since then, the compelling similarities of 
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in vivo morphologies and behaviours of cells grown in 3D environments have been well 
demonstrated [54]. Consequently, it is widely agreed that culturing cells in 3D provides a 
much more in vivo-like platform and this format is extensively used in an array of 
disciplines within scientific research such as: cancer medicine/tumour-immune system 
interactions  regenerative medicine and tissue fabrication technologies, and in the field 
of toxicology [15, 55-57].   
There are certainly a number of in vitro pharmacological models that have been 
developed to assess uptake, metabolism and detection of undesired effects, along with 
a vast number of publications that have addressed a number of desirable endpoints. 
However, only a small fraction of these models will inevitably become standardised 
industrial tools [58]. In part this is due to the specific internal requirements of industries 
and their capacity to incorporate these emerging technologies into their existing 
experimental framework. Industry screening comprises a battery of models that address 
single end points and in combination make up the tools for xenobiotic safety evaluations. 
Even though it is widely accepted that 3D cell culture provides a more representative and 
in vivo-like model, with large sets of historical data at their disposal, and potential 
difficulties in comprehensive characterisation and automation of novel 3D models, the 
widespread adoption of these 3D platforms into the already well-established battery of 
screening tools remains a challenge [59].  
1.5.1.1  Precision cut liver slices (PCLS) 
There are a number of desirable characteristics attributed to liver slices when compared 
with other in vitro liver models. Unlike primary cell isolations, liver slices do not require 
incubation with proteolytic enzymes and therefore, cell-cell interactions and other 
cellular components remain largely undisrupted. The maintenance of this 
microarchitecture also provides a more in vivo-like model. Additionally, with many in vitro 
systems, the conditions of isolation vary from species to species; counter to this, a 
reproducible, standardised procedure is used to prepare and incubate liver slices from 
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different species making this model particularly suitable to perform inter-species studies 
[60].  
Liver slices have been utilised extensively in the field of hepatotoxicity and drug induced 
liver injury (DILI) investigations with the main advantage of this system being that the 
liver microarchitecture remains intact with all liver cell types being present, along with 
zone specific CYP450 activity [60]. Human liver tissue can either be obtained from excised 
tissue removed during surgical procedures such as a partial hepatectomy or from the 
non-transplanted donor tissue [61]. Such liver slices have been utilised as an in vitro 
method for the prediction of human specific toxicity by toxicogenomics and proteomic 
investigations. However, human liver slices used from different donors, many of whom 
have underlying conditions, result in the introduction of inter-individual variability. This 
in turn means that reproducibility of the investigations can be difficult to achieve [15].   
Animal tissue on the other hand, is more readily available and can be controlled via 
perfusion methods using preservation solutions or simple buffers [15].  It has been shown 
that albumin production and phase II enzyme expression remain relatively stable for a 
period of up to 96 hours in culture, with studies typically lasting between 30 minutes and 
5 days using rat liver slices [62-64]. The main limitation with using freshly cut liver slices 
is their longevity, meaning that repeat-dose studies cannot be achieved with this model 
beyond 5 days. Inter-individual variability has also been seen in liver slices taken from 
different rats within a strain [65, 66].  
The literature has shown that the long-term conservation of metabolic competence for 
in vitro models is difficult to achieve, but it has been reported that metabolic capacity is 
better preserved in human liver slices when compared to PHH [61, 67]. However, 
conflicting reports have demonstrated that xenobiotic metabolism in liver slices is 
impaired after 24 hours of culture [68]. Research has demonstrated good in vitro-in vivo 
correlations for the qualitative metabolism of xenobiotics in liver slices obtained from 
multiple species. However, Lerche-Langrand et al. suggest that the use of liver slices may 
be limited to identifying low- and high-clearance compounds [60].  
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Despite their short-term viability, liver slices have been used extensively over the years 
to investigate metabolism and toxicity of a number of xenobiotics. Olinga et al. showed 
that in human liver slices, all hepatocytes within the slice had an equal rate of metabolism 
of lidocaine [67]. Elferink and colleagues further evaluated the utility of human liver slices 
as an in vitro platform for the prediction of human-specific toxicity by toxicogenomics 
[69]. They found that human liver slices retained a relatively stable protein expression of 
transporters and enzymes that are involved in drug metabolism during a 24 hour culture 
period.  
Liver slices have also been used in conjunction with bioreactor platforms such as the 
multiwell plate platform engineered by CN BIO Innovations [34]. This combined approach 
has been utilised as a means of increasing the complexity and representativeness of the 
liver slice platform as, fluid shear stress has been shown to improve liver-specific 
functional output [70]. Liver slices are placed into multiwell chambers of the plate and 
the media flow is controlled by a pneumatic underlay. This bioreactor is produced from 
polystyrene and has two connected chambers, one for the media reservoir, and the 
second is the reactor chamber. This reactor chamber can be used for culturing liver slices 
(as well as for the culture of isolated hepatocytes) with polycarbonate scaffolds [71]. This 
engineered platform enables the cells or liver slices to be cultured in an environment 
close to that of the in vivo liver. The system incorporates media flow, oxygen gradients 
and shear stresses. The experimental set up is able to recapitulate oxygen gradients 
similar to that seen within the liver sinusoid (145 µM to 50 µM at a flow rate of 0.25 
ml/minute) [71]. Hepatocytes cultured using this system have improved longevity when 
compared with conventional monolayer cultures. However, liver slices utilised in this 
platform are still not able to provide a model for repeat-dose toxicity studies due to their 
short term culture longevity and viability.  
1.5.2  Hepatic-derived Cell Lines  
To overcome some of the aforementioned limitations with PHH (1.5.1), immortalized 
hepatic-derived cell lines have been utilised extensively. Cell lines previously used in 
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toxicological investigations include; HepG2, C3A, HepaRG and Huh7 [72-75]. Use of these 
cell lines inherently overcomes the issue associated with inter-individual variability of 
primary hepatocytes, and these cells are characterised by having a relatively stable 
phenotype, ease of manipulation in the laboratory along with unlimited life-span [72, 76]. 
The main limitation with utilising these cell lines is that they generally possess reduced 
metabolic competence due to lack of expression of key metabolising enzymes [77]. 
1.5.2.1 HepG2 
Since its isolation in the 1970’s, extensive work has been carried out in the fields of 
toxicological and pharmacological assessment using the HepG2 cell line [62]. These cells 
possess a number of attractive characteristics such as: (i) nuclear transcription factor 
(Nrf2) expression, which is essential for drug metabolism and toxicity response [78]; (ii) 
availability, unlimited growth and the absence of inter-donor variation ensuring 
reproducible results [79]; and (iii) it is an easy-to handle cell line with uncomplicated 
culture protocols [80]. Research has targeted the development of classical monolayer 
formats to more complex 3D models including spheroids, with HepG2 spheroids showing 
markedly different gene expression when compared to monolayer cultures [81]. Chang 
et al. revealed that significantly more genes related to ECM, cytoskeleton, and cell 
adhesion were expressed in monolayer cells, whilst genes involved in liver-specific 
functions of xenobiotic and lipid metabolism were upregulated in HepG2 spheroids [81]. 
In addition, more genes involved in the cell cycle and regulation of growth and 
proliferation were upregulated in monolayers (Table 1). For example, CYP1A1 and ALB 
(albumin) expression was approximately 10 and 2-fold higher respectively, in 3D spheroid 
cultures when compared with monolayers, whilst COL1A1 (alpha 1 type-1 collagen) and 
GSPG2 (versican) expression was approximately 70 and 11-fold higher respectively, in 
monolayer cultures when compared with 3D spheroids. 
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Table 1 – Number of genes upregulated by at least 2-fold in HepG2 monolayers or 
spheroid as determined by microarray analysis [81]. 
 
 
 
Number of 
Genes 
Number of 
Genes 
Category Monolayer Spheroids 
Total 250 210 
Extracellular matrix 10 0 
Cytoskeleton 10 5 
Cell adhesion 21 4 
Cell cycle 13 7 
Growth/proliferation 25 10 
Xenobiotic metabolism 0 6 
Lipid metabolism 4 11 
Apoptosis/cell death 11 12 
Signal transduction 26 20 
Transcription 20 21 
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It has been demonstrated that, with the lack of appropriate levels of CYP expression 
when compared to PHH, HepG2 cells do not fully represent the phenotype of in vivo 
hepatocytes and therefore the detection of many hepatotoxic compounds utilising the 
HepG2 cells line is inaccurate, and for non-liver specific toxins this model is ineffectual 
[82]. It is, however, still the case that 2D cultures of hepatic-derived cell lines are valuable 
in the early stages of safety assessments, and liver cell lines can still provide a convenient 
and pragmatic tool for early screening and drug safety assessment [15, 83].   
1.5.2.2 C3A 
C3A cells are a sub-clone of the HepG2 cell line that demonstrate more advantageous 
characteristics compared with the parent cells. C3A cells are selected for their contact-
inhibited growth characteristics, increased albumin production and alpha fetoprotein 
production, alongside their ability to proliferate and thrive in glucose-deficient media 
[84]. These characteristics have made C3A cells a more representative model for 
hepatotoxicity studies with a number of researchers utilising this cell type in 3D culture 
systems [76].  
1.5.2.3 HepaRG 
The HepaRG cell line is another hepatocellular carcinoma-derived cell line that has been 
of interest over the last decade [85]. It is a human cell line that exhibits a number of 
attractive qualities and unique features when compared to the more commonly used 
HepG2 cells [74]. HepaRG cells have been shown to express a number of phase II enzymes 
and membrane transporters comparable to freshly isolated or cultured PHH [77, 80, 86]. 
HepaRG cells, when seeded at low density, acquire an elongated undifferentiated 
morphology. They then actively divide and after having reached confluence, form typical 
hepatocyte-like colonies surrounded by biliary epithelial-like cells [74]. In addition, the 
literature has reported enhanced CYP450 expression along with improved liver-specific 
functionality [15, 74, 77, 85].  
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Guillouzo et al. demonstrated that the HepaRG cell line was more sensitive to 
metabolism-mediated toxicity when compared with HepG2 cells [74]. They found that 
HepaRG cells expressed various CYPs (1A2, 2B6, 2C9, 2E1, 3A4) and the nuclear receptors, 
constitutive androstane receptor (CAR) and pregnane X receptor (PXR), at levels 
comparable to those found in cultured PHH, and much increased when compared to the 
expression levels in HepG2 cells. HepaRG cells also expressed phase II enzymes, apical 
and canalicular ABC transporters and basolateral solute carrier transporters, albumin, 
haptoglobin, as well as aldolase B which is a specific marker of adult hepatocytes. The 
findings of Guillouzo et al. demonstrate that HepaRG cell models have the potential to 
replace PHH models for xenobiotic metabolism and toxicity studies [74]. McGill et al. [87] 
concluded that HepaRG cells are a useful model to study mechanisms of APAP 
hepatotoxicity in humans. They found that HepaRG cells that were exposed to varying 
concentrations of APAP resulted in glutathione depletion, APAP-protein adduct formation, 
mitochondrial oxidative stress, peroxynitrite formation, mitochondrial dysfunction, and 
lactate dehydrogenase (LDH) release. This analysis indicated that these key mechanistic 
propagators of APAP-induced cell death were the same as in the in vitro rodent models 
and cultured primary mouse hepatocytes.  
Gerets et al. carried out a comprehensive assessment of the HepaRG cell line 
investigating mRNA levels and CYP activity in response to a number of inducers [77]. This 
study characterised PHH, HepG2 and the novel HepaRG cell lines in direct comparison 
with each other. All of the cells in this investigation were cultured in a monolayer 
multiwell format and were compared with regard to their metabolism and potential to 
detect hepatotoxicity. Gerets et al. concluded that HepG2 cells in this 2D environment 
responded weakly to the different inducers (β-napthoflavone, phenobarbital and 
rifampicin), when compared with PHH and the HepaRG cells at the gene expression and 
CYP activity levels, whilst HepaRG cells appeared to be most suitable for these induction 
studies. However, HepaRG cells were not as predictive for hepatotoxicity as PHH and 
were more comparable to HepG2 cells [77]. 
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One of the main limitations with the HepaRG cell line as a model for hepatotoxicity 
investigations is the long culture procedure that is required. HepaRG cells are seeded at 
low densities and after a period of 14 days, these cells differentiate into hepatocyte-like 
and biliary epithelial-like cells. This pre-differentiation culture phase incurs cost and also 
time when compared to more commonly used cell lines such as HepG2/C3A cells. 
Specialist culture media and supplements are required for the entirety of the culture 
procedure and licensing is required to culture the cells meaning the cost of culturing the 
HepaRG cells can be as much as one hundred times more expensive than the more 
commonly used cell lines. As a research tool this means that availability to all researchers 
is limited. However, terminally differentiated, commercially available cryopreserved 
HepaRG cells can be obtained [88]. 
1.5.3  Co-cultures 
It has been demonstrated that culturing hepatocytes with other cell types increases their 
longevity and functionality [89]. The culturing of hepatocytes with NPCs has been 
investigated since the late 1970’s and is still being intensively researched [90]. The 
predictive capabilities of isolated PHH can be limited [49]. Therefore, in order to 
represent the multicellularity of the liver, culturing primary hepatocytes with NPCs is an 
important facet for in vitro cellular models [58]. Prior research has demonstrated that 
culturing primary hepatocytes with NPCs not only increases liver-specific functionality, 
but also improves the longevity of the cultures [47, 48, 91]. Whilst there is a wealth of 
research regarding co-culture models in a 2D format, the emphasis has shifted to 
producing 3D co-cultures where not only multiple cell types can interact but they can 
grow in a physiologically relevant manner [58]. Figure 1-6 highlights various methods for 
producing co-culture models of hepatocytes that incorporate multiple NPCs within the 
model. 
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Figure 1-6 - Schematic of a selection of in vitro co-culture liver models. (A) shows hepatocyte cultures that have been grown on a collagen 
coated surface and then overlaid with NPCs. (B) demonstrates the much-utilised sandwich culture method whereby hepatocytes are cultured 
between two layers of collagen and then subsequently overlaid with NPCs. (C) demonstrates the structural formation of hepatocyte spheroids 
including NPCs. In this conformation there are multiple and direct cell-cell contacts between the parenchymal cells and the NPCs. There are a 
number of methods for culturing hepatocyte spheroids, however it is becoming more common to utilise low-attachment surfaces. (D) 
Sandwich culture whereby NPCs are in direct contact with the hepatocytes and then subsequently sandwiched between two layers of collagen 
matrix. 
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Research has shown that hepatocyte function and stability is improved regardless of 
whether the secondary cells used are primary or not. Bhandari et al. showed that when 
culturing PRH with murine 3T3 fibroblasts, there was a reciprocal relationship whereby 
the cellular interactions in the co-cultures ensured survival and increased stability and 
function of both cell types [46]. Thomas et al. further expanded the work of Bhandari 
and colleagues by producing a co-culture model where activated rat SCs were cultured 
with isolated PRH in a spheroid model [48]. This co-culture spheroid model displayed bile 
canaliculi-like structures, complex ECM within the spheroid and, when compared with 
monoculture spheroids, superior cytochrome P450 functionality.  
Peters et al. were able to demonstrate that PRH co-cultured with rat liver epithelial cells 
displayed higher levels of albumin secretion and the longevity of CYP enzyme activity was 
enhanced when compared to conventional PRH monolayer cultures [92]. It was 
concluded that this co-culture model was the most applicable method for investigating 
cytokine-mediated induction of acute-phase proteins, due to there being a threefold 
increase in fibrinogen secretion in comparison with monolayer cultures.   
Kang et al. produced a model system whereby PRH and LSECs were cultured on the 
opposite sides of a transwell membrane, allowing prolonged viability for a period of up 
to 39 days, as well as the stable presence of hepatocyte-specific differentiation markers 
[93]. Dedifferentiation of primary hepatocytes is a commonly discussed limitation of 
classical in vitro liver platforms. However, the model system developed by Kang and 
colleagues showed that PRH maintain this differentiated status for an extended period 
as verified by mRNA expression of albumin, transferrin, and hepatocyte nuclear factor 4 
[93].   
KCs have been the focus of much research and it is accepted that this NPC plays a role in 
the development of DILI. Jemnitz et al. produced a 2D co-culture model of PRH and KCs 
and concluded that the hepatocyte-KC co-culture model provided a good platform for 
the prediction of chemical hepatotoxic potential [94]. KCs have also been shown to detect 
hepatocyte stress and damage from model hepatotoxins in vitro, leading to the release 
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of cytokines [95]. Hepatocytes cultured in isolation are not able to capture this release 
of inflammatory response, further strengthening the view that co-culture and, in 
particular, co-culture with KCs may increase the sensitivity of in vitro liver models to DILI 
and specific hepatotoxins [95].  
BECs line the biliary tracts and are often targets of liver pathologies such as cholestatic 
liver disease and because of this, BECs have been the subject of much NPC research [15]. 
Auth et al. developed a model where hepatocytes were co-cultured with BECs and 
demonstrated substantially increased protein synthesis and urea production [96]. 
Hepatocytes in isolation exhibited low levels of CYP450 activity; however, in co-culture 
with BECs, CYP450 activity remained stable for up to 3 weeks. Auth and colleagues 
concluded that co-culture of human hepatocytes with BECs restored the synthetic and 
metabolic liver function in vitro [96].  
1.5.4 3D liver microtissues 
1.5.4.1  Spheroids 
3D cultures of hepatocytes and hepatic-derived cell lines is a rapidly developing field, 
whereby researchers and bioengineers endeavour to capture the complexity of the 
microenvironment with a view to improving the liver-specific functionality, longevity and 
relevance of the cultured cells [62]. The recent progress in 3D in vitro liver spheroid 
models may improve the ability to predict hepatotoxicity of novel compounds, in part 
owing to the better recapitulation of the native physiology of the liver [97]. It has been 
shown that the re-establishment of cellular polarisation is critical in maintaining gene 
expression and hepatocyte-specific function [98]. With 2D cultures of hepatocytes 
unable to model the multiple apical and basolateral membranes of the in vivo 
hepatocytes, it is crucial that liver models are capable of restoring this highly-complex 
microenvironment. There are now a number of 3D liver approaches which help restore 
this highly-complex microenvironment including hydrogel [30, 57, 99, 100] and scaffold 
based technologies [101], as well as the production of “hepatospheres” or liver spheroids 
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[102].  For the latter, techniques to produce spheroids have become progressively more 
refined and accessible, and they are being increasingly utilised to assess areas such as 
xenobiotic penetration, metabolism and hepatotoxicity [103]. 
The basic underlying principle for the production of spheroids is that monodispersed cells 
(isolated cells from fresh tissue or cell lines) are capable of reforming a 3D configuration 
via self-reaggregation if adhesion to the substrate in which they are being cultured in is 
prevented [104]. According to the prevalent theory of self-assembly, in the absence of 
external influences, cells will self-organize into a spherical conformation as a result of 
specific local interactions amongst the cells themselves [99]. In conjunction with this, the 
differential adhesion hypothesis (DAH) states that tissues are treated as liquids 
composed of mobile cells whose varying degrees of surface adhesion causes them to 
reorganize spontaneously in order to minimize their free energy [105]. Thus, cells will 
migrate to be near other cells of comparable adhesive capacity in order to maximize the 
strength of the bonds between them. This in turn produces a more thermodynamically 
stable structure [99].   
One of the main advantages of culturing cells in a spheroid is the increased cell-cell 
interactions and cell-ECM interactions when compared to 2D monolayer culture [43]. The 
majority of cells are in close contact with each other and are able to communicate and 
produce their own ECM. Cells within a spheroid have virtually 100% of their surfaces in 
contact with neighbouring cells unlike a 2D monolayer. On this basis, cells in a spheroid 
conformation mimic much more closely the cells natural in vivo-like state. Figure 1-7 
illustrates the differences between monolayer cells and cells grown in a 3D spheroid 
model.   
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Figure 1-7 - Comparison of monolayer cells and cells cultured in a spheroid. (A) 
Monolayer cells become flattened, have very few cell-cell contacts, unlimited access to 
the media as well as ease of waste product expulsion into the media. (B) Proliferative cell 
lines grown within the spheroid have numerous cell-cell contacts, do not become 
flattened and retain an in vivo-like morphology. Cells on the periphery of the spheroid 
proliferate and have greater access to media and can remove waste products easier than 
those cells situated in the centre of the spheroid. These cells have less access to the 
nutrients within the media and less access to oxygen due to an oxygen diffusion gradient. 
Waste products may also accumulate in this central area, and potentially this may cause 
necrotic regions. Over the duration of the culture period, the size of the spheroid can 
increase dramatically. (C) Non-proliferative cells such as PHH/PRH grown within a 
spheroid again have numerous cell-cell contacts and retain an in vivo-like morphology. 
Similar nutrient and solute gradients form within the spheroids. However, as there is no 
proliferative rim, the overall size of the spheroid remains relatively constant over-time, 
reducing the formation of necrotic areas due to hypoxia.   
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A number of hepatic-derived cell lines have been utilised extensively in research 
including; C3A, HepG2, HepaRG and Huh7 [43, 76, 106, 107]. These cell lines are capable 
of forming 3D liver spheroids and the resultant models are most commonly being used 
in the early stages of assessing xenobiotic safety [15]. HepG2 cells cultured as a spheroid 
model show the morphological characteristics of hepatocyte-like cells, as well as the 
formation of bile canalicular-like structures. HepG2 spheroids also exhibit a highly 
compact structure with tight cell-cell interactions [108]. Studies by Li et al. and 
Ramaiahgari et al. have assessed a number of key functional outputs including; (i) cellular 
interactions as shown by E-cadherin, electron microscopy, β1-integrin and β-catenin that 
are indicative of polarity; (ii) epithelial characteristics (CK7/8); and (iii) proliferative 
capabilities (Ki-67) [43, 100]. Wrzesinski and colleagues, along with others, have also 
investigated end points such as albumin and urea production, and metabolic competence 
via CYP activity (CYP1A1, CYP1A2, CYP3A4, & CYP7A1) [73, 76, 100]. These studies have 
conclusively elucidated that spheroids, and perhaps in general, 3D cultures of the HepG2 
cell line show enhanced liver-like functionality when compared to the more traditional 
2D cultures. However, it is widely accepted that with their low metabolic competence 
[15], HepG2 spheroids may be limited in their use as a model for toxicological 
investigations and may underestimate the toxicity potential of compounds [80].  
The formation of bile canalicular-like structures within HepG2 spheroids has been 
increasingly investigated in recent years [100, 109]. Much of the work has shown the 
formation of these structures but further investigation into whether or not they are 
functional in producing bile salts and their subsequent transport is required [15]. It has 
been shown in work previously undertaken with the HepG2 and C3A cell, that there are 
several quantifiably useful end points such as albumin, urea secretion and ATP content 
that can be used to confirm in vitro 3D liver model phenotype lines [43, 108, 109]. 
Recently, Gaskell et al. demonstrated secondary structure functionality in C3A spheroids 
via the transport of 5-chloromethylfluorescein diacetate (CMFDA) by the canalicular 
transporter MRP2 [76]. This line of investigation has yet to be fully characterised in 
primary hepatocyte spheroids and would help strengthen the case that 3D spheroid 
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cultures may be better placed to assess hepatobiliary transporter-based compounds. 
Nevertheless, HepG2 or C3A cells have poor metabolic competencies when compared 
with PHH in 2D and this is one of the main limitations with these commonly used cell 
lines [79]. 
There are a limited number of publications using HepaRG cells in a 3D liver microtissue 
model [15]. However, with the accumulation of studies detailing more comparable 
functionality to that of PHH and improved functionality when compared with the more 
commonly used cell lines such as HepG2 and C3A cells in 2D culture, it is anticipated that 
a 3D HepaRG model may bridge the gap between conventional monolayer cultures and 
in vivo physiology [74, 77, 85, 110]. 
Gunness et al. reported the production of 3D organotypic cultures using HepaRG cells via 
the high-throughput hanging drop method [111]. They were able to maintain the cultures 
for 3 weeks and showed conservation of high liver-specific function for the duration of 
culture via phase I enzymes (CYP3A4, CYP2E1), transporter activity (MRP2), expression 
of liver-specific proteins (albumin, urea) and response to a number of drugs (APAP, 
troglitazone and rosiglitazone). In order to assess whether the 3D HepaRG cultures were 
a more appropriate model to study drug toxicity, 2D HepaRG cultures were set up in 
parallel with the 3D cultures over 3 weeks. 3D HepaRG cultures showed higher sensitivity 
for APAP and troglitazone toxicity, and the 3D cultures maintained high levels of liver-
specific functionality, including phase I enzyme and transporter activity, and also 
production of liver-specific proteins including albumin and urea. These investigators 
therefore suggested that these 3D organotypic HepaRG cultures provide a suitable in 
vitro tool for assessment of drug-induced hepatotoxicity [111].  
HepaRG cells when cultured differentiate into hepatocyte-like cells and biliary-like cells 
and it has been demonstrated that bile canalicular-like structures form throughout 3D 
models [112]. The fact that the HepaRG cell line differentiates into two distinguishable 
cell types means that the resultant cultures are intrinsically co-cultures in nature. 
Compared with the more commonly used hepatic-derived cell lines, HepaRG cells 
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possess many more advantages with regards to specific functional output, formation of 
secondary structures, upregulated metabolic capacity and this makes them much more 
comparable to PHH [77, 86, 113]. 
The main advantage of 3D models, and in particular the spheroid model, is that very few 
cells are required to produce a functional spheroid [15]. For example, we have 
demonstrated that a functional PRH spheroid can be produced from as little as 2000 
cells/well on a 96-well plate (LOT).  
PRH spheroid models are well characterised and have been used since the 1980’s [42]. 
These spheroids have been shown to have a smooth outer surface with numerous pore-
like openings leading to secondary structures shown to be similar to bile canaliculi [41]. 
Cells within the spheroid have also shown polarisation by IHC staining of apical HA4 and 
basolateral HA321 membrane bounds proteins [41], and dipeptidyl peptidase 4 (DPP IV) 
by immunohistochemical staining as an apical membrane marker [114]. Earlier studies 
have focussed on characterising the cellular morphology and polarity in conjunction with 
the formation of bile canaliculi [41, 115]. However, more recent work has involved 
examining intra-cellular interactions and communication along with oxygen 
concentration and gradients throughout the spheroids [109, 116, 117].  
Due to metabolism and uptake of numerous solutes by hepatocytes, the composition of 
blood changes as it flows along the sinusoids from the periportal zone to perivenous zone. 
Concentration gradients of substrates, products and hormones are formed and 
subsequently drive liver zonation [118]. This sinusoidal zonation is extremely important 
to discuss when looking at hepatotoxic potential of xenobiotics. If we look at APAP 
toxicity for example, glucuronidation, the dominant pathway of phase II conjugation at 
high and prolonged APAP concentrations (>5 mM), has been shown to be more rapid in 
perivenous cells than in periportal cells. Prolonged exposure to high concentrations of 
APAP damages perivenous cells expressing higher levels of CYP2E1 than periportal cells 
[119]. This demonstrates that perivenous hepatocytes exhibit increased APAP 
vulnerability and extensive glutathione depletion when compared with periportal cells, 
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and emphasises the importance of being able to recapitulate liver-specific zonation and 
solute gradients in vitro. 
As one of the circulating signals, oxygen plays an important role in modulating zonation 
along the liver sinusoid. The partial pressure of oxygen is approximately 60 to 65 mm Hg 
(84-91 μmol/L) in the periportal blood and falls to about 30 to 35 mm Hg (42-49 μmol/L) 
in the perivenous blood [120, 121]. Research utilising liver spheroids has become 
progressively more interested in the physiological oxygen tension along the sinusoid, 
with increasing focus on trying to experimentally recapitulate oxygen profiles within 3D 
liver models.  
Oxygen demand and concentration throughout the in vitro spheroid models remains an 
interesting topic of research because it is desirable that all the cells remain viable and 
free from necrosis. The literature describes that spheroids with a diameter of greater 
than 150 µm form a necrotic core due to hypoxia and lack of nutrients (see Figure 1-7) 
[32]. For an in vitro model used in cancer medicine for example, necrosis is a desirable 
characteristic because; larger tumour spheroids are characterised by an external 
proliferating rim, an internal quiescent zone, and a necrotic core resembling the cellular 
heterogeneity of solid in vivo tumours [122]. However, for a model that attempts to 
recapitulate the in vivo-like liver microenvironment, this is an undesirable characteristic. 
Being able to determine the oxygen diffusion and consumption within spheroids, and 
using this information to mimic the oxygen profile seen within the liver sinusoid would 
provide a more accomplished model than classic monolayer culture, and a more 
comparable one to that of the liver in vivo. In the field of 3D tumour cell culture, research 
has been dedicated to the quantitative description of tumour vascular networks whilst 
the consideration of oxygen consumption has been largely neglected. Whilst oxidative 
respiration in standard 2D cell culture has been widely studied, this aspect of 
characterisation has been lacking with 3D in vitro liver models [123].  
Sakai et al. demonstrated that PRH cultured as spherical multicellular aggregates 
provided a more useful model than the traditional monolayer culture [109]. Using 
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quantitative polymerase chain reaction (PCR) it was shown that PRH rapidly lost 
expression of a number of liver-specific genes when cultured in monolayer from day 1 to 
day 5. In contrast, PRH spheroid cultures conferred higher levels of expression of these 
liver-specific genes when compared to the monolayer cultures for a period of up to 10 
days. These results suggested that PRH cultured as spheroids acquire intercellular 
organisation that may permit maintenance of metabolic competence [102, 109].   
As outlined previously, PHH are still considered by many to be the gold standard as an in 
vitro tool for DILI and toxicity investigations [37]. Despite the number of limitations with 
primary cells, spheroid systems can be produced from a low cell number, therefore a 
large number of spheroids can be produced from a small fraction of a single liver 
isolation/cell suspension [15]. It is also important to reiterate that hepatocytes isolated 
from different donors display marked variations in gene expression levels, and thus may 
respond differently in hepatotoxicity investigations. However, 3D spheroid culture 
enables the production of spheroids utilising cells from a single donor or pooled 
hepatocytes. The advantage of utilising pooled hepatocytes is that the resultant 
spheroids may better predict average population drug responses and conversely, 
spheroids produced from single donors allows for more direct in vivo variability 
comparisons [124].  
Messner et al. characterised a multi-cell type spheroid system incorporating PHH and 
liver-derived NPCs [125]. This system was shown to be functional for a period of up to 5 
weeks, demonstrating that longevity of the cultures is vastly improved compared with 
the conventional monolayer or sandwich cultures of PHH. Secondary structure formation 
was confirmed in these spheroids via immunohistochemical staining for the apical 
transporters MDR1 and BSEP, demonstrating functional polarisation of hepatocytes 
within the spheroids. In addition, these co-culture spheroids displayed improved 
longevity, stable albumin production over the duration of culture period and with KCs 
showed responsiveness to inflammatory stimuli. In these investigations, Messner and 
colleagues were able to incorporate both the 3D microenvironment and multiple cell 
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types within a single model, producing a more representative in vitro tool for the 
assessment of DILI [125]. These 3D, multicellular models show promise for drug discovery 
investigations as the much improved longevity and viability of the cells will enable the 
assessment of long-term effects of compounds over repeat-dose scenarios; an area 
initially highlighted as a limitation of many of the current commercially available in vitro 
liver models.  
A more recent study carried out by Bell et al. produced PHH spheroids using ultra-low 
attachment plates [126]. Primary spheroids in this instance were cultured for a period of 
up to 5 weeks in serum-free culture medium. Primary spheroids have shown to decrease 
in size over the culture period alongside increasing expression of E-cadherin, suggesting 
that the cells within the spheroid model are becoming more tightly incorporated via 
spheroid compaction [127]. MRP2 staining revealed the formation of bile canaliculi-like 
structures throughout the spheroid body over the 35 day culture period, indicative of 
stable functional polarisation of hepatocytes [126]. A direct comparison can 
subsequently be made between the multi-cell spheroids produced by Messner et al. and 
the monoculture spheroids by Bell and colleagues. Interestingly, both researchers 
demonstrate improved longevity of up to 5 weeks in culture compared to conventional 
models via stable albumin production over the duration of the culture period. This 
demonstrates that co-cultures of NPCs and PHH within this spheroid model may not be 
essential for improving the longevity. However, the co-culture spheroid models with the 
inclusion of KC place themselves well to investigate immune-mediated toxicities, whereas 
a monoculture hepatocyte spheroid model may be inadequate for capturing this specific 
end point analysis. Both models demonstrate preserved hepatic phenotypes and long-
term functionality for investigations into chronic toxicity assays and repeat-dose 
studies. 
There are a number of techniques that have been implemented for the production of 
PHH and PRH spheroids including, spinner vessels and orbitally shaken flasks [35].  
However, limitations of these systems include the inability to control spheroid size, 
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difficulties with manipulation in the lab as well as these systems requiring relatively high 
cell numbers. Scaffold-free systems that allow the formation of size controllable primary 
cell spheroids has currently only been performed using a hanging-drop system as 
described by a Kelm and Fusseneger and the use of ULA plates described by Bell et al. 
[126, 128].  
Sufficient supply of oxygen to the cells is crucial for a functional 3D in vitro model trying 
to recapitulate the liver microenvironment. Primary hepatocytes have a relatively high 
metabolic activity compared with their hepatic cell-line counterparts, and thus, primary 
hepatocytes have a high oxygen turnover which can be up to ten times greater than other 
types of non-proliferative cells [129]. Increased levels of albumin and urea production, 
along with other liver-specific functions have been seen to correlate with higher oxygen 
uptake rates (OUR) of hepatocytes [129]. The idea that increased functional output 
increases the oxygen demand on the cells suggests that, even the basic set up of in vitro 
liver models needs to be accurately determined to allow sufficient oxygen to diffuse 
through the media and into the cells. It also outdates the idea that spheroid diameter is 
the most crucial factor in determining the formation of central necrosis. It is much more 
likely that the combination of specific cellular OUR, along with proliferative 
characteristics and the experimental set up are equally as important.  
1.5.4.2  Scaffold and Hydrogel Technology 
In recent years it has been shown that the cellular microenvironment contributes to the 
spatially and temporally intricate signalling domain that directs cell phenotype, and thus 
the idea that cellular scaffolds serve simply as a vehicle with which to assess the 
expression of specific genes and subsequent functionality has become outdated [57]. 
Tibbitt et al. concluded that a cell can no longer be thought of as a single entity defined 
by its genomic material, but must also be regarded in the context of the ECM, soluble 
growth factors, hormones, and other molecules that regulate organ formation and 
function [57]. It is better understood that the extracellular microenvironment 
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coordinates intracellular signalling cascades that influences phenotype by altering gene 
and subsequent protein expression [130, 131].  
Spheroids can be produced by embedding hepatocytes into non-adhesive hydrogels 
[132]. Spheroids form via the process of cellular self-assembly, and the cells that self-
assemble into spheroids have been shown to achieve increased gene expression and 
retention of the native cell phenotype when compared to 2D cultures [99, 128]. Even 
though spheroids have been shown to form without scaffolds and hydrogels, not all cell 
lines are able to form spheroids via self-aggregation and thus, the 3D microtissue system 
required is heavily dependent on the cell type being utilised [133].   
Lee et al. were able to produce functional encapsulated spheroids using Huh7 cells [107]. 
These encapsulated spheroids were functional for a period of up to 3 weeks and the 
microenvironment in which they were cultured could be adapted depending on the 
stiffness of the hydrogels [107]. In this case, an in vitro model representative of normal 
liver could be generated by utilising low stiffness hydrogels, and cirrhotic liver by 
increasing the stiffness of the gels. Lee et al. also demonstrated that spheroids cultured 
within the low stiffness hydrogels had the highest rates of proliferation, albumin 
secretion and CYP450 expression over the culture period.  
Another way in which hepatocytes can be cultured to mimic the 3D microenvironment is 
the use of scaffolds produced from either natural or synthetic material [15]. Natural 
scaffold systems are thought to allow for biocompatibility with the cells, with the scaffold 
itself mimicking the native ECM and conferring multiple cell-ECM interactions. However, 
these natural liver-derived scaffolds are inherently variable leading to difficulties with 
experimental reproducibility. Decellularised human livers are considered the ideal ECM 
alternative because both the 3D microarchitecture and biological features of the native 
liver are preserved. However, human donor livers are in short supply as decellularised 
scaffolds, and the intrinsic inter-donor differences means that reproducibility of 
experiments can be difficult [134]. This limitation can be overcome with the use of 
synthetic scaffold systems and, similarly to hydrogels, they can be purposely engineered 
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to allow for specific 3D conformations and cell-specific scaffolds [135, 136]. Hepatocytes 
have been shown to have an affinity for galactose residues such that scaffold systems 
presenting galactose on their surfaces allows for improved hepatocyte adhesion leading 
to an improved functional system [137, 138].  
An example of synthetic scaffolds that has been increasingly used within the field of 3D 
cell culture is the Alvetex® (Reinnervate), which has been produced from cross-linked 
polystyrene. This system has been shown to be biocompatible and the manufacturing of 
the scaffold has shown little batch-to-batch variation allowing for more reproducible 
experimental data [31]. The scaffold is engineered into thin (200 µm) membranes that 
are able to fit into conventional multiwell plate plasticware. Knight et al. reported that 
cells seeded on to the scaffold system are able to form close cell-cell interactions and 
cellular differentiation, allowing the formation of thin tissue-like cultures [31]. 
Furthermore, the HepG2 cell line has been shown to have improved liver-specific 
functionality when cultured with the Alvetex® scaffold including higher viability over the 
culture period and the formation of bile canaliculi within the tissue-like cultures [139]. 
Rat hepatocytes have also been cultured using the Alvetex® scaffold system and have 
been shown to retain their native cuboidal morphology along with much improved 
viability when compared with conventional monolayer cultures. These 3D cultures 
display gene expression associated with phase I, II and III drug metabolism under basal 
conditions along with increased sensitivity to APAP toxicity [140].  
One on the main limitations with the hydrogel technologies is that there is poor mass 
transfer of nutrients, oxygen, xenobiotics and cell retrieval is more difficult [15]. Cell 
retrieval difficulties have been previously described by Godoy and colleagues, developing 
the idea that downstream analysis becomes much more challenging with reduced cell 
numbers. This potentially remains a major caveat of hydrogel systems, as altering the 
hydrogel stiffness may impact the ability to dissociate cells from the gels themselves. 
However, with the development of more simplistic methods, the utilisation of non-
adhesive hydrogels reduces cell-substrate interactions, thereby increasing the important 
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cell-cell interactions which are vital for retaining functionality as well as the driving 
process of self-assemble [99]. One of the main advantages of using non-adhesive 
hydrogels for the production of 3D microtissues is that hundreds of spheroids can be 
produced with a single pipetting step. This in turn means that the hydrogel method may 
lend itself to long-term, repeat-dose toxicological investigations [99].  
1.5.4.3  Liver Organoids 
Organoids are 3D culture models in which adult stem cells and their progeny grow and 
are able to recapitulate the natural physiology of the cells in vivo. Organoids have been 
successfully derived from a number of organ systems for both animals and humans [141]. 
“Organoid” is a term that, in the past, was used interchangeable for in vitro spheroid 
models. However, the term organoid refers to “stem cell-derived” self-organising 
organoids [142]. Organoids can be produced from two types of stem cells which include; 
pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) or induced pluripotent 
stem cells (iPSCs), and organ-specific adult stem cells (ASCs) such as hepatic progenitor 
cells (HPCs), which are tissue-specific resident stem cells. Organoid systems have the 
potential to aid in the development of personalised medicine/treatment strategies and 
have previously been utilised to investigate a number of disease models [142, 143].  As 
with hepatic-derived cell lines, 2D culture of PSCs is relatively amenable within the 
laboratory. However, long-term culture of PSCs with maintenance of stem cell 
characteristics is a limiting factor [144]. Additionally, 2D cultures fail to produce in vivo 
cell polarisation and intricate cellular interactions, and cannot recapitulate the complex 
3D microenvironment as seen in vivo [54]. As with hepatic-derived cell lines and primary 
isolated cells, 3D culture of PSCs has become a rapidly developing field in order to 
overcome the limitations of monolayer cultures. Huch et al. developed a 3D culture 
system of HPCs that demonstrated long-term genetically stable expansion (>1 year) [33, 
145]. The organoid models were derived from both Lgr5+ cells (mouse) and EpCAM+ 
(normal human liver) ductal cells. It was shown that the original phenotypic epithelial 
architecture of the cells were maintained and that organoids were differentiated in vitro 
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toward hepatocyte-like and cholangiocyte-like cells [142]. Additionally, upon 
transplantation of the Lgr5+ organoid into impaired mouse livers, this propagated the 
formation of functionally mature hepatocytes [145].  
Takebe et al. demonstrated the formation of vascularised, functional human liver 
organoids from human iPSCs via transplantation of liver buds created  in vitro (iPSCs-
LB) [146]. The researchers were able to show the formation of functional vasculatures 
that stimulated the maturation of iPSCs-LB into tissue that highly resembled the adult 
liver. Metabolically competent iPSC-derived tissue demonstrated liver-specific 
functionality including increased albumin production and human-specific drug 
metabolism [146]. Commercially available iPSCs have also been used as an in vitro tool 
for the assessment of hepatotoxic potential with Sirenko et al. demonstrating this with a 
large number of identified toxic compounds [147]. The researchers used iCell® 
hepatocytes (Cellular Dynamics International [CDI], Madison WI) which are human iPSC-
derived hepatocytes cultured in a 2D multi-well plate platform. The researchers 
demonstrated that high-content automated screening assays using iPSC-derived 
hepatocytes were feasible, and additionally this model provided useful information 
about the potential mechanisms of toxicity. These results suggest that this in vitro liver 
model may be well placed to assess drug and xenobiotic safety. Although this model does 
show promise, it is clear that monolayer cultures of iPSCs are not representative of the 
liver in vivo and the toxic potential of compounds was assessed over a 72-hour period 
only. Generation of 3D iPSCs may allow for repeat-dose of xenobiotics and it would be 
interesting to see the potential of this model in assessing chemicals with unknown 
toxicity and other novel xenobiotics. 
3D organoid systems provide an in vitro platform that is highly representative of the in 
vivo physiology of liver cells, and have developed our understanding of disease 
development and progression. Liver organoids have also demonstrated accurate 
recapitulation of disease pathways in vivo. Although much of the research to date 
concerning liver organoid systems are focused on the developing field of personalised 
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medicine, these 3D in vitro tools position themselves equally to be utilised within the 
field of xenobiotic safety and drug toxicity investigations. PSCs have been shown to be a 
promising model to assess hepatotoxicity in acute treatments, and also in response to 
chronic drug exposure and repeated-dose investigations, potentially overcoming some of 
the shortfalls of more commonly used hepatic-derived cell lines [36, 148]. See Table 2 for 
a summation of the advantages and limitations of the multiple cell types and culture 
platforms that have been described.  
1.5.5  In vitro to in vivo extrapolation (IVIVE) 
We have previously described a number of in vitro cell models. However, it is becoming 
more apparent that quantitative analyses of the various in vitro liver models is necessary 
to aid in demonstrating their potential for hepatotoxicity investigations compared to 
more qualitative measures such as physiological and functional improvements of the cell 
models. Many reviews have detailed improved physiological and metabolic status of 3D 
and co-culture in vitro liver models. However, few have combined this with IVIVE as a 
quantitative classification tool for the different models.  IVIVE refers to the transposition 
of experimental results or data in vitro to predict phenomena in vivo. Extrapolation of 
intrinsic clearance (CLint) measurements using hepatocytes to give predicted in vivo 
clearance (CLin vivo) involves a well-established ‘two-step’ mechanistic approach. Firstly, 
the physiological scaling from cell to whole liver and secondly the subsequent modelling 
of extraction from blood by the liver [15]. There have been a number of investigations 
that have compared in vitro liver model CLint as a means to develop the predictive 
capabilities with regards to xenobiotic safety assessments. 
Suspensions of PRH have been shown to provide a more accurate estimation of CLint rate 
when compared to conventional PRH monolayer cultures [149]. Griffin et al. investigated 
the incubation of seven compounds in both suspensions and monolayer cultures, and 
the CLint was obtained via metabolite formation or substrate depletion analysis [149]. 
However, the main limitation with this in vitro system was that cells rapidly 
dedifferentiated ex vivo in suspension, whereas often the processes of hepatotoxicity 
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manifest themselves over several hours. Therefore, hepatocytes in suspension are unable 
to maintain viability for the time necessary to capture the development of toxicities for 
some xenobiotics. As such the assessment of long-term or repeat-dose investigations 
with this in vitro model will in turn be ineffectual.  
Research utilising rat microsomes, hepatocytes and liver slices have indicated adequate 
accuracy with the aforementioned two-step mechanistic approach [150]. However, more 
recent investigations have demonstrated that rates of drug metabolism and CLint were 
found to be lower in rat liver slices than in isolated rat hepatocytes [151]. Other research 
has indicated that this two-step IVIVE mechanistic approach leads to under-prediction of 
human in vivo clearance when utilising human hepatocytes and microsomes [152].  
Although much of the work to date has particularly focused on suspensions and 2D 
cultures of cryopreserved and primary isolated hepatocytes, more recent publications 
have analysed the prospective competence of the more novel HepaRG hepatic-derived 
cells [153]. Zanelli and colleagues compared intrinsic clearance of 26 drug compounds in 
both cryopreserved hepatocytes and the more novel HepaRG cell line [153]. The CLint of 
the compounds was determined via substrate depletion and the results showed that 
there was a direct correlation of CLint for both cryopreserved hepatocytes and HepaRG 
cells (scaled to whole body) for the range of compounds used.  
Co-culture bioprinted systems have also been analysed to investigate their potential for 
hepatotoxicity studies. An example of this is the Hepregen system which is a collagen 
micro patterned substrate system where hepatocytes are seeded onto a feeder layer of 
a secondary cell type. When compared to human microsomes, and PHH suspensions, the 
Hepregen system allowed for longer incubations with 27 known liver-metabolised 
compounds and was able to generate a greater proportion of the major human 
metabolites normally found in vivo [154].  
Bioreactors and 3D cultures are rapidly becoming incorporated within industry and 
research as improved predictive platforms for xenobiotic safety assessments. Sivaraman 
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et al. demonstrated this by using a 3D bioreactor system to analyse the functionality of 
PRH spheroids [155]. This system was developed as it allowed the formation of 
heterotypic cell interactions, shear stresses via flow, and an in vivo liver-like 
microarchitecture. Toxicity testing utilising this bioreactor system included studies 
showing that clearance rates of compounds with known liver metabolism were 
comparable to those obtained in vivo [49, 62].  
Table 2- Advantages and limitations of cell lines and culture methods used in vitro liver 
models. 
Cell Type Advantages Limitations 
HepG2 Unlimited source of cells. 
Repeatability of experiments is more 
achievable. 
Easy-to-handle in laboratory with 
simplistic culture methods. 
No inter-donor differences. 
Some expression of liver-specific 
enzymes. 
Low metabolic competence and 
rapid loss of expression of liver-
specific enzymes/transporters. 
Loss of cellular polarity.  Absence of 
NPCs.  
 
C3A 
(HepG2/C3A) 
Selected for strong contact inhibited 
growth characteristics. 
High albumin production, alpha 
fetoprotein (AFP) production and 
ability to thrive in glucose deficient 
media. 
Low metabolic competence and 
rapid loss of expression of liver-
specific enzymes/transporters. Loss 
of polarity. 
Absence of NPCs. 
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HepaRG  Improved liver-specific functionality 
when compared with the commonly 
used HepG2 and C3A cells in 2D 
culture. 
More comparable to PHH for phase I 
& II, gene and transporter expression. 
More complex culturing methods 
when compared to more commonly 
used hepatic cell lines.  
Expensive consumables required 
for extended culture periods.  
Primary 
hepatocytes 
(human, rat) 
Improved metabolic competence and 
more physiologically relevant 
compared to hepatic-derived cell 
lines.  
Availability of cryopreserved 
hepatocytes. Full expression of liver-
specific enzymes.  
Good transferability of data for in 
vitro to in vivo models. Historical 
human data for numerous drugs 
allows for direct comparison with in 
vitro models.  
Limited availability for researchers 
and inter-donor variability.  
Short-term culture time. 
Rapid loss of expression of liver-
specific enzymes.  
Difficult isolation and subsequent 
culturing processes.  
Limitations can be partially 
overcome by 3D culturing. 
Stem cell 
based 
approaches  
Stem cells proliferate extensively in 
vitro and can differentiate into 
hepatocytes. This provides a stable 
source of hepatocytes for multiple 
investigations. iPSCs/HPCs have the 
potential to establish genotype-
specific cells, increasing the 
predictivity of toxicity assays.  
Dedifferentiation concerns after 
the long-term culture of PSCs. 
Few thorough investigation in 
toxicological applications. Complex 
reprogramming steps (iPSCs.) 
Variability in phenotype between 
preparations. 
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Potential to develop personalised 
medicine and hepatotoxicity 
investigations.  
Expensive when compared with 
other hepatic-derived cell lines.   
In-vitro 
Approach 
Advantages Limitations 
Monolayer 
cultures  
Simplistic culture methods and low 
set-up costs.  Good repeatability of 
experimental data.  
Can incorporate NPCs improving 
overall functionality and longevity. 
Cannot recapitulate the complex 3D 
microenvironment. 
Lack of in vivo-like cellular 
morphology. Poor gene and 
subsequent protein expression 
profiles. Loss of cell polarity. 
 
Sandwich 
cultures 
Sandwich cultured hepatocytes retain 
more in vivo-like properties, including 
polarised excretory function and 
enhanced morphology and viability of 
hepatocytes compared to monolayer 
cultures. 
Sandwich cultures lack complex 
cellular interactions and the 3D 
microenvironment. The expression 
of genes responsible for many liver-
specific functions decreases over 
time. 
 
Co-Culture Multi-cellular environment with 
direct cell-cell interactions mimicking 
natural environment. 
Positive reciprocal effect with 
improved functionality and longevity. 
Recovery of cellular polarity 
Limited availability of NPCs with 
difficult isolation procedures. 
Batch to batch variability between 
NPCs. 
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Co-culture models can be; 2D, 
sandwich cultures, and 3D cultures 
such as spheroids.  
Differentiation status and viability 
are varied depending on culture 
conditions. 
Scaffold and 
Hydrogels 
Formation of cellular interactions and 
representation of native ECM. 
Improved functionality and sensitivity 
to APAP. Ability to mimic pathologies 
via stiffness variation. 
Limitations with regards to mass 
transfer of oxygen and nutrients. 
Limitations with cell retrieval and 
subsequent analysis. Poor culture 
longevity 
3D Recapitulation of 3D 
microenvironment and ECM 
properties. Well established cellular 
interactions leading to improved gene 
and protein expression. 
Establishment of cellular polarity.  Can 
incorporate NPCs improving overall 
functionality and longevity. 
More complicated methods of 
culture. The literature has 
extensively discussed the formation 
of necrotic regions within 3D 
cellular models due to reduced 
oxygen diffusion to cells within the 
3D mass. 
Spheroids Multicellular environments 
recapitulating native 3D 
microenvironment.  
Cell-cell interactions and natural 
production of ECM. Spheroids can be 
produced with hepatic cell lines and 
primary hepatocytes. 
Maintain liver-specific functionality 
over longer periods of time. 
Enhanced CYP450 and transporter 
expression. 
Spheroids have a limited size due to 
formation of necrotic cores 
(~150μm). Limitations of oxygen 
and nutrient diffusion through 
multicellular aggregates.  
Comprehensive investigation with 
regards to optimal spheroid size for 
specifics cell types has yet to be 
done including cell-specific and 
model-specific OUR. 
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Formation of secondary structures 
(bile canalicular-like structures). 
Cellular polarity is recovered. Along 
with maintenance of native cuboidal 
morphology. 
More work needs to be done to 
improve basis for high-throughput 
system. 
Liver slices  Maintains multicellularity (all NPCs) in 
appropriate proportions and complex 
3D microenvironment.  
Can be incorporated into flow 
systems to allow shear stresses. 
Short term culture periods meaning 
liver slices are unsuitable for 
repeat-dose investigations. 
Specialised equipment and 
technical expertise required. 
 
1.6  Mathematical modelling of the liver 
The majority of earlier studies focussing on mathematical modelling of the liver has 
focused on pharmacokinetic (PK) modelling. This type of modelling can be 
subcategorised in to three distinct groups which are: simple compartmental models, 
physiologically based pharmacokinetic (PBPK) models, and the more recently emerging 
model-independent pharmacokinetic (MIPK) systems. 
1.6.1.1 Compartmental modelling 
Compartmental modelling is a pragmatic, experimentally-derived approach where 
compartments do not necessarily have a distinct physiological or anatomic basis [156]. 
Usually this modelling approach uses single or multiple compartments and although this 
approach is relatively uncomplicated when compared with more complex systems, many 
useful quantities (i.e. Ce, Vd, Cmax etc.) can be determined by comparing large numbers 
of historical and clinical data sets with predicted values [157].  
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1.6.1.2 Physiologically based pharmacokinetic modelling 
The concept of PBPK modelling was first introduced in 1937 by Toerell et al. [158]. PBPK 
models increase the complexity of the simple compartmental modelling approach by 
classifying the aforementioned compartments as specific anatomic spaces [159]. PBPK 
models are also made more complex than the simple compartmental PK models by 
incorporating experimentally-determined organ-to-organ transfer and flow rates along 
with acquired blood and tissue concentration ratios [160]. 
1.6.1.3 Model independent pharmacokinetic modelling 
MIPK modelling is an in silico technique and is based solely on mathematical evaluations 
[161]. MIPK modelling avoids the use of potentially unverified kinetic parameters, and is 
less complex in comparison to PBPK approaches. This approach of mathematical 
modelling provides useful information regarding clearance, adsorption and elimination 
rates etc. However, specific information such as drug distribution cannot be obtained. 
Model-independent systems are sometimes referred to as ‘Black box’ models. This 
approach provides an empirical and stochastic method for the study of complex systems 
[162]. This type of modelling requires assumptions that, while the input concentration 
of a drug to a region (e.g arterial concentrations) and the output concentration from that 
region (e.g venous concentrations) can be measured, the specific features that affect the 
dynamics of drug transport, uptake and extraction within the region are unknown. 
Consequently, the region in question is treated as a ‘black box’. Thus, these simplistic 
methodologies disregard the physiological and physicochemical information [162].  
1.6.1.4 Hepatic clearance modelling  
Mathematical modelling of aspects of the liver has been conducted for decades, with 
much of the literature reporting on metabolic clearance of xenobiotics in the form of 
hepatic drug clearance models [163-165]. Clearance within the liver is described as the 
volume of the perfusing blood that is effectively cleared of drug per unit time [166]. 
Therefore, clearance relates the concentration of drug entering the liver and the rate of 
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drug displacement. Despite the fact that total clearance is defined as the cumulative sum 
of all the eliminating organs of the body, an understanding of hepatic clearance is 
critically important as the liver is the major metabolising site [167].  
Hepatic drug clearance models initially take one of two forms: the “well stirred model”, 
which describes the liver as a well stirred compartment, with the liver concentration of 
the drug in equilibrium with that in the blood e.g. see [168]; and the “parallel-tube” 
model which describes the liver as being composed of a number of identical and parallel 
tubes along which drug concentration decreases progressively in the direction of blood 
flow, due to its elimination by hepatic enzymes [169].  Generally the “parallel-tube” 
model predicts that the steady-state drug concentration following a constant rate oral 
administration increases with an increase in hepatic blood flow [170]. The “well stirred” 
model on the other hand predicts that this parameter is not sensitive to changes in 
hepatic blood flow [170].  
Various assumptions are made for both types of mathematical models. One such 
assumption relates to whether the drug is bound or unbound. Bound drug is associated 
with either plasma or blood cell elements [156]. Typically, these type of models include 
a parameter that describes the ratio of the free concentration of drug to that of the 
bound concentration. This specific parameter is useful as only unbound drug can interact 
with enzymes or target receptors. Also within these models, there are intrinsically 
located eliminating liver enzymes whose activity can be defined  using Michaelis-Menten 
kinetics, namely the maximum velocity (𝑉𝑚𝑎𝑥)  and Michaelis-Menten constant (𝐾𝑚) 
[163]. Michaelis-Menten kinetics describe the concept that increasing the concentration 
of a substrate indefinitely does not increase the rate of an enzyme-catalysed reaction 
beyond a certain threshold. This threshold is reached when, for example, the substrate 
molecules completely saturate the enzyme's active sites [171]. 𝑉𝑚𝑎𝑥 then represents the 
rate of the enzymatic reaction under these conditions. The parameter 𝐾𝑚 introduces the 
idea of the binding affinity of enzymes to specific substrates [171]. It describes the 
substrate concentration at which half the enzyme's active sites are occupied by the 
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substrate. A high 𝐾𝑚 means that a lot of substrate must be present to saturate the 
enzyme, thus the enzyme has low affinity for the substrate. On the other hand, a low 
𝐾𝑚 means that only a small amount of substrate is required to saturate the enzyme, 
indicating a high affinity for the substrate.  
In terms of clearance of a compound in the liver, by Fick's principle, the rate of removal 
of the drug from the blood into the liver (𝑣) is given by the difference between the 
incoming concentrations of drug (𝐶𝑖𝑛) and outflowing drug concentration (𝐶𝑜𝑢𝑡) in the 
blood, multiplied by the hepatic blood flow (𝑄). This loss of drug from the blood is equal 
to the summation of uptake of drug into the liver, the rate of metabolism in the liver, and 
the biliary excretion [172]. At steady state, the net rate of change of drug in the liver is 0, 
and 𝑣 then equals the sum of the rates of metabolism and biliary excretion. Therefore, 
by definition, at steady state hepatic clearance (𝐶𝐿) can be defined as, 
 𝐶𝐿 =
𝑣
𝐶𝑖𝑛
=
𝑄(𝐶𝑖𝑛 − 𝐶𝑜𝑢𝑡)
𝐶𝑖𝑛
= 𝑄𝐸, 
 
(1-1) 
 
 where 𝐸, is the steady-state hepatic clearance ratio.  
Related to this, there is an additional concept that is introduced within these model 
systems referred to as intrinsic clearance (𝐶𝐿𝑖𝑛𝑡). This parameter attempts to measure 
the intrinsic enzymatic activity of hepatocytes, independent of hepatic blood flow and 
binding. Both compartmental modelling approaches, namely parallel tube and well 
stirred models, provide useful information. However, it is clear that for xenobiotics with 
either very high or very low extraction ratios, no distinction can be made between the 
models for clearance with respect to changes in either blood flow, drug binding within 
the blood, or intrinsic clearance [163]. Pang and Rowland concluded that to distinguish 
between these compartmental models, investigations looking at the changes in the 
features of hepatic clearance including hepatic blood flow, drug binding within blood, 
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and intrinsic clearance are required to see how these will affect the extraction ratio and 
clearance of xenobiotics with intermediate extraction ratios [163].  
PBPK modelling has been used to aid the prediction of the pharmacokinetic 
characteristics of xenobiotics in humans and other animal systems via the utilisation and 
implementation of clinical and preclinical data [173]. PBPK modelling has also been used 
to investigate the effects of physiological variables such as age, sex, ethnicity, and disease 
status [174]. PBPK modelling attempts have also been used to assess the risk factors 
associated with multiple drug interactions [175].  
PBPK models have a number of advantages over more simplistic compartmental models 
due to the inclusion of verifiably derived parameters and the ability to alter these 
parameters to represent physiological changes, e.g. perhaps due to disease pathologies 
and even to aid in the prediction of species-species differences. PBPK models provide 
robust estimates for classically described pharmacokinetic parameters such as clearance 
rates etc. and provide a quantitative mechanistic framework by which known drug-
specific parameters can be used to predict the plasma as well as organ concentration–
time profiles over time [156]. PBPK models can also be used for estimating variable 
responses in disease profiles by extrapolating a dose in healthy volunteers to one in a 
disease population by incorporating relevant organ-level specific physiological properties 
that may affect the functionality and dynamics of the target organ [156]. PBPK modelling 
therefore provides a more representative in silico system when compared to classic 
compartmental modelling due to its more representative structure and intensive use of 
experimentally derived data [176].  
1.6.1.5 Modelling oxygen diffusion and consumption 
Pharmacokinetic modelling typically aim at the clinical end of toxicology (i.e. dealing with 
in vivo data and modelling predictions). An alternative approach focusses on in vitro 
modelling aspects, with a particular focus on modelling oxygen diffusion and 
availability/cellular respiration in novel 3D in vitro systems [177, 178]. The supply of 
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oxygen to tissue cultures and the subsequent turnover of oxygen via cellular respiration 
is an extremely important factor to consider when developing new in vitro cellular 
models, and is an extensively underappreciated problem [179] .  
In recent years, oxygen supply has been intensely investigated in microfluidic devices 
[180], alongside the development of extracorporeal devices as a means of treatment for 
acute liver failure (ALF) [181]. The main limitation with the development of in vitro liver 
systems that incorporate fluid flow, such as bioreactor models or even simplistic 
perfusion devices, is the supply of oxygen to the hepatocytes. The main parameter that 
needs to be elucidated for these studies is the oxygen consumption rate (OCR) also 
described previously as the oxygen usage rate, (OUR) by the cultured cells [34, 182]. 
There have been a number of approaches to determine this experimental parameter, for 
a number of culture techniques including conventional monolayer cells, sandwich 
cultures, spheroid models and microfluidic or bioreactor platforms.  
Additionally, there have been numerous approaches for the replacement of liver 
function in patients with ALF, with whole liver transplantation being the most successful 
[183]. One of the more promising approaches that incorporates both in silico modelling 
and in vitro engineering is the development of a bioartificial liver which consists of 
functional hepatocytes cultured within platforms such as hollow fibre bioreactors, or 
microfluidic devices [184, 185]. For example, Rotem and colleagues developed a simple 
perfusion system based on a T-75 cell culture flask where hepatocytes were cultured and 
overlaid with collagen, with specific oxygen inlet and outlet channels and separate 
oxygen sensing probe attachments [181].   
The oxygen concentration at the inlet and outlet channels were determined using an 
oxygen electrode with the average OCR calculated from a simple mass balance equation, 
namely,  
 𝑂𝐶𝑅 = 𝑘(𝑃𝑖 − 𝑃𝑂)𝑄/𝑛 , (1-2) 
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where 𝑘 is the solubility of oxygen under 21% oxygen and atmospheric pressure, 𝑃𝑖 and 
𝑃𝑂 are the measured partial pressures of oxygen at the inlet and outlet respectively, 𝑄 is 
the volumetric flow rate, and 𝑛 is the total amount of cellular DNA (µg) in the T-75 flask.  
In order to determine the effect of the flow rate on the OCR, the researchers also carried 
out a number of experiments were the flow rate was varied between 1 and 8 ml/min. 
This work particularly demonstrated that oxygen can quickly become a limiting nutrient, 
negatively impacting on both the viability of the hepatocytes and the liver-specific 
functionality of the cells. Optimised operating conditions for the in vitro platform are 
therefore imperative for oxygen supply to remain appropriate and within the normoxic 
ranges required by the cells [181].   
Yarmush et al. [186] conducted a similar investigation (implementing equation (1-2) but 
substituting cell number instead of normalising the data to DNA). These researchers 
demonstrated that hepatocyte OCR increased during the first day and then remained 
approximately constant in the sandwich culture for up to 12 days. They further utilised 
the experimentally derived OCR values by developing a simple mathematical model to 
describe the functional response of the hepatocytes to variations in cell densities, depth 
of medium, and external oxygen tensions. The transport and consumption of oxygen 
within the culture dish was described with a diffusion-reaction equation in one 
dimension, namely; 
 
 
𝜕2𝑃
𝜕𝑥2
= 0, (1-3) 
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with boundary conditions, 
 −𝐷
𝜕𝑃
𝜕𝑥
=
𝑉𝑚𝑎𝑥𝜌𝑃
𝑘(𝐾𝑚 + 𝑝)
      𝑎𝑡          𝑥 = 𝛿¸ (1-4) 
 𝑃 = 𝑃𝑠          𝑎𝑡        𝑥 = 0¸ 
 
(1-5) 
where 𝑃 is the partial pressure of oxygen in the liquid media (mmHg), 𝑃𝑠 is the partial 
pressure of oxygen at the gas-liquid interface, 𝐾𝑚 is the partial pressure at which the 
oxygen uptake rate is half-maximal, 𝑉𝑚𝑎𝑥  is the maximal specific oxygen uptake rate 
derived experimentally (OCR), 𝜌  is the cell density, 𝛿  is the depth of liquid, 𝑥  is the 
variable distance from the air-liquid surface to the cell surface, and 𝐷 represents the 
diffusivity of oxygen in the liquid media. 
The results from this model coupled with cell culture observations demonstrated the 
need for optimised culture conditions. For this specific culture platform, cell attachment 
time and variations in media depth, external oxygen partial pressure etc. where shown 
to play a pivotal role in the subsequent functionality of the hepatocytes and their 
longevity. These investigations were consistent with the observations by Rotem and 
colleagues and suggest the requirement of precise and optimised operating conditions 
in order to maintain hepatocyte cellular functionality.  
1.6.1.6 Mathematical modelling of spheroids 
There are a number of notable mathematical modelling examples with regards to 3D 
spheroid systems [177, 187, 188]. A large number of mathematical modelling approaches 
have looked at tumour spheroids, the growth dynamics of the tumour cells, and the 
subsequent effect on drug diffusion and metabolism [177, 188, 189]. The majority of 
these models describe the tumour growth based on mass balance principles for cells and 
reaction–diffusion equations for interacting chemicals, such as growth factors [188]. 
There are a number of considerations that these models take into account such as; 
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tumour cell dynamics including, motility, proliferation and cell death, and they also 
assess the effect these spatio-temporal changes with regards to diffusing xenobiotics or 
particles.  
Byrne et al. provide an in-depth review of how these types of mathematical models 
utilise reaction-diffusion equations to predict the distribution within the tumour of the 
diffusing solute or xenobiotic [188]. Integro-differential equations are often used to 
describe the changes in the tumours volumetric growth rates via proliferation and cell 
death. A number of these models have been able to reproduce experimentally observed 
characteristics such as the three specific zones associated with tumour cell spheroid 
models (e.g. necrotic, quiescent, proliferative, see Figure 1-7). 
Ward et al. describe a mathematical model where the spheroid contains live cells which 
generate volume changes due to specific cellular birth and death events [187]. The 
equations utilised in this model have a multiphase form, with variables for the volume 
fraction of live tumour cells and a volume fraction for cellular material, with a no-void 
condition connecting the two. The authors use a combination of analytical approaches 
(asymptotic) and simulations to study drug dosing of the tumour spheroids. The 
researchers conclude that this modelling approach provides good qualitative agreement 
with experimental observations with regards to the dependence of cell survival on the 
drug dosage and treatment duration and on the initial spheroid size. 
The modelling such as that used by Ward et al. use what is described as a continuum 
approach, i.e. variables track the density of cells rather than the individual cells 
themselves [177, 187]. An alternative approach is known as cellular automaton, where 
the individual cells are tracked rather than the cell densities. An early example of this 
cellular automata modelling approach was constructed by Düchting and Vogelsaenger 
[190], who used it to investigate the effects of both radiation therapy and chemotherapy 
on tumour growth dynamics. More recent publications have implemented cellular 
automata modelling, for example, to investigate the effects of both oxygen and pH on 
tumour growth and morphology [191]. The researchers in this instance placed particular 
 
 General Introduction 
  
70 
 
emphasis on the impact of pH regulatory mechanisms and what effect these had on 
cellular pH gradients and subsequent tumour morphology. Such approaches have been 
applied to spheroids to explore features such as self-aggregation and self-sorting [192, 
193]. The differential adhesion hypothesis (DAH) as discussed previously (1.5.4.1), 
describes how cells will specifically arrange themselves as a result of specific local 
adhesion characteristics. The premise is simple and states that cells with similar adhesive 
capacity will co-localise with cells expressing high adhesion potential sorting to the centre 
of a spheroid, and cells with a lower adhesion potential sorting to the periphery [194]. 
This poses an interesting question with regards to co-culture spheroids produced from 
multiple cell types, as these specific local adhesion potentials may produce a model 
whereby the correct multiplex of cells is present in a 3D microtissue, but not in a 
conformation that allows the specific cell-cell interactions as seen in vivo.    
Although there are a large number of publications within the literature assessing the 
diffusion and metabolism of anti-cancer drugs on tumour cell spheroids, there is limited 
research on the mathematical modelling of liver spheroids produced from non-
proliferative cells such as primary isolated hepatocytes. There are some publications that 
have looked at oxygen diffusion within liver spheroid systems with the most recent and 
notable example of this is by Aleksandrova et al. [178]. These researchers utilise a 
Michaelis-Menten equation to describe the rate of oxygen consumption by the cells and 
assume that the oxygen consumption in the spheroid is constant and equal to 𝑉𝑚𝑎𝑥. For 
the steady state distribution of oxygen in the spheroid the researchers also assume 
spherical symmetry within the model. This mathematical approach was combined with 
experimental cell viability analysis (immunofluorescent viability staining) as a means of 
model validation. I will also look to derive spheroid-specific parameters from my 
experimental characterisation work and implement these values to facilitate a robust 
mathematical modelling prediction of oxygen gradients within the microtissues.  
Spheroids hold potential with regards to improving the representativeness of in vitro liver 
models for the assessment of hepatotoxicity. Conventional monolayer cultures are 
 
 General Introduction 
  
71 
 
unable to replicate a number of the required complexities seen in vivo and therefore their 
utility is limited. Previous mathematical models utilising tumour cells have assessed the 
diffusion distance of xenobiotics and shown that the relatively short diffusional path in 
monolayer cultures is unrepresentative of in vivo tumours. However, spheroid systems 
provide a more realistic in vitro platform where the xenobiotic has to diffuse through 
multiple zones consisting of functionally different cells before localising to the core [194]. 
In vitro and in silico models based on tumour spheroids have also been able to identify 
the effects of micro-architectural characteristics on xenobiotic transport profiles. These 
include cellular compaction (as demonstrated by isolated hepatocyte spheroid models) 
[126], specialised cell-cell junctions [195], and intercellular interactions with high 
interstitial fluid pressure that can provide a physical barrier to limit drug diffusion [196]. 
In order to increase the utility of in vitro and in silico models, it is clear that a reciprocal 
approach whereby in vitro models, either complex bioreactors or microfluidic devices or 
more simplistic 3D culture platforms, are set up with the optimised operating conditions. 
This optimisation step would benefit from mathematical modelling to assess key features 
such as, media flow rates, depth of media, OCR, and the incorporation of tissue-specific 
micro-architectural features that may impact on solute diffusion and subsequent 
metabolism.  
1.7 Biological and mathematical motivation  
As the need for more predictive in vitro liver models increases, emerging 3D and 
bioreactor technologies have started to become increasingly utilised for xenobiotic 
hepatotoxicity assessments [197]. The incorporation of shear stress and fluid-flow in 
bioreactor models and microfluidic devices has been shown to improve functionality as 
described previously [34, 70]. These more complex 3D in vitro models and bioreactor 
technologies have the potential to capture more of the intricate physiological aspects of 
the liver in vivo such as the solute and oxygen gradients of the liver sinusoid, and thus, 
may be able to better recapitulate the microenvironment of the native liver [3]. It has 
become clear that collaborative investigations between tissue engineers, toxicologists, 
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applied mathematicians etc. whereby a more detailed assessment of the in vitro liver 
model set up is analysed, has focused the development of 3D model systems and 
complex bioreactor models. The incorporation of features including the cellular 
microarchitecture, diffusion barriers, growth dynamics, shear stress and fluid-flow etc. 
will enable the further development of both representative in vitro and in silico models. 
While many of these systems show encouraging results, only a small number have 
provided extensive data that demonstrates the added value for hepatotoxicity 
investigations for human liver.  
Industry, along with academia are continually developing a multitude of 3D in vitro liver 
models for toxicological investigations. Prior to these model systems being incorporated 
and utilised for compound screening investigations, a pragmatic schedule of detailed 
evaluation and subsequent validation is needed to show relevant pharmacological and 
toxicological end points. To date, liver organoids and spheroid models in particular show 
good promise for assessment of hepatotoxicity. Furthermore, solute gradients including 
oxygen, have been identified as key physiological characteristics that play a vital 
modulating role for liver zonation and subsequent gene expression and metabolism [118]. 
Recent focus of in vitro liver models has been directed at trying to capture these gradients 
in a physiological fashion [178]. Multidisciplinary approaches in the development of more 
complex in vivo-like models will better aid human relevant translational research and 
yield diagnostic advances that will reduce the risk of hepatotoxic potential at pre-clinical 
and clinical levels. Approaches such as quantitative systems pharmacology will play a 
pivotal role in this development and further comprehension of in vitro model systems 
utilised for xenobiotic safety investigations for researchers and across industry.  
To date, no 3D in vitro liver primary cell model has been fully characterised 
experimentally or optimised to recapitulate sinusoidal oxygen tensions for extended 
culture periods. Liver spheroid systems have been extensively characterised with regards 
to metabolic competence and liver-specific functionality. However, there has been no 
reported system that remains devoid of necrosis for extended culture periods, allowing 
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for potential repeat-dose toxicology investigations. As such, a functional in vitro liver 
spheroid model that remains devoid of necrosis for extended culture periods, and that is 
able to replicate the sinusoidal oxygen tensions as seen in vivo, would provide an 
experimental model to better understand the intricacies of xenobiotic transport, 
diffusion and metabolism in a more representative way. 
1.8 Thesis aims and objectives 
The aim of this thesis is to produce a novel 3D microtissue model that can be cultured 
for extended periods whilst remaining devoid of necrosis. It is hoped that an extensive 
experimental characterisation will show that this model may be suitable for repeat-dose 
assessments during hepatotoxicity investigations. This is of particular interest to 
Syngenta as agrochemical exposure scenarios are inherently repeat exposures, and 
consequently in order to identify and confirm product safety, in vitro and in silico 
modelling approaches need to be representative and suitable to these applications.   
I will employ various mathematical modelling techniques to aid the in vitro model 
optimisation, in order to better bridge the gap between in vitro and in vivo. The key 
outcome from my mathematical modelling is to be able to predict the optimal spheroid 
size that maintains liver oxygen gradients for as long as possible. As experimental 
derivation of these parameters is difficult, I will use the mathematical modelling 
alongside experimental data in order to answer this question. This reciprocal in vitro and 
in silico modelling will as be used to determine key information that will be used to assess 
the appropriateness of the resultant model. In order to make these predictions the initial 
laboratory characterisation work is imperative in order to derive the experimental sizes 
of PRH spheroids and how this changes over time, and also the model-specific oxygen 
consumption rates of the cells. 
1.9 Thesis outline 
In Chapter 1, I critically evaluate a number of culture techniques and cell types that are 
used during the development stages of xenobiotic discovery. In particular I 
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comprehensively describe the multiple in vitro models that are utilised across industry 
sectors, for the evaluation of hepatotoxic potential of compounds. This introductory 
review demonstrates the future potential of spheroid systems in the wider field of in 
vitro liver models, and as a potential high-throughput tool that may be well placed to 
facilitate the screening of early-stage xenobiotics.  
In Chapter 2, I describes an in-depth experimental characterisation of a primary rat 
hepatocyte (PRH) spheroid model. The application of the liquid-overlay technique (LOT) 
coupled with a non-proliferative cell type, namely primary isolated rat hepatocytes, 
results in the formation of a reproducible microtissue model. The 96-well plate format 
lends itself to potential high-throughput and repeat-does investigations. This in vitro 
system replicates the cellular morphology as observed in vivo, exhibiting both structural 
polarisation (demonstrated by F-actin), functional polarisation (as shown via P-gp and 
MRP2 staining), along with active and functional MRP2 transporters. 
Immunohistochemical analysis along with basic histology and transition electron 
microscopy also demonstrates that the spheroid model does not develop central 
necrotic cores.  
Chapter 3 describes the construction of a mathematical model of oxygen diffusion for 
my specific experimental in vitro spheroid system. The model utilises experimentally-
derived OCR values for varying initial seeding cell densities to predict oxygen profiles 
within the spheroids. This model is further developed, and implemented, to derive 
optimised operating conditions for the in vitro model over the duration of an extended 
31 day culture period, to maintain both the periportal and pericentral oxygen tensions 
as observed in the in vivo sinusoid. 
Finally, Chapter 4 describes the development of a mathematical model based on porous 
media modelling to describe the diffusion and transport of various xenobiotics. A 
number of xenobiotics are analysed and multiple physical and chemical properties are 
derived including molecular size and weight, spherical radius, pKa, LogD7.4, etc. The 
model utilises specific experimentally-derived parameters from the characterised 
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spheroid model, including potential barriers to compound diffusion such as, tortuosity 
and volumetric porosity. The model describes how spheroid compaction and potential 
stratification of peripheral cells impacts on the characteristics of paracellular transport, 
and what effect this has on the subsequent transport of xenobiotics.  
Chapter 5 highlights the conclusions of the thesis along with the pertinent novel 
contributions of the work that has been carried out. My extensive experimental 
characterisation provides insight into the morphology and functionality of the 
hepatocytes within the spheroid model, and focuses on the prevention of necrotic 
regions within the spheroids which is a major problem originally highlighted in the thesis 
aims. The results show that the culturing of PRH with the LOT allows for the production 
of an in vitro liver model that remains devoid of central necrotic zones. This result alone 
demonstrates that this model may be better suited for long-term assessments and 
repeat-dose investigations, not only for agrochemicals but also for pharmaceuticals, 
cosmetics, industrial chemicals etc. The use of mathematical modelling has provided key 
information that allows for the culturing of PRH spheroids with specific operating 
conditions, namely the incubator oxygen concentration, that maintains in vivo-like 
sinusoidal oxygen gradients within the spheroids for as long as possible. This novel 
contribution demonstrates that for my specific spheroid model, there is no single optimal 
size/cell seeding density required to capture in vivo oxygen gradients. Also, these results 
help rebut the idea that spheroids larger than 150 µm will become necrotic due to the 
inability of oxygen to diffuse beyond this threshold. This historical literature-derived 
value is too generalised and I suggest that in order to determine optimal spheroid size, 
model specific sizes, oxygen consumption rates and growth characteristics need to be 
taken into account. All of these results demonstrate the added value that could be gained 
from the implementation of the in vitro system for early-stage xenobiotic screening, and 
long-term, repeat-dose investigations.  
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Chapter 2: Characterisation of a functional 
primary rat hepatocyte spheroid model 
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2.1  Introduction  
The determination of xenobiotic safety is crucial and effects numerous industries, such 
as pharmaceuticals, agrochemicals, industrial chemicals, cosmetics and environmental 
contaminants, and therefore robust systems for xenobiotic assessment are required [7]. 
DILI, one of the most common forms of ADRs, is the main reason for the withdrawal of 
xenobiotics from the market [198, 199]. DILI is a common side effect of many xenobiotics 
and is a considerable encumbrance in the field of drug discovery. The reactions involved 
are complicated and often require interactions between the multiplex of parenchymal 
hepatocytes and non-parenchymal cells, such as SCs, KCs and LSECs. DILI represents a 
vast spectrum of manifestations: (i) the impairment of mitochondrial function, (ii) 
inflammation and lethal effects of immune response, (iii) cell death via necrosis and (iv) 
apoptosis, and pathologies including microvesicular steatosis and cholestasis [200]. 
Freshly isolated PHH are currently considered the “gold standard” for an in vitro model 
to assess hepatocyte function and hepatotoxic potential of compounds [201]. However, 
there are a number of limitations to these models including: the absence of the 3D 
microenvironment, failure to capture the complexities of multicellularity, inter-donor 
differences, diminished viability for the study of long-term effects and limited availability 
to all researchers [15]. In addition, PHH rapidly lose liver-specific functionality and 
undergo rapid dedifferentiation [202]. 
In vitro liver models that possess favourable predictive DILI capabilities are therefore 
imperative during the preliminary stages of drug development in order to aid candidate 
selection for early research compounds [203]. Many in vitro liver cell models, including 
2D systems, utilised for xenobiotic safety assessments, suffer from major limitations 
arising from a lack of preservation of physiological phenotype and metabolic competence. 
To circumvent some of these limitations there has been increased focus on producing 
more representative 3D models. It has been shown that culturing primary hepatocytes 
(both human and rat) and hepatic cell lines (C3A, HepG2, Huh7 and HepaRG), in a 3D 
conformation has a profound effect on improving liver-specific functionality, cellular 
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morphology and phenotype, metabolic competence, and toxicological response when 
compared to conventional 2D/monolayer cultures [43, 76, 97].  
There are multiple methods for the generating 3D liver models including hydrogel and 
scaffold based technologies [30, 99], as well as the production of hepatospheres [102] or 
liver spheroids. There are also a number of 3D spheroid culture protocols both for 
monocultures of hepatocytes and cell lines and also cultures including secondary or 
multiple cell types, all of which vary according to individual practices [76, 103, 125, 126]. 
Spheroids have the potential to be used for both long-term and repeat-dose 
investigations, with many platforms allowing for high-throughput analysis for pre-clinical 
and non-clinical investigations.  
One of the main limitations from using a number of these previously described protocols 
such as rocked and spinner flask methods in particular, is that the resultant spheroids 
vary considerably in size. This size variation of spheroids makes the direct comparison of 
results difficult. An additional limiting factor with the implementation of other systems 
such as the specialised hanging-drop method [125], is the cost implications e.g. a 96-well 
plate of InSphero spheroids can cost in excess of £1000. These systems are extremely 
expensive and thus, are not a feasible option to all researchers and industry sectors.  
2.1.1 Aims of experimental characterisation  
The aim of my initial work is to construct a size controllable, 3D hepatic spheroid model 
using freshly isolated PRH by implementing a more cost-effective method for production. 
The liquid-overlay technique (LOT) is used in combination with freshly isolated cells 
whereby PRH cultured using this experimental platform, spontaneously self-assemble in 
to 3D microtissues. PRH are chosen for the production of spheroids because the isolation 
of rat hepatocytes has become a relatively routine procedure with good repeatability of 
experimental results, along with the culture procedures of PRH being well documented 
and characterised. Also, a number of industry sectors (including Syngenta) use rodents 
as model species to investigate the toxic potential of environmental compounds. 
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PRH do not proliferate ex vivo and thus, it is hypothesised that the size of the spheroids 
will remain relatively constant over the duration of the culture period. This is in contrast 
to hepatic-derived, human cell lines that proliferate in vitro and form ‘classic’ tumour-
like spheroids characterised by regions of necrosis.  A scaffold-free protocol for spheroid 
production is implemented to negate the adverse effects of manufactured or 
decellularised scaffolds and other ECM components. These protocols have been shown 
to be reproducible and high-throughput. The experimental procedures subsequently 
described are implemented to fulfil a comprehensive and robust characterisation the 
spheroid structure and functionality. The sizes of spheroids and compaction 
characteristics over the duration of the culture period will be implemented within 
subsequent mathematical modelling as spheroid-specific sizes at certain culture times 
will be extremely important due to previously reported compaction. I will also analyse 
the oxygen consumption rates (OCR) of the spheroids over a number of time points as 
an additional model-specific parameter. This parameter has been identified as crucial for 
my mathematical modelling predictions of oxygen gradients within the PRH spheroid 
system, and unlike previous attempts to model spheroid oxygen gradients, I do not wish 
to rely on literature-derived values as the variation in reported values seems to be 
extensive. I hypothesise that PRH spheroids will display in vivo characteristics including 
direct cell-cell contacts, cellular polarisation, 3D cellular morphology, and formation of 
functional secondary structures throughout the spheroid.  
2.2  Materials and methods 
2.2.1  Production of liquid-overlay plates  
Spheroids were produced using the liquid-overlay technique (LOT) as previously 
described [8]. A solution of 1.5 % agarose (high gelling temperature 42 ± 1.5°C - Sigma 
A3768) in serum-free Williams’ medium E was produced. The solution was autoclaved 
and subsequently, 100 µl of the solution was added to each well of a flat-bottomed 96-
well plate. Plates were left for 30 minutes for agarose to fully solidify. Lids were placed 
back onto 96-well plates and the plates were inverted and stored at 4°C for 2 weeks to 
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allow for appropriate hydration prior to cell seeding. (See Figure 2-1 for experimental 
plate layout for LOT plates).  
 
 
 
 
 
 
 
 
Figure 2-1 Spheroid culture plate layout. Red crosses indicate the wells that were not 
used for culturing spheroids. White circles indicate the cultures spheroids.  
Figure 2-1 shows the spheroid culture plate layout. When culturing the PRH spheroids in 
96-well plates, only the inner 60 wells were used, as the outer wells had inconsistencies 
in spheroid formation and cell density due to a boundary/evaporation effect [204].  
2.2.2  Primary rat hepatocyte isolation and culture 
Hepatocytes were isolated from the whole liver of adult male Wistar rats, weighing 
between 175 -200 g, by a modified two-step collagenase perfusion technique described 
originally by Seglen [205]. Briefly, the rat liver was perfused through the portal vein with 
Ca2+/Mg2+-free HBSS containing 10 mM glucose, 10 mM HEPES, and 0.3 mM EDTA 
followed by HBSS containing 0.05% collagenase type IV (Sigma C5138). The cell 
suspension was spun down at 50 g for 2 min. After three washes, hepatocytes were 
resuspended in Williams’ medium E, supplemented with 10% FBS, 10,000 units/ml 
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penicillin, 10 mg/ml streptomycin, 2 mM L-Glutamine, 10 µg/ml insulin, 5.5 µg/ml 
transferrin, 6.7 ng/ml selenium and 100 nM dexamethasone (this will hereafter be 
referred to as supplemented media) under standard culture conditions. Cell viability was 
determined using the trypan blue exclusion method where 40 µl of the cell suspension 
was transferred to a 0.5 ml Eppendorf tube with 10 µl of trypan blue stain. 10 µl of the 
resultant cell suspension was loaded onto a haemocytometer and cells were counted 
(both total and viable). Isolated cell populations with >85% viability used for the 
subsequent spheroid cultures. 
2.2.3  Spheroid formation  
LOT plates were pre-warmed in an incubator at 37°c for 30 min prior to cell seeding and 
then left to air dry in laminar flow cabinet in order to remove condensation from plate 
lids. PRH were then seeded at 2000, 3000, 4000 and 5000 cells per well (inner 60 wells 
of 96-well plate. See Figure 2-1) in 100 µl of supplemented media. 200 µl of sterile PBS 
was added to the outer wells to create an evaporation barrier. Plates were briefly pulse 
spun in a plate spinner at 100 g for 90 seconds and incubated for 72 hours to allow 
spheroid formation.  After this time, media was changed twice weekly were 50 µl was 
removed and replenished with another 50 µl of supplemented media. Spheroids were 
cultured for up to 31 days. 2000 cells were chosen as the lower limit for PRH spheroid 
formation as determined by previous work, and spheroids did not form with seeding less 
than 2000 cells. Additional seeding densities were chosen to analyse the effect of 
increasing cell number on spheroid diameter, cellular morphology and subsequent 
downstream analysis.   
2.2.4  Phase contrast microscopy   
Spheroid diameter was analysed via light microscopy utilising a phase-contract 
microscope (ECLIPSE TS100/100-F, Nikon). Images were taken at 4x magnification using a 
digital camera head (DS-Vi1, Nikon) and a stand-alone controller and display unit (DS-L3, 
Nikon). The maximum spheroid diameter was measured from these images using in-built 
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microscope software. 3 measurements were taken per spheroid and the average value 
was subsequently derived (n=3 in triplicate). 
2.2.5  Histological analysis  
Spheroids were washed in PBS, fixed for 1 hour in 4% paraformaldehyde (PFA) and 
embedded in 2% agarose (low EEO) in 4% PFA before being subjected to routine 
histological processing and finally paraffin wax embedded. 5 µm sections were cut using 
a Leica RM2235 microtome (Leica microsystems) and stained with Haematoxylin and 
Eosin (H&E). 
2.2.6  Immunohistochemical analysis  
Sections were dewaxed, rehydrated through a series of alcohol dilutions, and 
endogenous peroxidase neutralised with 3% hydrogen peroxide in methanol for 20 
minutes. Antigen retrieval was achieved by using 0.01M Tri sodium citrate buffer (pH 6) 
at high temperature. After blocking with normal goat serum for 20 minutes at room 
temperature, sections were incubated with primary antibodies at a 1:50 dilution for Ki67-
abcam CK19-abcam and cleaved-caspase 3, and a 1:500 dilution for Vimentin, for 1 hour 
at room temperature. Secondary antibody and avidin-biotin complex (ABC) provided with 
Vectastain Elite ABC kit (Vector labs, Peterborough, United Kingdom) were used in 
accordance with the manufacturer’s instructions. Finally, 3¢-diaminobenzidine 
tetrahydrochloride (DAB; Vector labs) was used to visualise peroxidase activity and the 
sections were counterstained with haematoxylin, dehydrated, and mounted in DPX. Light 
microscope images were taken using an Olympus BX51 microscope and Colour view IIIu 
camera with associated Cell^D software (Olympus soft imaging solutions, GmbH, 
Münster, Germany). (Vimentin and cleaved-caspase 3 staining was conducted by the 
Veterinary pathology department, Leahurst campus, University of Liverpool).  
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2.2.7 Ultrastructural analysis of hepatocytes via Transition electron microscopy  
Spheroids were fixed in fresh 2.5% glutaraldehyde in 0.1 M phosphate buffer, overnight 
at 4oC. Spheroids were then washed in 0.1 M phosphate buffer twice with 30 minute 
intervals at 4oC. Secondary fixation was carried out in 2% OsO4 for 2 hours at room 
temperature and pressure (RTP) and then washed in 0.1 M phosphate buffer. 
Dehydration occurred through a graded ethanol series. Infiltration was accomplished by 
a 50/50 mixture of Propylene oxide/Araldite resin. Specimens were embedded in Araldite 
Epon for 6-8 hours at RTP and then placed in fresh Araldite Epon for 48-72 hours at 60oC. 
Ultrathin sections (approximately 70-90 nm) sectioned by Reichert Ultracut E 
ultramicrotome and stained by 3% aq. uranyl acetate and Reynold’s lead citrate for 5 
minutes. Sections were examined using a FEI Tecnai Transmission Electron Microscope at 
an accelerating voltage of 80 Kv. Images were taken using a Gatan digital camera ( Work 
carried out by the Biomedical Sciences Electron Microscopy Unit, The University of 
Sheffield).  
2.2.8 Immunofluorescent analysis of spheroids  
Spheroids were transferred to flat-bottomed 96-well plates, washed three times in PBS 
and subsequently fixed in 4% PFA for 1 hour at 4°C. Spheroid were incubated in a 
permeabilization buffer (0.5% Triton X-100 in Tris-buffered Saline with 0.5% Tween20 
(TBST)) overnight at 4°C and then blocking buffer (0.1% Triton X-100, 3% BSA in TBST) for 
2 hours at room temperature. Primary antibodies P-glycoprotein (P-Glycoprotein 
anitbody [EPR10364-57] ab170904) and Multidrug resistance protein-2 (MRP2 antibody 
(M2III-5) ab15603) were diluted 1:50 in 0.1% Triton X-100, 1% BSA in TBST and spheroids 
were incubated with primary antibodies overnight at 4°C. Spheroids were then washed 
3 times for 1 hour in 0.1% Triton X-100 in TBST and then incubated with secondary Alexa 
Fluor 568 donkey anti-mouse (for MRP2) and Alexa Fluor 568 donkey anti-rabbit (for P-
gp) (Thermo Fisher Scientific) diluted to 1:1000, with Hoechst diluted to 1:5000 and 
Phalloidin 680 diluted to 1:250 in 0.1% Triton X-100, 1% BSA in TBST overnight at 4°C. 
Spheroids were then washed twice for 1 hour in 0.1% Triton X-100 in TBST and then 
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mounted onto a microscope slide with ProLong Gold antifade mountant (Thermo Fisher 
Scientific). Maximum intensity projection images were taken using a Zeiss Axio Observer 
microscope with Apoptome platform using 10x and 40x oil objective. 
2.2.9  Analysis of transporter functionality  
Spheroids were incubated with 5 µM 5-chloromethylfluorescein diacetate (CMFDA-
Thermo Fisher Scientific), a fluorescent cell tracker which has been shown to be cell 
permeable until it is converted by cytosolic esterases into glutathione-methylfluorescein 
(GSMF), an auto-fluorescent substrate that is transported by MRP2 [206]. Spheroids were 
incubated with CMFDA for 2 hours at 37°C. Spheroids were subsequently washed 3 times 
in PBS and prepared for IF as previously described (2.2.8). 
2.2.10 Quantification of albumin production  
Albumin production was quantified in spheroid media supernatant samples using Rat 
Albumin ELISA Kit (Abcam) following the manufacturer’s protocol. Supernatant samples 
were collected 4 days after media changes over the 31 day culture period and stored at 
-80°C until analysis. All incubations were performed at room temperature. Albumin 
standards were prepared and 50 μl added to the wells of a pre-coated 96-well plate, 
along with samples for analysis, and incubated for 1 hour. The plate was washed 5 times 
with 200 μl wash buffer and incubated with 50 μl of biotinylated albumin antibody for 
30 min. The plate was washed as previously described and incubated with 50 μl SP 
conjugate for a further 30 min. Again the plate was washed and incubated with 50 μl 
Chromagen solution for 20 min then 50 μl stop solution added. The absorbance was read 
at 450 nm using a microplate reader (Thermo Scientific Varioskan Flash). The albumin 
concentration in the samples was calculated using values obtained from the standard 
curve and normalised to initial cell number. 
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2.2.11 Quantification of urea secretion 
Urea secretion from spheroid supernatant samples were quantified using a Urea Assay 
Kit (Abcam), according to the manufacturer’s protocol. Supernatant were collected 4 days 
after media changes over 31 days of culture and stored at -80 °C until analysis. Urea 
standards were prepared and 50 μl added to the wells of a 96-well plate, along with 
samples for analysis, and incubated with 50 μl urea reaction mix for 1 hour at 37 °C, 
protected from light. The absorbance was read at 570 nm using a microplate reader 
(Thermo Scientific Varioskan Flash). Urea concentration in the samples was calculated 
using values obtained from the standard curve and normalised to initial cell seeding 
number.  
2.2.12 Oxygen consumption rate analysis    
OCR was analysed using Seahorse XF technology. Seahorse XF technology is a system that 
utilises oxygen sensing probes to determine the rate at which cells are consuming oxygen 
(basal respiration). This system can be used for both monolayer and spheroid systems. It 
is commonly used for analysing extracellular acidification rates; however, it is well suited 
to determine the OCR of our experimental system. Briefly, the sensor cartridge from the 
extracellular flux assay kit was hydrated in XF calibrant at 37 °C in a non-CO2 incubator 
overnight. For spheroid analysis, the Seahorse spheroid microplate was coated with Cell-
Tak (200μl in 2.8 ml 0.1 M sodium bicarbonate), incubated for 1 hour at 37 °C, washed 
twice with 200 μl sterile H2O and left to air-dry. Seahorse medium was prepared using 25 
mM glucose, 2 mM L-glutamine and 1 mM in base medium minimal DMEM (Seahorse). 
The pH was adjusted to 7.4 and warmed to 37 °C. 175 μl Seahorse medium was then 
added to the spheroid microplate and spheroids were transferred into the centre of each 
well, one at a time. The outer wells of the Seahorse culture plates were filled with 175μl 
media and used to calculate background readings (see Figure 2-2  for plate layout). 
Spheroids were incubated for 1 hour in a non-CO2 incubator prior to analysis. Spheroid 
OCR analysis was then performed using Seahorse XFe96 Extracellular Flux Analyser and 
Wave software which analyses OCR. Data was analysed using Seahorse XF Test Report 
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Generator and data normalised to initial cell seeding number. A minimum of 6 spheroids 
was analysed for each experiment. 
 
 
 
 
 
 
 
 
 
 
Figure 2-2– Seahorse plate set-up for spheroid OCR analysis. All outer wells of the 
seahorse spheroid plate were used as background readings. 2000-cell spheroids were 
transferred from culture plates to seahorse plates in lanes 2B-G, 3B-G, 10B-C and 11B. 
3000-cell spheroids in lanes 4B-G, 5B-G, 10D and 11C-D. 4000-cell spheroids were in lanes 
6B-G, 7B-G, 11E and 10E-F. 5000-cell spheroids were in lanes 8B-G, 9B-G, 10G and 11F-G. 
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2.3  Results  
2.3.1  Optimisation for size-controllable spheroid production  
In the initial stages of experimentation I compared spheroid formation utilising two 
different techniques; the LOT and ultra-low adhesion (ULA) plates. It was noted that 
spheroids grown on the ULA plates had an irregular morphology in comparison to those 
grown utilising the LOT. ULA spheroids were also less spherical, not as compact and had 
a less well-defined membrane around the periphery of the spheroids (see Figure 2-3). All 
further experimentation was carried out on spheroids that had been produced using the 
LOT.    
 
 
 
 
 
 
 
 
 
Figure 2-3- Formation and morphology of spheroid produced using the liquid-overlay 
technique (LOT) or ULA plates for different initial seeding cell numbers. Figure 2-3 shows 
phase-contrast images (4x magnification) of spheroids produced using 2000, 3000, 4000 
and 5000 PRH cells at day 3 and day 7. Scale bar = 200 µm. 
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2.3.2 Effect of initial cell seeding number on spheroid size and morphology 
To determine how the number of PRH initially seeded affected spheroid morphology and 
size, spheroids were produced by seeding 2000, 3000, 4000 and 5000 cells and 
monitored over 31 days. The initial seeding density resulted in spheroids of varying sizes, 
with all cells initially seeded aggregating to form one uniform single spheroid within 3 
days. Spheroids produced from the seeding of 2000 cells reduced in diameter over the 
31 day culture period from 353 ± 18.95 μm to 212.5 ± 22.36 μm. 3000 cell spheroids 
reduced in diameter over the culture period from 400 ± 15.38 μm to 256 ± 14.56 μm, 
whilst 4000 and 5000 cell spheroids reduced in diameter of the culture period from 423 
± 21.91 μm to 276 ± 20.3 μm and 467 ± 26.46 μm to 278 ± 20.64 μm, respectively. All 
spheroids remained relatively uniform in shape over the duration of the 31 day culture 
period (Figure 2-4 (A)). Figure 2-4 (B) shows the mean diameter of PRH spheroids plotted 
against culture time. Linear regression analysis was used to produce best fit lines.  
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Figure 2-4 - Effect of initial cell seeding density on spheroid size and morphology. 
Spheroids were produced from seeding 2000, 3000, 4000 and 5000 PRH per well in 100 
µl complete Williams’ medium e and cultured for up to 31 days. (A) phase-contrast images 
of spheroids taken at time points (3, 7, 11, 18, 21, 28 and 31 days). Scale bar = 100 µm. 
(B) compaction of spheroids / reduction of spheroid diameter over 31-day culture period. 
Data are represented as mean ± standard deviation (n=3 in triplicate). Straight lines 
represent linear regression analysis using Graphpad Prism. The R2 values for linear 
regression lines were 0.96, 0.96, 0.95 and 0.97 for 2000, 3000, 4000 and 5000 cell 
spheroids respectively.  
A 
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2.3.2.1  Statistical analysis of spheroid compaction. 
 
Figure 2-5 – Statistcal analysis of spheroid compaction over culture time. There was a 
time dependent decrease in spheroid diameter up to 31 days in culture. Figure 2-5 (A) 
describes the decrease in spheroid diameter for 2000-cell spehroids, (B) for 3000-cell 
spheroids, (C) for 4000-cell spheroids and (D) for 5000-cell spheroids. For 2000-cell 
spheroids, days 18, 21, 28 and 31 were considered statistically significantly smaller when 
compared to day 3. All other spheroid diameters for 3000, 4000 and 5000-cell spheroids 
were considered statistically significantly smaller compared to day 3 spheroids,  by One-
way ANOVA *P value <0.05 and ***P value <0.001. 
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2.3.3 Histological analysis of spheroids 
Haematoxylin and Eosin (H&E) staining was performed on spheroids with an initial cell 
seeding density of 5000 cells over 21 days of culture to assess cell morphology and 
cellular arrangement (Figure 2-6).  H&E staining revealed a compact internal cellular 
arrangement with a defined outer perimeter of cells. Cells within the spheroid had close 
cell-cell interactions, however, the outer perimeter of cells increased in thickness over 
the duration of the culture period (See Figure 2-7 for statistical analysis). It was also noted 
that over the duration of the culture period, staining consistent with the formation of 
central areas of necrosis was not observed. As previously mentioned, it was also noted 
that spheroids were encapsulated by an uninterrupted cell layer at the periphery (Figure 
2-8). It is entirely possible that these cells may represent the mesothelial cells lining the 
external surface of the liver in vivo similar to the Glisson membrane as previously 
described [42] . 
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Figure 2-6 – Spheroid internal structure and morphology. Spheroids were created on liquid-overlay plates seeded at 5000 cells per well in 
100 µm and fixed at day 3,7,11,18, and 21 of culture, paraffin embedded, sectioned and stained with H&E. Green arrows indicate cell nuclei 
(purple staining), yellow arrows show vacuoles within the spheroids, and intense pink staining indicates cell cytoplsm (eosinophilia).  Images 
represent mid-sections through the spheroids at 40x magnification. Scale bar = 50 µm.
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Figure 2-7 - Graph describing spheroid cell perimeter thickness. ImageJ was used to 
quantify cell-perimeter thickness over time. There was a time dependent increase in cell 
perimeter thickness up to 21 days in culture. For the calculation, six areas along the 
perimeter were measured per spheroid. All spheroid cell perimeters were considered 
statistically significantly thicker compared to day 3 spheroids by One-way ANOVA **P 
value <0.0022 and ****P value <0.0001. 
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Figure 2-8 – Encapsulated spheroid morphology at the microtissue boundary. (A) a 
photomicrograph of the edge of a H&E stained section of a 200 µm rat liver cell spheroid 
at day 11 [42], and (B) a phase contrast image of a H&E stained, 5000-cell PRH spheroid 
at day 11 (40x magnification), showing the presence of elongated cells forming an 
encapsulated spheroid with a distinct boundary. Arrows show elongated cell nuclei within 
peripheral cells. Scale bar = 35 µm and 100 µm respectively. 
 
2.3.4  Nuclear staining of spheroid sections 
The internal structure of the spheroids was analysed using immunofluorescent analysis. 
This was conducted to assess the viability of cells within the spheroids. Sections cut at 5 
µm thickness from 5000-cell spheroids were stained with Hoechst over 21 days of culture.  
Nuclear staining was visualised to assess cellular arrangement within the spheroid 
(Figure 2-9). Sections from the same blocks as in Figure 2-6 were analysed for direct 
comparison. H&E stained sections displayed some areas of intense eosinophilic staining 
and subsequently made nuclear staining difficult to determine. Immunofluorescent 
analysis was required to better visualise nuclear staining and cellular arrangement within 
A B 
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the spheroid over the culture period. DAPI stained sections revealed viable central 
hepatocytes and no presence of a necrotic core.
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Figure 2-9 - Cellular morphology and nuclear distribution within spheroids. Spheroids were created on liquid-overlay plates from 5000 cells 
per well and fixed at day 3, 7, 11, 18, and 21 of culture, paraffin embedded, sectioned and stained with Hoechst to stain for cell nuclei. Images 
represent mid-sections through the spheroids at 20x magnification. Scale bars = 100 µm.
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2.3.5 Immunohistochemical analysis 
The internal structure of the spheroids was analysed using immunohistochemical analysis 
(IHC). These experiments were conducted to determine if there were multiple different 
cell types present within the spheroids and to assess cellular phenotypes. CK19 staining 
was performed on spheroids with initial cell seeding number of 5000 cells over 11 days 
culture period, as a specific stain for biliary epithelial cells (BECs) (Figure 2-10). This was 
done to assess if there was a secondary cell type present from the initial hepatocyte 
isolation procedure that may have been forming this encapsulated boundary. Positive 
control slides were produced from pancreatic ductal carcinoma samples which have been 
shown to highly express CK19. CK19 staining showed negative staining for this BECs 
marker within the spheroid samples. 
 Ki67 staining was performed on spheroids with initial cell seeding number of 5000 cells 
over 11 days culture period to assess the potential proliferative characteristics of the cells 
encapsulated at the boundary (Figure 2-11). This was done to assess if there was a 
proliferative cell type present from the initial hepatocyte isolation procedure that may 
have been forming this encapsulated boundary. Positive control slides were produced 
from breast carcinoma samples which have been shown to highly express Ki67 (Sheffield 
Diagnostic Oral Pathology department). Ki67 staining revealed negative proliferative 
characteristics of these boundary cells and similarly throughout the entire microtissue.   
Vimentin staining was performed on 5000-cell spheroids over 21 days of culture. 
Vimentin has been shown to positively stain for mesothelial cells and as such this stain 
was chosen to determine whether or not the cells on the boundary of the spheroids 
where mesothelial in phenotype (Figure 2-12). Positive control slides were produced 
from rat liver sections which stained positively for mesothelial cells throughout the tissue 
but also specifically at the boundary of the samples indicating the presence of this 
mesothelial lining. Vimentin staining showed positive staining over the culture period for 
mesothelial cells, however, this staining was increasingly constrained to the peripheral 
cells within the spheroids as the culture time increased.  
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5000-cell spheroids where additionally stained over 21 days of the culture period with 
cleaved-caspase 3 which is an apoptotic cell marker (Figure 2-13). This staining was done 
to assess the presence of cell death and as a means to support the findings of the 
histological analysis whereby I assert that PRH spheroids are devoid of the central 
necrotic core. Positive control slides were produced from rat liver sections. Cleaved-
caspase 3 staining showed some cell death at early culture time (apoptosis). However, 
later samples showed negative staining for apoptosis within the spheroids.  
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Figure 2-10 – CK19 staining for boundary cell characteristic analysis. Spheroids were 
created on liquid-overlay plates from 5000 cells per well and fixed at day 3, 7 and 11 of 
culture, paraffin embedded, sectioned and stained with CK19. Slides were counterstained 
with haematoxylin (blue) to stain for cell nuclei. Intense brown staining shows the 
presence of CK19. Images represent mid-sections through the spheroids at 20x 
magnification. Scale bars = 100 µm. 
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Figure 2-11 – Ki67 staining for boundary cell characteristic analysis. Spheroids were 
created on liquid-overlay plates from 5000 cells per well and fixed at day 3, 7 and 11 of 
culture, paraffin embedded, sectioned and stained with Ki67. Slides were counterstained 
with haematoxylin (blue) to stain for cell nuclei. Intense brown staining shows the 
presence of Ki67. Images represent mid-sections through the spheroids at 20x 
magnification. Scale bars = 100 µm.
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Figure 2-12 - Vimentin staining for boundary cell characteristic analysis. Spheroids were created on liquid-overlay plates from 5000 cells per 
well and fixed at day 3, 7, 11, 18 and 21 of culture, paraffin embedded, sectioned and stained with Vimentin. Slides were counterstained with 
haematoxylin (blue) to stain for cell nuclei. Intense brown staining shows the presence of mesothelial cells. Images represent mid-sections 
through the spheroids at 20x magnification. Scale bars = 100 µm.
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Figure 2-13- Cleaved caspase 3 staining for analysis of apotptotic cell death. Spheroids were created on liquid-overlay plates from 5000 cells 
per well and fixed at day 3, 7, 11, 18 and 21 of culture, paraffin embedded, sectioned and stained with cleaved-caspase 3. Slides were 
counterstained with haematoxylin (blue) to stain for cell nuclei. Brown staining shows the presence of apoptosis. Images represent mid-
sections through the spheroids at 20x magnification. Scale bars = 100 µm.
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2.3.6 Ultrastructural analysis of hepatocytes 
Cellular ultrastructure was analysed utilising transition electron microscopy (TEM) analysis. Upon spheroid formation (day 3), TEM images 
showed characteristic hepatic ultrastructures, and specialised intracellular adherent junctions could be seen clearly at day 7. Images were 
taken using a Gatan digital camera. 
 
 
 
 
 
Figure 2-14 - Ultrastructural features of a 5000-cell spheroid by transmission electron microscopy (TEM) at day 3 of culture. (A) shows the 
presence of characteristic hepatic ultrastructures. Both glycogen vesicles (Gl) and granular glycogen (G) were abundantly expressed, as well 
as bile canaliculi (B) forming throughout the spheroid. The PRH spheroids display a large quantity of metabolism-related organelles; including 
mitochondria (M), rough endoplasmic reticulum (rER), peroxisomes (P), and evidence of endocytosis or exocytosis (indicated by black arrow). 
There was also presence of tight junctions (Tj), indicating hepatic cell-cell interaction throughout the spheroid. (B) shows the presence of 
glycogen (G), desmosomes (D) and specialised intracellular adherent junctions (Tj). The paracellular space between the two hepatocytes was 
analysed using ImageJ software to estimate the pore radius (𝒓𝒑). Scale bar = 1 µm and 0.5 µm respectively.
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2.3.7 Cellular polarisation in spheroids 
This experiment was conducted to analyse the formation of cytoskeletal components and 
ECM properties within PRH spheroids. The internal structure of spheroids was analysed 
by immunofluorescence (IF) utilising phalloidin (red) to stain for F-actin and Hoechst 
(blue) as the standard stain for cell nuclei. Visualisation was performed by confocal 
microscopy (Figure 2-15). Upon spheroid formation (day 3), F-actin filaments can be seen 
to form throughout the spheroid and at day 21, F-actin structures can be seen to remain 
throughout the spheroid body creating an intricate network. F-actin staining 
demonstrates the cuboidal morphology of the cells within the spheroid. 
  
Figure 2-15 – Formation of cytoskeletal F-actin throughout spheroids. 5000-cell 
Spheroids were cultured on liquid-overlay plates for 3 days (A) or 21 days (B), fixed and 
stained with phalloidin (red) to stain F-actin and Hoechst (blue) to stain the cell nuclei. A 
single plane snap shot was taken for (A) at 10x magnification whilst a maximum intensity 
projection image was taken for (B) at 40x magnification. Scale bars = 100 µm and 20 µm, 
respectively. 
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2.3.8  Secondary structure formation in spheroids 
 Secondary structure formation (structural polarisation of hepatocytes) was determined 
via IF analysis. P-gp and MRP2 transporters are isolated to the apical/canalicular 
membrane of polarised hepatocytes. The expression of these two canalicular 
transporters was analysed to affirm the structural polarisation of the PRH within the 
spheroid and to confirm the formation of bile canalicular-like structures. Spheroids were 
analysed for up to 18 days for P-gp expression (Figure 2-16). The staining pattern of the 
P-gp transporter was consistent with the staining seen with the phalloidin (Figure 2-15). 
The secondary structures could be seen forming from day 3 of culture until at least day 
18.  
 
Figure 2-16 – P-gp staining of bile canalicular formation throughout spheroids. 5000-
cell Spheroids were cultured on liquid-overlay plates for 3 days (A) or 18 days (B), fixed 
and stained with P-gp (green) and Hoechst (blue) to stain the cell nuclei. A single plane 
snap shot was taken for (A) at 10x magnification whilst a maximum intensity projection 
image was taken for (B) at 40x magnification. Scale bars = 100 µm and 20 µm respectively. 
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Spheroids were analysed for up to 11 days for MRP2 expression (see Figure 2-17). This 
figure demonstrates the co-localisation of the canalicular transporter MRP2 (green) with 
the cytoskeletal F-actin (red) resulting in the yellow overlay image.  
 
Figure 2-17 – MRP2 staining of bile canalicular formation throughout spheroids. 
Spheroids were cultured on liquid-overlay plates for 7 days, fixed and stained with 
pahlloidin (red), MRP2 (green) and Hoechst (blue) to stain the cell nuclei. 16 maximum 
intensity projection images were taken for Figure 2-17 at 40x magnification using a Zeiss 
Axio Observer microscope, and stitched together utilising a moving platform. Scale bars 
= 100 µm. 
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2.3.9  Analysis of transporter functionality   
Functionality of secondary structures was assessed using a fluorescently labelled dye. 
Spheroids were incubated with 5 µM 5-chloromethylfluorescein diacetate (CMFDA-
Thermo Fisher Scientific) for 1 hour (Figure 2-18). Spheroids were washed in PBS and 
prepared for IF as previously described (2.2.8). PRH spheroids exhibited some limited 
retention of CMFDA substrates within the cell cytoplasm, but also and an accumulation 
and co-localisation of the CMFDA substrates within the secondary bile canalicular-like 
structures, shown by MRP2 staining (white) and complementary F-actin staining (red). 
 
Figure 2-18 – Functional transport of CMFDA by MRP2 into secondary structures. 
Spheroids were cultured on liquid-overlay plates for up to 21 days. 5000-cell spheroids 
were cultured on liquid-overlay plates for up to 21 days. Spheroids were incubated with 
CMFDA (green) for 1 hour, fixed and then stained with MRP2 (white), phalloidin (red) (to 
stain F-actin) and Hoechst (blue) to stain the cell nuclei. A maximum projection image 
was taken for at 40x magnification. White Arrows represent the overlay of the 
canalicular-like structures and substrate along with F-actin indicating co-localisation 
within the secondary structures. A Zeiss Axio Observer microscope was used for both 
images. Scale bars = 20 μm.  
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2.3.10  Urea quantification  
In order to assess hepatocyte functionality, both urea and albumin secretion was 
analysed as these end point analyses are demonstrative of liver-specific functionality. 
Urea synthesis from 5000-cell spheroids was quantified over 28 days of culture (Figure 
2-19). Urea synthesis decreased from 10.71 ± 1.79 nmol/μl to 1.32 ± 0.42 nmol/μl for 
5000-cell spheroids from day 3 to day 11. Urea synthesis was at its lowest at day 11 for 
the 5000-cell spheroids but then increased over time to 2.63 ± 0.52 nmol/μl at day 28 of 
culture.  
 
Figure 2-19 – Urea synthesis in the spheroids. Spheroids were produced from on liquid-
overlay plates. Urea secretion was quantified in 5000-cell spheroid supernatant samples 
and plotted again culture time (days). Data are represented as mean ± SD (n=3 in 
triplicate). Urea production was considered statistically significantly lower for all other 
time points compared to day 3 by One-way ANOVA, *** p<0.001.  
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2.3.11  Albumin quantification  
Albumin production from the 5000-cell spheroids was quantified over 28 days of culture 
period (Figure 2-20). Albumin production initially decreased but stabilised and then 
increased over the culture period. Albumin production decreased from 146.02 ± 17.48 
ng/ml to 64.14 ± 17.62 ng/ml from day 3 to day 11. From day 11 until day 28, albumin 
production steadily increased from the observed low of 64.14 ± 17.62 ng/ml to 175.23 ± 
42.02 ng/ml. 
 
Figure 2-20 – Albumin production from spheroids. Spheroids were produced from 5000 
cells on liquid-overlay plates. Albumin production was quantified in supernatant samples 
over a 28 day period. Data are represented as mean ± SD (n=3 in triplicate). Albumin 
production was considered statistically significantly lower for day 7 and 11 time points 
compared to day 3 by One-way ANOVA, ** p<0.01, * p<0.05.. There was no statistically 
significant difference in albumin production between day 3 and day 18, 21 or day 28.  
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2.3.12 Oxygen consumption rate analysis 
The oxygen consumption rate of spheroids was analysed at day 7 and day 11 (Figure 2-21). At day 7, 2000-cell spheroids had an oxygen 
consumption rate of 0.0189 ± 0.0039 mol s-1 m-3 and this decreased to 0.0133 ± 0.0018 mol s-1 m-3 by day 11. For 3000- and 4000-cell spheroids, 
OCR decreased from 0.0132 ± 0.0028 mol s-1 m-3 to 0.0157 ± 0.0038 mol s-1 m-3, and 0.0140 ± 0.002 mol s-1 m-3 to 0.0133 ± 0.0018 mol s-1    
m-3 respectively from day 3 to day 11. Finally, 5000-cell spheroid OCR increased from 0.0051 ± 0.0018 mol s-1 m-3 on day 7 to 0.012 ± 0.0017 
mol s-1 m-3 by day 11. 
 
 
 
 
 
 
 
 
Figure 2-21 – The oxygen consumption rate (OCR) of spheroids was quantified in live spheroids on day 7 and 11 of culture. Data are 
represented as mean ± SEM (n≥6). Oxygen consumption rate was considered statistically significantly lower for 4000- and 5000-cell spheorids 
at day 7 when compared to 3000-cell spheorids by One-way ANOVA, * p<0.05. There was no statistically significant difference in oxygen 
consumption rate between 2000-, 3000-, 4000- and 5000-cell spheroids at day 11 of culture.
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2.4 Chapter discussion  
Previous research has shown 3D liver spheroids to be an improved in vitro model when 
compared with 2D cultures [43, 76, 109], so much so that there are now a number of 
companies that sell ‘ready-made’ spheroids as platforms for xenobiotic toxicity 
assessments [125]. Hepatocyte spheroid models have been shown to maintain liver-
specific functions for extended periods of time in culture [81, 126]. However, some of 
the key characteristics previously discussed needed to be evaluated more 
comprehensively. This more extensive characterisation represented an area that required 
more attention within the field of in vitro liver models. In particular, functional 
polarisation of primary hepatocytes within liver spheroid systems was an area that 
required more in-depth investigation.  
In this study, I have developed a cost-effective and reproducible method for producing 
PRH spheroids. PRH used in combination with the LOT had not previously been 
investigated. However, much interest had previously been given to the hanging-drop 
method, as implemented by Messner et al. [125], and the utilisation of ready-made ULA 
plates [126]. PRH were chosen because primary cells demonstrate a number of inherently 
advantageous characteristics when compared to the more utilised hepatic derived cell 
lines. 
Firstly, primary cells do not proliferate ex vivo and as an initial hypothesis, it was 
speculated that the resultant spheroid sizes would be more stable when compared with 
a proliferative hepatic cell line. It has previously been reported that C3A 
hepatocarcinoma cells display contact inhibited growth characteristics when compared 
with their parent HepG2 cells and as a result do not proliferate to the same extent when 
cultured in a spheroid conformation [73]. However, histological and image analysis has 
demonstrated that the C3A cells within the microtissue do proliferate considerably over 
the duration of the culture time to the point where extensive areas of necrosis form [76]. 
The formation of necrosis within 3D liver models over extended culture periods is one of 
the key difficulties that remains to date.  
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The literature has previously reported that the physiologically occurring oxygen gradient 
was considered to be crucial for zonation within the liver lobule [118]. However, more 
recent investigations have reported that the oxygen gradient within the liver lobule is a 
regulator of zonation [12]. This is important when discussing the formation of necrotic 
regions within 3D liver models as this apparent lack of oxygen diffusion throughout the 
entirety of the microtissue will inevitable negatively impact on the zonated properties of 
the 3D model, as well as gene expression and subsequent functionality.  
Within the liver lobule blood coming from the portal triad flows through the sinusoids to 
the central vein. Due to uptake, metabolism and elimination of xenobiotics along the 
sinusoid, the composition of this blood changes. Gradients of substrates, and in particular 
oxygen, are formed as a result. Consequently, there has been a drive in recent years to 
produce viable long-term 3D liver models that remain devoid of necrosis throughout the 
entirety of the culture period. With this in mind, I have conducted experimental ORC 
analysis in order to parametrise my mathematical model for the investigation of oxygen 
gradient formation with PRH spheroids. These experimentally-derived values along with 
spheroid growth characteristics will be invaluable to validate my in silico approach.  
Phase contrast imagery (Figure 2-4) demonstrated that over the course of our culture 
period the spheroid diameter decreased in size. The literature has reported this 
phenomenon previously with other primary isolated spheroid cultures [127] and up-
regulation in key ECM components and cytoskeletal elements such as E-cadherin and 
beta-1 integrin etc. have been attributed to this observation. Histological analysis (Figure 
2-6 and Figure 2-8) demonstrated the compact morphology of the hepatocytes within 
the spheroids and highlighted tight cell-cell interactions comparable with the 
morphology hepatocytes exhibit in vivo. This is in contrast with conventional monolayer 
cultures whereby the cellular morphology is altered to a flattened state, and cells have 
relatively few cell-cell and cell-ECM interactions. This has previously been reported for 
HepG2 spheroids and monolayer cultures by Li et al. [43]. Our PRH spheroids show no 
visible sign of the characteristic central necrotic zones often observed in multicellular 
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tumour spheroids. This may be partly due to the non-proliferative properties of primary 
hepatocytes ex vivo.  
The literature has previously reported that spheroids with a diameter greater than 150 
µm form necrotic cores due to hypoxia and lack of nutrient penetration [32]. However, 
little quantitative research has focused on the factors and specific conditions that may 
contribute to the formation of these necrotic zones. These factors may include the cell 
type being cultured, the initial size of the spheroids upon formation, the specific oxygen 
consumption rate (OCR) of the cells and the culture conditions themselves. A much more 
robust analysis of these factors required for the adequate characterisation of 3D liver 
microtissues and its applications are needed. It is for this reason that in Chapter 3 I will 
focus on answering this question applying a number of the experimental parameters 
taken from this initial characterisation work. Although I was unable to investigate 
necrotic markers specifically in my PRH spheroids, immunohistochemical analysis with 
cleaved-caspase 3 (Figure 2-13) confirmed small areas of apoptotic cells at early time 
points such as day 3, however, there were no central regions of necrosis within the PRH 
spheroids contrary to that reported previously with other hepatic-derived spheroids. This 
result along with the histological (Figure 2-6), IF (Figure 2-9) and TEM (Figure 2-14) 
results increasingly suggest that this spheroid model remains devoid of necrosis for 
extended periods of culture. 
Immunohistochemical analysis demonstrated the presence of another cell type, namely 
mesothelial cells as shown via Vimentin staining (Figure 2-12). These results confirm the 
formation of a mesothelial lining/capsule surrounding the spheroids similar to the 
Glisson membrane seen encapsulating the exterior of the liver in vivo. It is important to 
note that the formation of the capsule becomes extremely apparent by day 21. On day 
18, we can see a thin cell layer lining the spheroid boundary, however, this rapidly 
thickens to a stratified outer membrane by day 21. 
Specific transporters are expressed on the canalicular, and sinusoidal membranes of the 
hepatocytes [207]. Due to this transporter expression, bile canaliculi form between 
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adjacent hepatocytes. The formation and maintenance of hepatocyte polarity is essential 
for a multitude of functions and I have been able to recapitulate this in vivo-like 
characteristic within my in vitro spheroid model. The establishment of structural 
polarisation was confirmed via IF analysis where the canalicular membrane transporters 
P-gp and MRP2 were stained and visualised (Figure 2-16 and Figure 2-17). This analysis 
has previously been carried out with HepG2 and C3A spheroids [76]. However, the bile 
canalicular networks present in the PRH spheroids are much finer, more extensive and 
complete when compared to the more globular-like secondary structures of HepG2 and 
C3A spheroids.  
As well as identifying the formation of these networks, I have been able to observe the 
functionality of these structures (functional polarisation) utilising CMFDA, a cell tracker 
that is passively taken up by hepatocytes (Figure 2-18). CMFDA substrates were actively 
transported out of the hepatocytes via MRP2. IF analysis revealed that this cell tracker 
substrate co-localised with the MRP2 transporter showing functionality within our 
spheroids. 
I was also able to demonstrate that PRH spheroids were able to produce albumin and 
secrete urea consistently over the duration of the culture period (Figure 2-19 and Figure 
2-20). Urea secretion was seen to be significantly higher in PRH spheroids when 
compared to the previously characterised C3A and HepG2 spheroids [76]. Albumin 
production was also seen to be stable over the culture period. Urea secretion was 
significantly lower compared to day 3 for all other time points. After an initial decline in 
albumin production, functional stability was achived from the point of spheroid 
formation until day 28. Albumin production and urea secretion are well defined 
physiological functions of hepatocytes in vivo [15, 208] and therefore, the analysis of the 
production of these two functional end points provides an indicative measure of liver-
specific functionality in our spheroid model. These findings help to assert that the 
culturing of cells in 3D provides a more representative model that recapitulates a number 
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of in vivo-like characteristics that are not apparent in more commonly used monolayer 
cultures [81].  
2.5 Conclusion  
3D liver models have long been acknowledged as an improved platform for toxicological 
investigations due to the more representative morphology, improved functionality and 
increased viability for the duration of culture when compared with 2D methods. The 
technique described in Chapter 2 for the formation of PRH spheroids allows for a high-
throughput platform with the potential for repeat-dose investigations. A key attribute of 
this spheroid system, particularly when compared with other spheroid models that utilise 
hepatic-derived cell lines, is the ability to be cultured over a 31-day period without the 
formation of necrotic regions as demonstrated via multiple histological and IF analyses. 
However, this is an area of research that requires further investigation with a view to 
characterise more precisely the causative factors for the formation of these necrotic 
regions. It may be that oxygen is unable to diffuse more than 150 µm within spheroid 
models, or it could be due to other specific factors such as the oxygen usage by cells, 
their proliferative characteristics and cellular functional output, or a combination of all 
of these factors.  
In conclusion, I have successfully developed a reproducible technique for creating 
uniform, size controllable, PRH spheroids, and characterised their growth characteristics 
over a culture period of 31 days. The resultant spheroids exhibit an in vivo-like 
morphology, intricate cell-cell and cell-ECM interactions, as well as structural and 
functional polarisation. I additionally confirmed liver-specific functionality by analysing 
albumin production and urea secretion. I was also able to demonstrate that the 
canalicular transporters were functional. The culmination of these analyses further affirm 
that 3D liver spheroids provide a model that recapitulate the in vivo liver more closely 
than currently utilised 2D cultures.  
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In Chapter 3, I will utilise experimental data from my characterisation work and look at 
how oxygen diffuses through the in vitro spheroid system. I will look at mathematically 
modelling the diffusion and consumption of oxygen within my spheroids, and analyse 
the subsequent oxygen profiles in order to determine the representativeness of the 
experimental model. Seahorse OCR results will be used from Chapter 2 to parameterise 
the mathematical model in order to develop a PRH-specific oxygen diffusion model.  
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Chapter 3: Mathematical modelling of 
oxygen diffusion through primary rat 
hepatocyte spheroids 
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3.1  Biological motivation   
Hypoxia occurs when the amount of oxygen within a tissue decreases to a level lower 
than the physiological amount required and this may be caused by, increased demand, 
decreased supply or abnormal utilisation by the cells [208]. In much of the current 
literature regarding liver 3D microtissues, including spheroids, oxygen consumption rate 
(OCR) and oxygen diffusion remain poorly characterised. When using tumour spheroids 
and other tumour 3D models, oxygen distribution is an important factor to consider as it 
has been shown that, tumours that exhibit hypoxia tend to be associated with a poor 
prognosis [209]. It is, for this reason, that hypoxia within tumour spheroids may be a 
desirable characteristic to replicate in vitro, as it is more representative of the in vivo 
situation. However, for an in vitro liver model that attempts to recapitulate the native 
liver microenvironment, this is an undesirable characteristic as necrosis and hypoxia are 
features of liver disease states and not the healthy liver [210].  
Oxidative respiration in standard 2D cell culture models has been widely studied. 
However, as 2D cell cultures fail to acquire the intricacies of the 3D microenvironment, 
the findings from these 2D investigations may not provide the required information when 
looking at 3D liver microtissue models. In particular, how the 3D microenvironment will 
impact on the diffusion of oxygen into the microtissues and the subsequent OCR of the 
cells [123]. An important aspect to consider regarding 3D hepatocellualr models, is that 
with an improvement in functional output by the cells, there is potential for an increase 
in OCR. Cho et al. [129] demonstrated that albumin and urea production increased in line 
with an increased OCR by hepatocytes. These researchers evaluated the effect of cell 
seeding densities on OCR and the subsequent expression of liver-specific functions. In 
this study, PRH were co-cultured with mouse 3T3-J2 fibroblasts at varying hepatocyte to 
fibroblast (H-F) seeding ratios. A 1:9 H-F seeding density was considered to be a low 
hepatocyte density, 1:3 H-F was a medium hepatocyte density, and 9:1 H-F was a high 
hepatocyte density. For all of these experiments, the total number of cells seeded 
remained constant. Results from these investigations showed that there was an inverse 
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relationship between the hepatocyte density and OCR of hepatocytes in the co-culture 
systems. That is, PRH seeded at lower densities exhibited much higher OCR compared to 
those seeded at higher densities. It was noted that the increase in OCR correlated well 
with increased liver-specific functionality [129]. However, detailed investigations of 
oxygen supply to cell cultures in vitro is challenging and still remains an issue [211]. 
Regarding spheroids, the wider literature discusses the maximal size of these 3D 
microtissues based on the ability of oxygen to diffuse through the cellular aggregates.  
Generally, the literature states that spheroids that have a radius of greater than 150 µm 
will become necrotic due to the inability of oxygen to diffuse beyond this point [32]. 
Clearly, it is also the case that the specific OCR of the cells will also impact greatly on the 
diffusion distance of oxygen, along with the amount of oxygen available in the medium. 
There have been some investigations conducted in an attempt to answer the question of 
optimal liver spheroid size utilising simple mathematical modelling [178, 212]. These 
previous investigations have provided useful outcomes as the increasing use of 
experimental data alongside in silico modelling has provided better means of prediction 
validation. Aleksandrova et al. [178] concluded that, according to their mathematical 
model, the necrotic core is absent in spheroids consisting of 5,000 and 10,000 HepaRG 
cells, and the threshold size of HepaRG spheroids is 12,000 cells. However, there is still a 
clear need to improve the specificity of these in silico models by utilising cell specific and 
model specific parameters derived from experimental investigations.  
It is important to note that there are a number of variables that need to be taken into 
account when assessing cellular necrosis and the potential for hypoxia. OCR may vary 
between cell types, and the same cells may have varying OCR depending on the way in 
which they are cultured [213]. The utilisation of more commonly used proliferative 
hepatic-derived cell lines, such as HepG2 and C3A cells, means that the subsequent in 
vitro 3D model will increase in size over the duration of the culture period. Non-
proliferative cells, such as primary isolated hepatocytes, do not proliferate ex vivo and as 
a result the size of the 3D microtissue reduces over the culture period due to the impact 
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of the upregulation of key extracellular matrix (ECM) components. In this case, the 
number of hepatocytes within an in vitro 3D model will not increase over the culture time 
and this, coupled with increasing ECM and cytoskeletal components whereby the 
interactions between cells becomes more stable, causes the 3D microtissues to become 
more compact.  
Unlike conventional tumour spheroid models for example, spheroids produced from 
isolated hepatocytes can be thought as being quiescent with no proliferative outer rim. 
Initial work that we have carried out with PRH spheroids and C3A spheroids has shown 
that the size of spheroids can be controlled via the initial seeding density of cells [76]. 
With this in mind, it is reasonable to assume that the specific OCR of the cells, (whether 
the cells are proliferative or non-proliferative), and initial size of the 3D spheroid model 
will both have an impact upon the formation of necrotic zones within the spheroids. 
There are a number of researchers that have analysed OCR of cells in various 3D liver 
models. However, with these values being taken from a variety of different models 
(spheroids, sandwich cultures, co-cultures, bioartificial livers (BAL) etc.), the OCR values 
published tend to vary considerably.  
3.1.1 Aims of the chapter 
These studies seek to establish a more definitive answer for the optimal spheroid size for 
PRH based on a combined in vitro and mathematical modelling approach. Using this 
approach, I will propose optimised cell culture operating conditions to mimic in vivo 
characteristics, such as the maintenance of sinusoidal oxygen tensions, for a long as 
possible. 
With the ability to control the initial size of PRH spheroids via cell seeding density, and 
the fact that primary hepatocytes are non-proliferative ex vivo, I hypothesise that I can 
produce a mathematically-optimised 3D spheroid liver model, cultured for an extended 
period of up to 31 days that remains devoid of necrosis. I suggest that the formation of 
these necrotic regions is ultimately determined by, (i) the model-specific OCR of the cells 
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and the availability of oxygen in culture and; (ii) the stability of spheroids in terms of their 
size during the culture period.  
Previous work with tumours has demonstrated that the presence of vasculature does not 
necessarily translate to a well-oxygenated tissue and thus, to first understand oxygen 
diffusion and transport, an avascular in vitro model is desirable [123].    
I have analysed oxygen diffusion and OCR utilising PRH spheroids produced using the LOT 
as previously described [8]. To investigate OCR in PRH spheroids, I derive a mathematical 
model which describes the diffusion and consumption of oxygen through a homogenous, 
avascular PRH spheroid.  
3.1.2 Modelling background   
When modelling the movement of a dynamic variable, we must consider how that 
variable changes over time and space. Such modelling has been previously applied to a 
number of applications such as population dynamics [214], the modelling of disease 
states [215] and the proliferation and metastatic processes of cancer [216]. One standard 
method for analysing these types of problems involves the use of partial differential 
equations (PDEs). In the case of using PDE models, we can describe the movement of 
biological variables such as chemicals or solutes.  
I define 𝑐(𝑥, 𝑡) as a chemical concentration at position 𝑥 and time 𝑡, contained within an 
arbitrary volume 𝑉, enclosed by a surface 𝑆, that contains 𝑐 where 𝑑𝑆 is the outer unit 
normal to 𝑆 (Figure 3-1).  
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Figure 3-1 – Schematic representation of biological movement. The oval represents 
some arbitrary volume with S representing the surface area. dS is the outward facing 
norm (note that dS is short hand for ndS, where n is the outward pointing normal of the 
boundary S) and flux represents the movement of a drug, for example, in or out of the 
volume. Changes in the variable also occur due to production or loss e.g. birth and death 
rates within a population.  
 
A change in the concentration of 𝑐 within the volume 𝑉 can occur due to the processes 
of production or consumption of 𝑐. We also need to account for the flux, 𝐽(𝑥, 𝑡), which 
describes the net movement of 𝑐  across the surface, 𝑆 , at position 𝑥 . The biological 
movement of 𝑐 can now be formulated mathematically as a conservation law, 
 
𝜕
𝜕𝑡
∫𝑐(𝑥, 𝑡)
𝑉
𝑑𝑉 =  − ∫𝐽 𝑑𝑆
𝑆
+  ∫ 𝑓(𝑐) 𝑑𝑉
𝑉
, (3-1) 
where 𝑓 is a function that describes the growth or decay of 𝑐 depending on its current 
concentration. 
 ∫ 𝐽 𝑑𝑆 =  ∫∇ ⋅ 𝐽 𝑑𝑉
𝑉
,
𝑆
 (3-2) 
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applied to equation (3-1) we therefore obtain; 
 ∫ (
𝜕𝑐
𝜕𝑡
+ ∇ ⋅ 𝐽 − 𝑓(𝑐)) 𝑑𝑉 = 0.
𝑉
 (3-3) 
 
Because the volume 𝑉 is arbitrary, equation (3-3) can only be satisfied if the integrand is 
zero, namely; 
 
𝜕𝑐
𝜕𝑡
= −∇ ⋅ 𝐽 + 𝑓(𝑐). (3-4) 
 
Equation (3-3) is for a general n-dimensional volume 𝑉. In one spatial dimension this 
becomes,  
 
𝜕𝑐
𝜕𝑡
= −
𝜕𝐽
𝜕𝑥
+ 𝑓(𝑐). (3-5) 
In this case (e.g. oxygen diffusion), I assume Fickian diffusion where 𝐷 is the diffusion 
coefficient and net movement is assumed to be down the gradient of 𝑐.  
This is described by the following equation (Fick’s first law) in 1 dimension, 
 𝐽 =  −𝐷∇𝑐 = −𝐷
𝜕𝑐
𝜕𝑥
 . (3-6) 
If I now substitute equation (3-6) in to equation (3-5) I derive the following equation, 
 𝜕𝑐
𝜕𝑡
=  −𝐷
𝜕2𝑐
𝜕𝑥2
+ 𝑓(𝑐) . (3-7) 
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3.1.3 Modelling oxygen diffusion  
Mathematical models of oxygen transport tend to be based on a simple diffusive process 
through a homogeneous medium governed by the equation, 
 
𝜕𝑐
𝜕𝑡
= 𝐷𝛻2𝑐 −  𝐾, (3-8) 
where 𝑐 is the oxygen concentration within the tissue, 𝐷 is the diffusion coefficient of 
oxygen within the tissue, and 𝐾 describes the constant oxygen consumption rate. In the 
original model described by Krogh [217], which describe how oxygen diffuses from 
capillaries in to muscle tissue, a Dirichlet boundary condition was imposed upon a blood 
vessel wall where the concentration of oxygen was fixed. The constant uptake rate 
assumption for 𝐾 requires that equation (3-8) needs an additional assumption stating 
that, when the concentration is equal to zero, the consumption rate is also equal to zero. 
This assumption prevents the equations from providing solutions with negative 
concentrations.  
A more comprehensive form for the oxygen consumption term 𝐾 in equation (3-8) is the 
Michaelis-Menten form,  
 𝐾 =  
𝑉𝑚𝑎𝑥𝑐
𝐾𝑚 + 𝑐
. (3-9) 
With this nonlinear consumption rate, as 𝑐 → ∞ , the consumption asymptotes to the 
constant value 𝐾 =  𝑉𝑚𝑎𝑥,  so that when oxygen is abundant, consumption is 
approximately constant [218]. However, when oxygen is limiting, oxygen consumption is 
linearly proportional to the available oxygen. 𝐾𝑚 indicates the concentration of oxygen 
required to achieve 50% saturation with these values being negatively correlated with 
substrate affinity. By using equations (3-8) and (3-9) I can derive a reaction diffusion 
equation to model the diffusion of oxygen within my spheroids. 
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3.2 Mathematical methods  
My experimental PRH spheroid system is a 3D in vitro model composed of multiple cells. 
To mathematically describe the spatio-temporal dynamics of oxygen in my system, a 
partial differential equation (PDE) model is required. I therefore suggest that the changes 
in oxygen distribution within the spheroid model are driven by two factors. Firstly, the 
diffusion of oxygen into the spheroid from an external source (namely, the media), and 
secondly the consumption of oxygen by the hepatocytes under normal respiratory 
conditions. For my initial simulations, I assume the diffusion coefficient is constant. My 
mathematical model of oxygen tensions in PRH spheroids assumes that the medium is 
continuously renewed and oxygen concentration around the spheroid can be considered 
to be constant. The rate of oxygen consumption by cells is described by Michaelis–
Menten kinetics (3-9).  
Since I will be considering oxygen transport and consumption dynamics, which varies on 
a much quicker timescale than normal cell reorganisation, growth and division, I make 
the assumption that the radius of the spheroid, 𝑅, is constant. 
Because I am dealing with spheroids, I write the Laplacian operator with respect to 
spherical coordinates, (𝑟, ∅, 𝜃) and can re-write (3-8) as follows: 
 
𝜕𝑐
𝜕𝑡
= 𝐷 (
1
𝑟2
𝜕
𝜕𝑟
 (𝑟2
𝜕𝑐
𝜕𝑟
) +
1
𝑟2 sin(𝜃)
𝜕
𝜕𝜃
 (sin 𝜃
𝜕𝑐
𝜕𝜃
 )
+
1
𝑟2 sin2 𝜃
𝜕2𝑐
𝜕∅2
) −
𝑉𝑚𝑎𝑥𝑐
𝐾𝑚 + 𝑐
 , 
(3-10) 
where,     
 𝜃 ∈ [0, 𝜋], ∅ ∈ [0,2𝜋], and 𝑟 ∈ [0, 𝑅]. (3-11) 
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For my purposes of modelling within 3D spheroids, I assume radial symmetry so that the 
problem is reduced to a 1D equation in variable 𝑟, the radial coordinate. With this 
assumption, the terms 
𝜕
𝜕𝜃
 and 
𝜕
𝜕∅
 are taken to be zero. I therefore obtain; 
 ∇2=
1
𝑟2
𝜕
𝜕𝑟
(𝑟2
𝜕
𝜕𝑟
), (3-12) 
and my specific PDE can therefore be written as, 
 
𝜕𝑐
𝜕𝑡
=
𝐷
𝑟2
𝜕
𝜕𝑟
(𝑟2
𝜕𝑐
𝜕𝑟 
) −  
𝑉𝑚𝑎𝑥𝑐
𝐾𝑚 + 𝑐
 . (3-13) 
I use the initial condition,  
 𝑐(𝑟, 0) = 𝑐𝑅, (3-14) 
where 𝑐𝑅is the oxygen concentration in the media.  
I also use the boundary conditions, 
 
𝜕𝑐
𝜕𝑟
= 0 , at 𝑟 = 0, 
𝑐 = 𝑐𝑅, at 𝑟 = 𝑅, 
(3-15) 
The first condition is due to spherical symmetry and the second is where I fix the oxygen 
at the spheroid perimeter to that of the media.  
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3.2.1 Numerical methods 
The Matlab function, pdepe, numerically integrates PDE systems using finite difference 
approximations in the spatial dimension to reduce the problem to an ordinary differential 
equation (ODE) problem. Using my PDE as an example, the spatial dimension can be 
appropriately discretised to derive the following finite difference approximations, 
𝜕𝑐(𝑟, 𝑡)
𝜕𝑟
=
𝑐(𝑟 + ∆𝑟, 𝑡) − 𝑐(𝑟 − ∆𝑟, 𝑡)
2∆𝑟
, 
𝜕2𝑐(𝑟, 𝑡)
𝜕𝑟2
=
𝑐(𝑟 + ∆𝑟, 𝑡) − 2𝑐(𝑟, 𝑡) + 𝑐(𝑟 − ∆𝑟, 𝑡)
(∆𝑟)2
. 
Therefore, I can re-write my PDE model as; 
 
𝜕𝑐
𝜕𝑡
=
𝐷
𝑟2
𝜕
𝜕𝑟
(𝑟2
𝜕𝑐
𝜕𝑟
) −
𝑉𝑚𝑎𝑥𝑐
𝑐 + 𝐾𝑚
= 𝐷 (
𝜕2𝑐
𝜕𝑟2
+
2
𝑟
𝜕𝑐
𝜕𝑟
) −
𝑉𝑚𝑎𝑥𝑐
𝑐 + 𝐾𝑚
, (3-16) 
 ⇒
𝑑𝑐𝑖
𝑑𝑡
=
𝐷
∆𝑟
(
𝑐𝑖+1 − 2𝑐𝑖 + 𝑐𝑖−1
∆𝑟
+
𝑐𝑖+1 − 𝑐𝑖−1
𝑟
) −
𝑉𝑚𝑎𝑥𝑐𝑖
𝑐𝑖 + 𝐾𝑚
, (3-17) 
for 𝑖 = 1. . 𝑁 + 1  ( 𝑟 = 0. . 𝑅 ) where I use notation 𝑐𝑖+1 =  𝑐(𝑟 + ∆𝑟, 𝑡)  such that an 
increase by 1 in subscript 𝑖 corresponds to a radial increment in ∆𝑟 as defined by the 
discretisation of the mesh (spatial domain). I must also now consider the boundary 
conditions in order to determine special case boundary values.  
In the case where 𝑖 = 1 I have 
𝑑𝑐1
𝑑𝑡
=
1
∆𝑟
(
𝑐2 − 2𝑐1 + 𝑐0
∆𝑟
+
𝑐2 − 𝑐0
𝑟
) −
𝑉𝑚𝑎𝑥𝑐1
𝑐1 + 𝐾𝑚
, 
and therefore, I need to determine the value of the ghost node 𝑐 at 𝑖 = 0, i.e. 𝑟 = 0 −
∆𝑟 . In order to do this I apply the Neumann boundary condition, 𝜕𝑐/𝜕𝑟 = 0 , for the 
sphere centre boundary: 
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𝜕𝑐1
𝜕𝑟
=
𝑐2 − 𝑐0
2∆𝑟
= 0, 𝑟 = 0, (3-18) 
 ⇒ 𝑐0 = 𝑐2.  (3-19) 
Therefore, 
 𝑑𝑐1
𝑑𝑡
=
2
(∆𝑟)2
(𝑐2 − 𝑐1) −
𝑉𝑚𝑎𝑥𝑐1
𝑐1 + 𝐾𝑚
. (3-20) 
When 𝑖 = 𝑁 I have 
𝑑𝑐𝑁
𝑑𝑡
=
𝐷
∆𝑟
(
𝑐𝑁+1 − 2𝑐𝑁 + 𝑐𝑁−1
∆𝑟
+
𝑐𝑁+1 − 𝑐𝑁−1
𝑟
) −
𝑉𝑚𝑎𝑥𝑐𝑁
𝑐𝑁 + 𝐾𝑚
 
and I determine the value of 𝑐 at 𝑖 = 𝑁 + 1, i.e. 𝑟 = 𝑅. In order to do this, I apply the 
Dirichlet boundary condition, 𝑐 = 𝑐𝑅, at the sphere outer boundary. 
 𝑐 = 𝑐𝑅 = 𝑐𝑁+1 𝑟 = 𝑅 (3-21) 
Therefore, 
 
𝑑𝑐𝑁
𝑑𝑡
=
𝐷
∆𝑟
(
𝑐𝑅 − 2𝑐𝑁 + 𝑐𝑁−1
∆𝑟
+
𝑐𝑅 − 𝑐𝑁−1
𝑟
) −
𝑉𝑚𝑎𝑥𝑐𝑁
𝑐𝑁 + 𝐾𝑚
 (3-22) 
The time integration is done with ode15s, which is a variable-step, variable-order (VSVO) 
solver based on the numerical differentiation formulas (NDFs) of orders 1 to 5 [219]. 
Convergence to steady state was confirmed by using a stopping condition in the Matlab 
file which halted the code when the least squares difference between solutions at 
successive time points was less than the relative error tolerance of the ode15s solver 
(RelTol=10−5).   
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3.3 Fixed boundary oxygen profile simulations  
3.3.1 Parameter values  
Table 3 – Initial paramter values used for oxygen simulations. 
Simulation parameters Values 
Spheroid radius 150 µm 
Boundary oxygen concentration 9% 
Diffusion coefficient  1.6×10-9 m2 s-1 
𝑉𝑚𝑎𝑥 1.22×10
-16 mol s-1 cell-1 
𝐾𝑚  6.24×10
-3 mol m-3 
 
The spheroid radius, 𝑅 was set at 150 µm as this has been previously reported to be the 
maximal distance that oxygen is able to diffuse through in vitro spheroids before the 
onset of necrosis [116, 220]. The external concentration of oxygen at the spheroid 
boundary, 𝑐𝑅, was fixed at 9%, based on values obtained from estimated liver periportal 
tensions in the literature [118, 221]. The diffusion coefficient of oxygen, 𝐷, through the 
homogenous spheroid was taken to be the 1.6×10-9 m2 s-1 [222]. The reaction diffusion 
coefficient value was calculated from spheroids produced from human S-type 
neuroblastoma cells (SK-N-AS). Mathematical modelling and fitting of experimental 
observations of the oxygen uptake rate and diffusion inside the spheroid allowed for the 
estimation of this parameter. This value for the diffusion coefficient seems to be a 
plausible estimate when compared to the mean diffusion rate of oxygen in water        
(2×10-9  m2 s-1) [223]. The 𝑉𝑚𝑎𝑥 of the cells was taken to be 1.22×10
-16 mol s-1 cell-1 for 
initial simulations [181]. This value is an experimentally derived parameter for the oxygen 
uptake rate of freshly isolated PRH cultured on a single layer of collagen. I will initially use 
a literature-derived OCR value that has been well accepted and this will allow for a direct 
comparison to my experimental seahorse values which will be implemented in the model. 
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Finally, the value for the half maximal consumption rate (𝐾𝑚) was taken to be 6.24×10
-3 
mol m-3 [224]. This value was calculated from experimental observations for primary rat 
hepatocytes in a hollow fibre bioreactor setting [225, 226]. 
3.3.2 Oxygen concentration conversion  
Oxygen was converted to % 𝑂2 using the following relationship; 
𝑂2𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 = 𝐾 × 𝑃𝑂2(𝑚𝑚𝐻𝑔) (3-23) 
Where (𝐾 is the solubility of oxygen in water at standard pressure and temperature);  
 𝐾 =  1.39 × 10−3 𝑚𝑜𝑙 𝑚−3𝑚𝑚𝐻𝑔−1   
and, 
 
%𝑂2
100
× 760 = 𝑃𝑂2 𝑚𝑚𝐻𝑔 (3-24) 
The concentration of oxygen (𝑚𝑜𝑙 𝑚−3) is therefore approximately, the %O2 divided by 
100. 
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3.3.3 Single parameter value simulations  
Figure 3-2 – Simulation of oxygen profile with single parameter estimates. The curve 
from (A) shows the decreasing oxygen profile from the boundary of the spheroid,            
(150 µm) to the core of the spheroid (0 µm). (B) describes the same oxygen profile as (A) 
assuming spherical symmetry. This figure provides a representative visualisation for the 
oxygen profile described in my spheroid system.  
 
In Figure 3-2 (A), the horizontal black line at 9% represents the oxygen tension at the 
spheroid boundary. The horizontal blue line at 4% O2 represents the pericentral O2 
tension in vivo and below this threshold cellular hypoxia is observed [118]. The red line 
at 1% O2 is demonstrative of this hypoxia threshold for cellular survival, i.e. cell death. 
When using these parameters the model predicts that a PRH spheroid with a radius of 
150 µm will be hypoxic and that the central oxygen tension is close to zero. Although the 
model does predict hypoxia, it is important to note that this is not for the entire spheroid 
body. The oxygen tension falls below the 4% threshold at around 120 µm, and below the 
1% threshold at around 70 µm. Figure 3-2 (B) has been rotated round 360° in order to 
plot the same information as a heat plot where the changing oxygen concentrations are 
represented by the change in colour.  
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These initial simulations demonstrate the need for a better understanding of some of the 
initial parameters as, when comparing this result to some of the previously characterised 
experimental work, it is clear that my PRH spheroids do not exhibit zones of necrosis, 
whereas this initial simulation does (i.e. O2 <  1%). Although OCR analysis had been 
conducted in Chapter 2, a literature search for OCR values for rat hepatocytes was 
conducted in order to assess the potential variability within the reported values and to 
determine the potential validity of our Seahorse experimental results. 
 
Table 4 – Literature reported rat hepatocyte oxygen consumption rates 
Ranges for OCR (mol s-1cell-1) Reference 
1.25×10-16 to 3.5×10-16 Wagner et al. 2011 [213] 
2×10-16 Guarino et al. 2004 [227] 
3.8×10-16 to 4.3×10-16 Foy et al. 1994 [182] 
1.0395×10-16 to 8.162×10-17 Rotem at al. 1992 [181] 
1×10-15 to 7×10-16 Smith et al. 1996 [211] 
2.4×10-16 to 3.3×10-16 Cho et al. 2007 [129] 
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3.3.4 Literature OCR value simulations  
From Table 4, it is clear that there is wide variability of OCR for rat hepatocytes and this 
is largely down to the particular in vitro model in which the cells have been cultured. The 
method by which cellular OCR values have been evaluated also differs between 
publications, and hence there are a wide range of reported values. I was subsequently 
able to utilise this range of OCR values (8.162 × 10-17 to 1 × 10-15 mol s-1 cell-1) from the 
literature within my simulations to understand the effects of these different OCR (𝑉𝑚𝑎𝑥) 
values on the oxygen profiles (see Figure 3-3). 
 
 
 
 
 
 
 
 
 
Figure 3-3 – Oxygen tension simulations for 150 µm radius spheroids for multiple 
literature OCR values. The wide variability in OCR values from the literature produces 
huge variation in predicted oxygen profiles for the spheroid system. As the OCR increases 
by the cells, the core oxygen tension decreases dramatically from around 5% to 0%. With 
some of the higher literature OCR values, hypoxia is predicted at around 140 µm, and the 
cell survival threshold is reached at around 120 µm.  
Increasing OCR (𝑉𝑚𝑎𝑥) 
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Simulations utilising the range of literature values provide useful information with 
regards to estimating the OCR of my PRH spheroids. From previous experimental analyses 
(Figure 2-6 and Figure 2-9) I have been able to show that my PRH spheroids do not show 
signs of classic necrosis. Consequently, the model seems to suggest that the OCR for the 
PRH within my spheroid model must be close to the lower end of the values identified in 
the literature.  
3.3.5 Experimentally-derived spheroid radii simulations  
In order to incorporate this experimental data, a single OCR value was chosen from the 
literature values (8.162 × 10-17 mol s-1 cell-1) and simulations were conducted 
implementing the range of spheroid radii as described in Figure 2-4. From my 
experimental work, observations from histological analysis were not consistent with the 
formation of necrosis. As I do not visualise these necrotic cores, I made the assumption 
that the cells within our spheroid may be consuming oxygen at a rate similar to the lower 
end of my initial estimates from the literature. Hence, the lowest values for the oxygen 
consumption rate was used in subsequent simulations.  
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Figure 3-4 – Oxygen profile for fixed OCR with varying spheroid radii from experimental 
data. The steady state oxygen profiles for this range of spheroid sizes shows that the 
larger spheroids (R >180 µm) become hypoxic where the core oxygen falls below the 4% 
pericentral oxygen value. However, none of the spheroids fall below the critical 1% cell 
survival threshold. This simulation suggests that the critical size of spheroid before the 
onset of necrosis is just over 180 µm. This is larger than the literature reported 150 µm 
value, but the simulation provides an extremely plausible value at this radius.  
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Figure 3-4 shows simulations for the oxygen profiles with a fixed OCR for my 
experimental spheroid sizes relevant to ranges observed in my experiments. From these 
simulations, and utilising literature-derived parameter values for 𝑉𝑚𝑎𝑥 (8.162×10
-17mol   
s-1 cell-1), I demonstrate that spheroids of around 180 µm radius (orange dashed line) 
recapitulate the liver oxygen tension of 9% at the boundary and 4% in the core (as seen 
in the in vivo liver sinusoid). However, the main limitation that arises from Figure 3-4 is 
that simulations predict that PRH spheroids with a radius >180 µm may be necrotic in the 
central regions due to hypoxia, which is contrary to the experimental characterisation. In 
order to investigate this more robustly, the experimental analyses of PRH spheroid OCR 
that was carried out in Chapter 2 was implemented for subsequent simulations. 
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Table 5 – Seahorse OCR readings for spheroids of different initial cell seeding numbers with unit conversions.  
Spheroids cell seeding number (Day 7) Mean OCR Seahorse readings 
(pmol min-1) 
Conversion 
(mol s-1 cell-1) 
Spheroid Radius 
(m) 
Spheroid volume 
(m3) 
Cell density 
(cell m-3) 
OCR values for  Matlab 
(mol s-1 m-3) 
3000 21.52 1.1958×10-16 186.5 2.717×10-11 1.10407×1014 0.0132 
4000 22.15 9.2272×10-17 191 2.919×10-11 1.37048×1014 0.0126 
5000 17.08 5.6933×10-17 208.75 3.810×10-11 1.31221×1014 0.0075 
Spheroid cell seeding number (Day 11) OCR Seahorse readings 
(pmol min-1) 
Conversion 
(mol s-1 cell-1) 
Spheroid Radius (m) Spheroid volume 
(m3) 
Cell density 
(cell m-3) 
OCR values for Matlab 
(mol s-1 m-3) 
2000 20.39 1.6991×10-16 169 2.022×10-11 9.89194×1013 0.0168 
3000 21.64 1.202×10-16 181.75 2.515×10-11 1.19291×1014 0.0143 
4000 23.38 9.7429×10-17 195.5 3.129×10-11 1.278×1014 0.0125 
5000 23.20 7.7333×10-17 200.75 3.388×10-11 1.47542×1014 0.0114 
Total average 
OCR (day 7 and 
11) 
0.0126 
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3.3.6 Spheroid-specific OCR value simulations  
Table 5 shows the results from my Seahorse analysis which were used to determine the 
OCR of the cells within my PRH spheroids. As with previous studies, I will utilise the mean 
OCR value calculated from the values in Table 5 (spheroids at day 7 and 11 of the culture 
period). 
 
Figure 3-5 Oxygen profiles for average experimental OCR with varying spheroid radii 
from experimental data. The oxygen profiles for my experimental spheroid radius ranges 
look very similar to the profiles utilising the lowest literature OCR value (see Figure 3-4). 
None of the profiles for this spheroid radius range fall below the critical cell survival 
threshold of 1%, and the simulation predicts an increase in spheroid radius threshold for 
oxygen diffusion from 180 µm in Figure 3-4 to approximately 210 µm (orange dotted line).  
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Figure 3-5 shows simulations for the oxygen profiles with a fixed average OCR based on 
the experimental Seahorse analysis (Table 5). The simulation implies that spheroids with 
a radius of approximately 210 µm (orange dashed line) best recapitulates the sinusoidal 
oxygen tension of 9% at the boundary and 4% in the core. These simulations display 
similar qualitative results to that of Figure 3-4. However, the issue remains that even 
though my spheroids are devoid of classical necrosis staining as demonstrated by 
previous experimental work and characterisation (Figure 2-6, Figure 2-9, Figure 2-13and 
Figure 2-14), these simulations suggest that hypoxia may be present within the larger 
spheroids (>210 µm). The fact that the larger spheroids correspond with early culture 
times in my experiments, (i.e. the largest spheroids are at day 3), poses an interesting 
question as to the representativeness of taking the average OCR value for all of the 
simulations. I therefore important to take a more in-depth look at how OCR varies against 
spheroid size.   
3.3.7 Analysis of experimental OCR measurements    
The experimental OCR values obtained from the Seahorse XF analysis (see Table 5) were 
scrutinized in more detail to determine if there was a relationship between the initial cell 
seeding density, or the size of the spheroids, and the OCR alues. As I had analysed the 
OCR of spheroids for 2 separate time points, I could also look at the effect of spheroid 
compaction to see if this had any effect on OCR.  
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Figure 3-6 – OCR of PRH spheroids on days 7 and 11 of culture. OCR of PRH spheroids 
were analysed on day 7 of culture for 3000-, 4000- and 5000-cell spheroids denoted by 
black triangles, and for 2000-, 3000-, 4000- and 5000-cell spheroids on day 11 denoted 
by clear circles. OCR measurements were normalized to initial cell seeding density to 
provide an OCR value per cell. Results are mean ± standard deviation (SD). 
 
From Figure 3-6 we can see that spheroids with smaller initial cell seeding densities seem 
to have an increased OCR. The OCR values from day 11 (clear circles) are slightly higher 
than the values for day 7 (black triangles) but there is no significant difference between 
the values for spheroids of the same cell number between time points.  The original OCR 
data from Figure 3-6 was plotted against spheroid radius to take into account the effect 
of spheroid compaction during the culture period (again for day 7 and day 11 time points).  
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Figure 3-7 – Seahorse OCR measurements plotted against spheroid radius. Smaller 
spheroids have an increased OCR. The red line is from linear regression analysis (R2=0.93) 
and represents the relationship by which subsequent OCR-radius coupled simulations 
were carried out. Results are mean ± standard deviation (SD).  
 
Interestingly, from Figure 3-7 I was able to determine a definitive relationship between 
the experimentally-derived OCR values from the Seahorse analysis, and spheroid radius. 
The data shows that as spheroid radius decreases (due to compaction over the culture 
period), the OCR of the component cells increases. Assuming a linear relationship 
between OCR and spheroid radius we obtain, 
 𝑉𝑚𝑎𝑥 = 260.78 −
𝑅
4977.5
  . (3-25) 
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Within the mathematical model, I can now determine the OCR parameter (𝑉𝑚𝑎𝑥) based 
on the relevant spheroid radius (𝑅) according to this relationship. Therefore, instead of 
using the fixed average OCR value as in Figure 3-5, this radius-dependant OCR variable 
was introduced. To evaluate the effects of this relationship, the simulations 
corresponding to the plots in Figure 3-5 were repeated with both the fixed average OCR 
(1.26 x 10-2 mol s-1 m-3), and with OCR as a radius-dependent parameter for the range of 
my observable spheroid radii given by equation (3-25).  
3.3.8 Radially-coupled OCR simulations  
Figure 3-8 (A) shows the new oxygen profiles with the radius-coupled OCR values, as 
indicated by the blue lines. The green lines are the same profiles as seen in Figure 3-5. 
This result suggests that the largest spheroids have higher core oxygen tensions than the 
smallest spheroids. We can visualise the results of these two cases more clearly by 
plotting the core oxygen tensions in the cases where OCR (𝑉𝑚𝑎𝑥)  is fixed at the average 
value versus OCR being a function of spheroid size (𝑅).  
 
 
A 
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Figure 3-8 – (A) Oxygen profiles for both average experimental OCR, and spheroid-
radius-dependent OCR with varying spheroid radii. (B) Boundary oxygen tensions 
plotted with core oxygen tensions for varying spheroid radii. The orange line shows 
the core oxygen tensions when I assume OCR is fixed at 1.26 x 10-2 mol s-1  m-3. The blue 
line shows the core oxygen tensions where OCR is coupled with spheroid radius (R).  
 
These results indicate that it is the intermediate sized PRH spheroids that most closely 
resemble the in vivo oxygen tension found within the liver sinusoid and that with OCR 
taken to be a function of the radius, spheroids stay devoid of necrosis. This is due to the 
effect of the reduction in OCR within the larger spheroids.  
The main aim of my modelling efforts was to aid in the characterisation of the PRH 
spheroid system.  The possibility of maintaining appropriate in vivo oxygen gradients and 
conditions for as long as possible would implicate the model as highly appropriate in its 
utility. One main limitation with the relevance of these initial simulations is the principle 
B 
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assumption that the boundary tension of oxygen at the spheroid periphery is fixed at 9%, 
when this may not be necessarily accurate. Within my experimental set-up, the spheroid 
is observed at the bottom of the well within the culture plate. Spheroids are cultured 
under standard conditions whereby the incubator oxygen levels are at 21%. Therefore, I 
can assume that there is 21% oxygen at the media-air interface. Oxygen consequently 
has to diffuse through 100 µl of culture media to reach the cells within the spheroid, 
which is referred to as the media-cell interface. Oxygen is subsequently consumed via 
cellular respiration. With these observations, and for my modelling efforts, it is important 
to discern the actual oxygen tension experienced at this media-cell interface. It may also 
be important to note that the physical dimensions of the spheroid in the well may impact 
on the oxygen tension experienced at the very bottom of the well.  
3.4 Oxygen profile simulations with non-fixed boundary conditions  
In order to be able to better understand the spheroid perimeter oxygen condition within 
the PDE model, further work is needed to ascertain the oxygen tension experienced by 
the cells at the media-cell interface within the experimental setup. To more accurately 
model the oxygen diffusion and consumption, I take into account the amount of media 
that is in the well (100 µl), and what effect this will have on the diffusion profile of the 
oxygen. This requires an extension of the mathematical model in order to more 
accurately determine the relevant spatial parameters of the spheroid system and the 
dimensions of the wells in which the spheroids are cultured. However, it is not possible 
to exactly model the geometries of the LOT plates due to the variability in production, 
therefore I have utilised the geometry of the ULA plates originally used for initial 
comparative characterisation work (Figure 2-3). I subsequently approximate the LOT well 
dimensions with the ULA ones. The spatial and dimensional parameters of the ULA plate 
wells are inferred in Figure 3-9 .  
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Figure 3-9 – Typical dimensions of ULA plates and volume of medium. As LOT well 
dimensions were not attainable, I approximate the dimensions from the ULA plates as 
appropriate parameters for my experimental system. The spheroids tend to sit at the very 
bottom of the well, and do move slightly as they are not stuck down to the substratum. 
Understanding the total depth of the media in the well provides relevant information 
regarding the distance over which oxygen must diffuse to reach the cells.  
 
For simplicity, I retain the assumption of radial symmetry within the model, and assume 
that the physical liver spheroid sits within a larger sphere of media. I assume that the 
radius of this sphere of media is representative of the typical media depth in the ULA 
plate well (3.848mm). 
The oxygen tension at the media-spheroid interface is unknown. However, PRH spheroids 
in my experiments were cultured under normal cell culture conditions where there is 
21% oxygen in the incubator (i.e. the media-air interface). In order to account for this, 
within the model a new equation is added to account for the diffusion of oxygen in the 
media, namely, 
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𝜕𝑐
𝜕𝑡
= 𝐷2
𝜕2𝑐
𝜕𝑟2
       where ℎ > 𝑟 > 𝑅, 
(i.e. the media) 
(3-26) 
 
𝜕𝑐
𝜕𝑡
= 𝐷1
𝜕2𝑐
𝜕𝑟2
−
𝑉𝑚𝑎𝑥𝑐
𝐾𝑚 + 𝑐
   where 0 ≤ 𝑟 ≤ 𝑅, 
(i.e. the spheroid) 
(3-27) 
where 𝑅 is the spheroid radius and ℎ is the well depth. 
In order to calculate 𝐷2,  I utilised the Stokes-Einstein equation for a spherical particle 
diffusing through a liquid with a low Reynold’s number, which states, 
 𝐷 =
𝐾𝐵𝑇
6𝜋𝜂𝑟
 , (3-28) 
where 𝐾𝐵 is the Boltzmann constant value, 𝑇 is the temperature value (Kelvin), 𝜂 is the 
viscosity of the medium, and 𝑟 is the size of the diffusing particle value which was taken 
to be 2 Å (for oxygen). The viscosity of Williams’ medium E was taken to be same as for 
DMEM/F12 media as described by Wang et al. [228]. From these parameters, the 
diffusion coefficient of oxygen in Williams’ medium E was taken to be 1.456×10-9 m2 s-1. 
The well depth was set to 3.848 × 10-3 m which corresponds to the total depth of 100 µm 
of culture media within the dimensions of the ULA plates. I vary the spheroid radius from 
106.5 µm to 233.5 µm in line with the sizes observed in my experiments.  
The boundary condition at 𝑟 = ℎ (the media-air interface) was set to be 21% in line with 
my experimental culture conditions, and, for an initial simulation, a single spheroid radius 
of 106.5 µm (representing the smallest spheroid radius for 2000-cell initial seeding 
density) was used along with the appropriate OCR given by equation (3-25) (see Figure 
3-10). 
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Figure 3-10 – Steady state oxygen profile for 106.5 µm spheroid utilising diffusion 
coefficients D1 and D2 and the cellular OCR term coupled with spheroid radius. The 
vertical orange line represents the boundary of the spheroid (R), and the media-spheroid 
interface. In the model, the oxygen concentration in the media is 21% initially, the same 
concenration as in the incubator.   
 
In Figure 3-10, the blue line represents the oxygen profile, which varies over space, and 
the vertical orange line indicates the position of the spheroid boundary (106.5 µm). As 
previously stated, for 𝑟 > 𝑅, the change in oxygen profile is driven by the diffusion of 
oxygen only, and for 𝑟 ≤ 𝑅  the change in the oxygen profile is driven by both the 
diffusion of oxygen through the spheroid and consumption of oxygen by the cells through 
the process of respiration. We can see from the curve that, in this case, the boundary 
oxygen tension for this spheroid is around 14% with a corresponding core oxygen tension 
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of around 10%. The simulation was repeated for the whole range of spheroid radii 
observed with the initial cell seeding density of 2000 cells, with OCR (𝑉𝑚𝑎𝑥) again given 
by equation (3-25) (see Figure 3-11).  
 
Figure 3-11 – Oxygen profiles for spheroid radii corresponding to 2000-cell initial 
seeding density with OCR coupled with spheroid radius. Vertical lines represent the 
spheroid boundary for the range of spheroid sized observed in my experiments. Y axis 
values shows the end solutions corresponding with the core oxygen tensions.   
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Figure 3-11 shows the oxygen profiles for all the spheroid radii observed over the culture 
period for spheroids with an initial seeding density of 2000 cells (i.e. 106.5 µm to 176.5 
µm). The coloured vertical lines denote the respective spheroid boundaries. 
As the boundary and core oxygen tensions are difficult to visualise, I present the data in 
a clearer format whereby I show the boundary and core oxygen tensions only, and how 
these values vary with regards to spheroid radius. In Figure 3-12, the results were plotted 
as boundary and core oxygen tensions for these varying spheroid radii. For completeness, 
I also show the results for spheroid radii corresponding with 3000-, 4000- and 5000-cell 
initial seeding densities in later results (see Figure 3-13 and Figure 3-14).  
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Figure 3-12- Boundary and core oxygen tensions for radii corresponding to spheroids with 2000 cell initail seeding density. Solid lines 
represent boundary oxygen values and the dashed lines represent the core oxygen tension. (A) shows spheroid boundary and core oxygen 
steady stae profiles plotted against varying spheroid radii; (B) shows the equivalent oxygen profiles but this time plotted against culture time 
using the simple linear regression relationship shown by the straight lines in Figure 2-4. 
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For the simulation in Figure 3-12 (B) the spheroid radii corresponding to the initial cell 
seeding density of 2000 cells were converted to time using the following relationship (R2 
= 0.96);  
 𝑡𝑖𝑚𝑒 =
377.4 − 2𝑅
5.273
 . (3-29) 
Figure 3-12 provides us with extremely important information regarding the oxygen 
profile within my in vitro model. When I fixed the spheroid perimeter oxygen to 9% I can 
predict that the PRH spheroids remain devoid of necrosis. This information can go some 
way to validate the observations made with the experimental characterisation, and the 
fact that central zones of necrosis were not observed within the experimental model.  
Similarly to the 2000 cell seeding density spheroids, to assess the effect of the varying 
the initial cell seeding densities, 3000-, 4000- and 5000-cell spheroid radii were 
converted to culture time using the following relationships; 
For 3000-cell spheroids (R2 = 0.96),  
 𝑡𝑖𝑚𝑒 =
416.6 − 2𝑅
5.722
 . (3-30) 
For 4000-cell spheroids (R2 = 0.95),  
 𝑡𝑖𝑚𝑒 =
436.7 − 2𝑅
5.719
 . (3-31) 
For 5000-cell spheroids (R2 = 0.97),  
 𝑡𝑖𝑚𝑒 =
473.4 − 2𝑅
6.788
 . (3-32) 
These values are again derived from the straight lines fitted through my experimental 
data (see Figure 2-4) using the inbuilt linear regression analysis in Graphpad Prism.  
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Figure 3-13 – Boundary and core oxygen tensions for 2000-, 3000-, 4000- and 5000-cell 
seeding densities plotted against culture time (days). Solid lines represent boundary 
oxygen whilst dashed lines represent core oxygen tensions.  
 
Figure 3-13 illustrates the oxygen profiles for all of my experimental spheroids with 
segregated initial cell seeding densities. Periportal and pericentral oxygen tensions 
ranges were taken from the literature [118, 120, 221]. That is, periportal oxygen tensions 
have been describes as ranging from 60-70 mmHg (8.10 - 9.45%), and pericentral oxygen 
tensions have been reported in the range of 25-35 mmHg (3.37 - 4.72%). These 
simulations demonstrate a number of key points. Firstly, by incorporating the specific rat 
hepatocyte OCR for the cells cultured as a spheroid, the phenomenon of spheroidal 
contraction over time, and the conversion of the spheroid radius to culture time, I can 
assert that the PRH spheroids have the potential to remain devoid of necrosis for the 
Green – 2000 cells 
Red – 3000 cells 
Blue – 4000 cells  
Black – 5000 cells 
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duration of the culture period (31 days). The formation of necrosis within in vitro systems 
can represent a major limitation to their utility, and physiological relevance to liver 
studies in particular. Therefore, the characterisation of a ‘healthy’ in vitro liver model 
would have a significant impact. From these simulations, however, we can see that the 
model does not capture either the desired periportal or pericentral tensions at any point 
during the culture period. Although I would have liked to have seen my experimental 
spheroid systems exhibiting core and boundary oxygen tensions within these ranges, a 
number of interesting questions are raised. Can I recapitulate these liver oxygen tensions 
by varying the concentration of oxygen within the incubator? And if so, what fixed 
incubator oxygen concentration is the most suitable to attain the desired in vivo oxygen 
tensions? Also, if I can continually change the external oxygen at source, can I replicate 
these tensions for the entirety of the culture period? Note that in my model, the 
incubator oxygen corresponds to the boundary condition 𝑐(ℎ, 𝑡) = 21%. 
3.4.1 Oxygen profile simulations with varying incubator oxygen supply 
In order to see how the external oxygen availability impacts upon the simulations and 
subsequent boundary and core oxygen tensions, the initial boundary oxygen 
concentration was reduced by 2% (from 21% to 19%), and then further reduced to 17%, 
and all other parameters within the model remained the same as for Figure 3-13. Thus, I 
can make a direct comparison between the original profiles where I have 21% incubator 
O2, and the profiles for the spheroids in 19% and 17% O2 within the incubator. 
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Figure 3-14 – Boundary and core oxygen profiles of spheroids (2000- to 5000-cell seeding densities) plotted against culture time (days), 
with (A) 19% incubator oxygen, and (B) 17% incubator oxygen. The green box represents the periportal oxygen tension ranges described in 
the literature and the red box represents the corresponding pericentral oxygen tension ranges. Dotted lines represent spheroid core oxygen 
tensions whilst solid lines represent spheroid boundary oxygen tensions.   
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Figure 3-14 (A) shows the profound impact that changing the incubator oxygen 
concentration to 19% has on the oxygen profiles of the spheroids. When the initial oxygen 
concentration was at 21%, none of the spheroids captured either the desired periportal 
or pericentral oxygen tensions. However, by reducing the incubator oxygen to 19% we 
can see that the 3000- and 4000-cell spheroids are exhibiting periportal oxygen tensions 
for most of the 31-day culture period as indicated by the green box (8.10-9.45%). It is 
interesting to note that there is a difference between the boundary and core oxygen 
profiles as both curves are not parallel, and thus, although the periportal oxygen tension 
may be achieved at this external oxygen concentration, this does not necessarily mean 
that the pericentral oxygen tension will also be achieved at the same time. Figure 3-14 
(B) shows the spheroid oxygen profiles with the external oxygen set at 17%. This figure 
demonstrates that the periportal oxygen tensions may be achieved within the spheroids, 
however, spheroids may not be able to recapitulate the pericentral oxygen tensions 
simultaneously. This can be seen for the 2000-cell spheroids (green lines), where the 
boundary oxygen values are within the limits of the periportal range from approximately 
day 22 to day 30. However, the pericentral oxygen tension is only maintained until 
approximately day 25.  
This has implications for the utility of the spheroid model for hepatotoxicity assessments 
because different xenobiotics exhibit toxicity in different ways. For example, hepatocytes 
within the pericentral zone of the sinusoid are susceptible to toxicity caused by APAP 
overdose due to enzymatic gradients along the sinusoid. Consequently, it can be implied 
that if these gradients are not maintained, toxicity may not be adequately represented 
within these models. However, when compared with other models that are currently 
being utilised within the battery of experimental tools for hepatotoxicity investigations, 
the maintenance of specific gradients, including oxygen, is often overlooked. The fact 
that hepatic-derived cell lines proliferate means that the subsequently derived models 
increase in size over time, and inevitably form areas of necrosis. Currently there is 
insufficient literature with regards to the effect of cellular necrosis on the functionality, 
gene-expression, and microarchitecture of in vitro 3D liver microtissues. It would be fair 
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to assume that areas of necrosis will have a negative influence on these functional 
aspects of the model, and clearly in vitro liver models that exhibit necrotic regions are 
not representative of the healthy liver in vivo [210].  
My simulations suggest that for the PRH spheroid model, if we are able to control the 
external oxygen within the culture incubator, 19% external oxygen would confer the best 
results in terms of recapitulation of both the periportal and pericentral oxygen tensions 
for the longest period possible. The simulations provided by the mathematical model 
indicate that 2000-cell spheroids may be used for repeat-dose investigations from initial 
formation (day 3) to approximately day 15, whilst 5000-cell spheroids may be used from 
approximately day 10 to day 31 of the culture period.  
3.5 Proposed optimal culture conditions for maintenance of sinusoidal oxygen 
gradients 
Whilst this information is extremely useful for experimental applications, I now want to 
see if I can use the mathematical modelling to determine a specific incubator oxygen 
concentration that would allow the in vitro system to maintain the periportal and 
pericentral oxygen tensions for the duration of the culture period. In order to do this, I 
separated the boundary and core oxygen tensions for the discrete seeding densities, and 
examine more closely the effect of varying incubator oxygen concentrations on these 
levels (see Figure 3-15). For subsequent simulations, the mean values from the ranges of 
the periportal and pericentral oxygen tensions were used for fitting. The required mean 
periportal oxygen tension was taken to be 8.7%, whilst the mean pericentral oxygen 
tension was taken to be 4.05%. I want to determine the optimal incubator oxygen 
concentration that tolerably satisfy both the mean periportal and pericentral oxygen 
tensions. Simulations were initially optimised for 2000-cell spheroids.  
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Figure 3-15 – Required incubator oxygen concentration to achieve (A) mean periportal, and (B) mean pericentral oxygen tensions.  The 
white contour lines demonstrate this required incubator oxygen concentration. We can see that the lines are not parallel curves and therefore 
different oxygen concentrations are required in order to achieve the required periportal or pericentral oxygen tensions.  
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Figure 3-16 -Overlay of both core (red curve) and boundary (black curve) curves from 
Figure 3-15 (A) and (B) with an optimally fitted curve (blue) to capture both sinusoidal 
zones. 
 
3.5.1 Normalised error function for optimisation fitting  
In order to determine the optimised incubator oxygen profile to recapitulate both the 
required boundary and core oxygen tensions (blue line Figure 3-16 and Figure 3-17), I 
utilised normalised error functions. Namely, the error for the simulated boundary and 
core oxygen tensions from Figure 3-15 (A) and (B) were calculated as, 
 𝐸𝑟𝑟𝑜𝑟 𝐵𝑑 =
(𝐵𝑑 − 8.7%)2
𝐵𝑑
 , (3-33) 
 
C 
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 𝐸𝑟𝑟𝑜𝑟 𝐶𝑟 =
(𝐶𝑟 − 4.05%)2
𝐶𝑟
 , (3-34) 
where, 
 𝐵𝑑 ≡ 𝑏𝑑(𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑡𝑖𝑚𝑒, 𝑖𝑛𝑐𝑢𝑏𝑎𝑡𝑜𝑟 𝑂2), (3-35) 
and,  
 𝐶𝑟 ≡ 𝐶𝑟(𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑡𝑖𝑚𝑒, 𝑖𝑛𝑐𝑢𝑏𝑎𝑡𝑜𝑟 𝑂2), (3-36) 
are the boundary and core oxygen levels given in Figure 3-15 (B) and (A) respectively. 
From these calculated normalised errors I calculated the total error function, 
 𝑇𝑜𝑡𝑎𝑙 𝑒𝑟𝑟𝑜𝑟 = 𝐸𝑟𝑟𝑜𝑟 𝐵𝑑 + 𝐸𝑟𝑟𝑜𝑟 𝐶𝑟. (3-37)  
Figure 3-16 plots both the incubator oxygen values required to recapitulate a boundary 
oxygen tension of 8.7%, denoted by the contour line from (A), the required external 
oxygen required to recapitulate a core oxygen tension of 4.05%, denoted by the contour 
line from (B), and the optimally fitted curve to best satisfy both conditions.  
The blue line in Figure 3-17 is the optimally fitted curve and represents the minimum of 
this total error from the normalised error function. It is also important to note that these 
simulations were based on optimisation for the mean observed periportal and 
pericentral oxygen tensions. By nature, these two zones of the in vivo sinusoid have 
oxygen tension ranges as previously described. This implies that there may already be 
some acceptable error already built in to the simulation as a result of this mean fitting.  
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Figure 3-17 – Optimal culture operating conditions for 2000-cell spheroids to 
recapitulate in vivo periportal and pericentral oxygen tensions.  The optimally fitted line 
demonstrates the required incubator oxygen concentration to maintain in vivo-like liver 
oxygen tensions. 
 
The aim of this aspect of my mathematical modelling was to ascertain the optimal in vitro 
culturing conditions (i.e. incubator oxygen levels) to replicate the in vivo sinusoidal 
oxygen profiles. By further extending the model to incorporate varying external oxygen 
concentrations, I have now been able to discern the most appropriate operating 
conditions for my PRH spheroids with an initial cell seeding density of 2000 cells as given 
by Figure 3-17. This figure shows that in order to capture the required periportal and 
pericentral oxygen tensions, the incubator oxygen concentration needs to be reduced 
continually over the duration of the culture period. The initial incubator concentration 
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starts at around 19.5% and by day 31 the incubator oxygen needs to be decreased to 
around 15%. As I have been able to mathematical model the optimised operating 
conditions for 2000-cell spheroids, I wanted to see if there was a difference between the 
cell seeding densities and how the spheroid radius-coupled OCR (𝑉𝑚𝑎𝑥) and compaction 
characteristics may have affected these operating conditions. That is, the final aim of this 
part of the mathematical modelling was to develop optimised operating conditions for 
all of the cell seeding densities that I have used throughout the experimental 
characterisation work. Currently there is no work within the literature that has used 
mathematical modelling to optimise an in vitro liver system to recapitulate in vivo oxygen 
tensions in this way. Therefore, my aim is to provide experimentalists with appropriate 
operating conditions in order to achieve these desired characteristics. The premise of this 
kind of mathematical optimisation allows potential end users to culture PRH spheroids 
in different oxygen conditions depending on their application.  
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Figure 3-18 - Required external oxygen concentration to achieve (A) mean periportal, 
(B) mean pericentral oxygen tensions, (C) both core and boundary curves with a best fit 
curve for both hepatic zones and (D), the optimal operating conditions for 3000-cell 
spheroids over the duration of the culture period. 
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Figure 3-19 – Required external oxygen concentration to achieve (A) mean periportal, 
(B) mean pericentral oxygen tensions, (C) both core and boundary curves with a best fit 
curve for both hepatic zones and (D), the optimal operating conditions for 4000-cell 
spheroids over the duration of the culture period.  
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Figure 3-20 - Required external oxygen concentration to achieve (A) mean periportal, 
(B) mean pericentral oxygen tensions, (C) both core and boundary curves with a best fit 
curve for both hepatic zones and (D), the optimal operating conditions for 5000-cell 
spheroids over the duration of the culture period.  
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Figure 3-18, Figure 3-19 and Figure 3-20, demonstrate the external oxygen concentration 
regimes required to achieve recapitulation of observable in vivo oxygen tension for 3000-, 
4000- and 5000- initial cell seeding densities respectively over the duration of the culture 
period. We can see from these figures that the required incubator oxygen concentrations 
vary dramatically depending on the initial cell seeding density. This observation is clearly 
influenced by the relationship between OCR (𝑉𝑚𝑎𝑥) and spheroid radius. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-21 – Overlay of optimal operating conditions (the required incubator oxygen 
%) for all PRH cell seeding densities. The red curve represents the optimally fitted curve 
for 2000-cell spheroids, the blue curve is for 3000-cell spheroids, the green curve is for 
4000-cell spheroids and the cyan curve is for 5000-cell spheroids.  
– 2000 cell spheroid 
– 3000 cell spheroid  
– 4000 cell spheroid 
– 5000 cell spheroid 
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Figure 3-21 shows all of the optimised incubator operating conditions (in terms of the % 
oxygen required in the incubator) needed to capture both the periportal and pericentral 
oxygen tension as seen in vivo. From these results, the 2000-cell spheroids require a 
continual reduction in incubator oxygen levels (%) to achieve the desired oxygen profiles, 
as previously discussed. 3000-cell spheroids require an initial incubator oxygen of 
approximately 18.7% on day 3 of culture, and then a steadily increase in % oxygen to 
approximately 19.5% at day 15. Finally, a gradual decrease to approximately 17% oxygen 
is required for the remainder of the culture period. 4000-cell spheroids require the initial 
oxygen levels in the incubator to be just under 18%. A gradual increase is then required 
to approximately 19.2% oxygen by day 17, and then a gradual reduction back to 
approximately 18% is required for the duration of the culture period. Interestingly, the 
5000-cell spheroids require a completely different incubator oxygen profile when 
compared to the other seeding densities.  At day 3, 5000-cell spheroids initially require 
approximately 16.2% oxygen inside the incubator. The oxygen needs to be gradually 
increased to approximately 19.3% by day 20, and finally a gradual decrease to 
approximately 18.5% is required for the remainder of the culture period.  
3.6 Chapter discussion  
The principle aim of my mathematical modelling in this chapter was to be able to 
optimise the in vitro PRH spheroid model, previously characterised experimentally in 
Chapter 2, to display sinusoidal oxygen gradients that are characteristic of the healthy in 
vivo liver sinusoid. The premise of modelling oxygen diffusion within spheroid models 
has a long history and has been investigated and published by several authors (e.g. see 
[229, 230]). The diffusion of oxygen into a spheroid containing oxygen-consuming cells 
has been investigated with results indicating that the oxygen profile can be determined 
by the OCR per cell and the diffusion coefficient [231]. As such, it was imperative that 
reliable values for each of these parameters could be identified within my own model.  
There has been some recent work undertaking a similar aim. For example, a recent 
publication looked at the determination of oxygen gradients within HepaRG spheroids 
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[178]. In this paper, the authors cultured HepaRG spheroids and utilised image analysis 
from fluorescence staining of propidium iodide (PI) to determine the degree of necrosis 
within the spheroids. The cellular OCR was described by a Michaelis–Menten term and 
numerical values were taken from reported literature on HepG2 cells, as the specific OCR 
values for HepaRG cells are unknown. A principle limitation of this study is that the 
mathematical modelling of optimal spheroid size is based on the assumption that the 
HepaRG spheroids will have a similar OCR to HepG2 cells. There have been numerous 
studies that have demonstrated that HepaRG cells (in 2D and 3D), have improved liver-
specific functionality when compared with HepG2 cells [87, 232, 233]. This improved 
cellular output is highly likely to have an effect on cell-specific OCR. However, this 
mathematical modelling approach, with analysis of fluorescent images to determine 
levels of necrosis throughout the spheroids, does allow for a robust investigation in terms 
of validating simulations against known oxygen profiles within the in vitro model.  
In a similar way, I took cellular OCR values from the literature and observed the vast 
variation in these parameter values. Thus, it was vitally important to determine not only 
cell-specific OCR, but also experimental model-specific OCR. Utilisation of the Seahorse 
platform to undertake these investigations provided us with a more comprehensive 
understanding of the process of oxygen usage by the cells within the spheroid, and also 
the interesting dynamics between the consumption of oxygen and its relationship 
spheroid radius. For most of the previous investigations of oxygen consumption rates by 
spheroids, the derived consumption rates are treated as mean values. The literature has 
previously reported the interesting phenomenon of OCR being a function of spheroid 
radius [231, 234]. These previous investigations with tumour spheroids describe OCR of 
spheroids decreasing as the spheroid radius increases. Experimental OCR values have 
shown that as spheroids increase in size (radius) due to cell proliferation, the cells tend 
to turn over less oxygen. This relationship has been seen when normalising to spheroid 
radius and, in the case where necrotic cores are observed, OCR values have been 
normalised to viable rim size, and the data still demonstrates the same trend. However, 
to my knowledge, there have been no studies that have implemented this relationship 
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within a mathematical model to simulate relevant oxygen profiles. Furthermore, there 
has been no research that use these profiles to subsequently propose optimised culture 
conditions in order to mimic sinusoidal-specific gradients.  
Additional experimental work, similar to that of Aleksandrova et al. [178], would have 
provided further means to validate my mathematical modelling predictions. There have 
been numerous ways in which experimentalists have attempted to utilise image analysis 
to derive oxygen profiles for spheroids including the use of hypoxyprobe analysis [235, 
236] and fluorescence lifetime imaging analysis [222]. This type of supplementary 
experimental assessment would provide an appropriate benchmark from which to 
compare my predictions. Although this potential future work would strengthen and 
potentially improve the validity of my modelling efforts, the previously undertaken 
histological, IHC and IF analysis does imply that my PRH spheroids produced using the 
LOT are devoid of necrosis.  
In direct comparison with hepatic-derived cell lines (C3A, HepG2 etc.) the growth 
characteristics of spheroids produced from proliferative cell lines limits their utility for 
toxicological investigations. It is entirely probable that proliferative HepG2 and C3A cells 
have an increased OCR when compared with isolated primary hepatocytes, as this aspect 
of the cell cycle requires a much-increased turnover in ATP and thus, increased 
consumption of oxygen. A recent publication described the effects of octyl gallate (OG) 
in HepG2 cells and the intrinsic mechanisms involved [237]. They reported that treatment 
with OG for 24 hours inhibited HepG2 cell growth by decreasing mitochondrial activity 
and mass, which subsequently led to the reduction of ATP levels. This reduction in the 
ATP supply initiated a decrease in Ki67 protein expression (a marker of cell proliferation), 
leading to cell-cycle arrest [237]. From this study, it is clear that cell proliferation requires 
increased levels of ATP, and consequently an increased oxygen consumption demand on 
the cells. It is possible that hepatic-derived cell line spheroids are increasingly limited in 
terms of radius expansion due to the presence of these proliferating cells.  
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From Figure 1-7 (B), we can see that there are three distinct zones within a classic tumour 
spheroid and it is the proliferative rim that has an increased OCR when compared with 
the quiescent zone [234]. This may be partly responsible for the formation of necrotic 
regions due to hypoxia. In my spheroid model, the isolated hepatocytes do not proliferate 
ex vivo and consequently these cells behave much more similarly to the quiescent zone 
of a tumour spheroid. Also, the effect of spheroidal compaction due to upregulation of 
ECM elements and components of the cytoskeleton leads to an overall reduction in 
spheroid size during culture. The size stability of these 3D microtissues may facilitate 
oxygenation of the spheroids over the entire culture time. However, analysis of PRH 
spheroid OCR shows that there is an increase in the consumption of oxygen in line with 
this decrease of overall spheroid size. This may be caused by an increase in the liver-
specific functionality of the cells within spheroids over the duration of the culture period.  
It may be the case that by altering the concentration of the incubator oxygen supply, 
instead of capturing the normal sinusoidal oxygen tensions of a healthy liver, it may be 
possible to produce an in vitro system that is representative of various liver disease states. 
Although simple recapitulation of oxygen tensions seen in liver disease manifestations 
may not be wholly representative of a liver disease, an oxygen gradient replicating this 
unhealthy sinusoidal gradient will certainly affect the potential zonation of the cells and 
subsequent enzyme and gene expression. The normal oxygen gradient of the liver 
sinusoid previously described by [118, 120] plays a vital role in liver zonation. This 
normalised oxygen supply and subsequent sinusoidal gradient, also known as ‘normoxia’, 
results in hepatocytes displaying specific functional and structural characteristics [120, 
238]. Hypoxia of the liver would describe an oxygen tension that falls below the normoxic 
pericentral oxygen tension (around 4%), and conversely ‘hyperoxia’ would describe an 
oxygen tension greater than that of the normoxic periportal region (around 9%). Despite 
the variation in oxygen tensions within the liver sinusoid for both periportal and 
pericentral regions, hypoxia is not observed in the normal healthy liver in vivo [239, 240]. 
Modest changes in liver oxygen tensions occur due to a number of disease manifestations, 
such as, infection with viral hepatitis, metabolic disorders, steatohepatitis, inflammation 
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and carcinogenesis [240-242]. In other studies looking at the effects of oxygen 
supplementation for patients with poorly functioning lungs, hyperoxia has been shown 
to alter mitochondrial thiol status in the liver [243]. 
The ability to recapitulate oxygen tensions for specific liver diseases may allow the in vitro 
model to capture required end points in order to investigate how novel xenobiotics and 
compounds with unknown outcomes are converted and metabolised for diseased liver 
models. 
3.7 Conclusion 
The results from my mathematical modelling show the potential to optimise in vitro liver 
models by recapitulating specific gradients as seen within the liver sinusoid. My initial 
aim was to establish guidance for viable spheroid size limitations based on a combined 
in vitro and in silico approach. In this work, I have been able to propose optimised cell 
culture operating conditions in order to replicate in vivo characteristics. The next stage 
of characterisation would be to now test my optimised spheroid system with known liver 
toxicants.  
Finally, further experimental investigations, whereby I could look at controlling the 
external oxygen concentration at source, would provide vital validation for my modelling 
predictions. The use of hypoxyprobes or other immunofluorescent imaging would be 
able to provide vital information with regards to the formation of necrosis due to hypoxia. 
This additional experimentation would be able to attest to the validity of the 
mathematical model and its subsequent utility, not only for the testing of novel 
xenobiotics for hepatotoxic investigations, but also its potential for recapitulating the 
sinusoidal oxygen tensions displayed with various forms of liver injury or disease.  
The aim of this chapter was to better understand the limitations of spheroid sizes due to 
the effects of oxygen diffusion and consumption. I have been able to answer this question 
for my specific experimental model, and I have further developed the mathematical 
model to optimise operating conditions. The changing spatio-temporal dynamics of 
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oxygen are relatively straight forward due to the fact that oxygen is a relatively small 
diffusing particle. I wanted to be able to understand how other molecules and solutes 
are transported in my experimental model, and develop a mathematical model to see 
how the transport of other solutes is different when compared with oxygen. As oxygen 
diffuses through cells and across cellular membranes, I do not need to account for 
diffusion barriers and other transport routes within the model. However, when 
considering other solutes including xenobiotics, because these particles are much larger 
than oxygen, it is highly likely that the cellular microenvironment will affect the ability of 
these solutes to be transported.  
The aim of Chapter 4 is to develop a mathematical model to better understand how larger 
molecules are transported within my experimental spheroid system. I aim to incorporate 
PRH spheroid-specific parameters pertaining to features of paracellular transport (and 
potential barriers of diffusion) in to the model and analyse how these may impede the 
ability of solutes to be transported.  
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Chapter 4: Mathematical modelling of 
xenobiotic transport through hepatocyte 
spheroids 
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4.1 Biological motivation  
Much of our understanding regarding the effects of xenobiotics on cells in vitro is based 
on investigations using conventional monolayer cultures, and until recently this was due 
to limitations of experimentation. More recent studies have utilised 3D models including 
spheroid systems to investigate xenobiotic effects, however, many of these 3D platforms 
are relatively poorly characterised [187]. Previous investigations using spheroids derived 
from tumour cell lines have shown promise with regards to assessing the effects of 
xenobiotics. These investigations have provided some insight into the potential efficacy 
of xenobiotics on tumours in vivo [231, 244, 245]. Classic tumour spheroids are 
characterised by three specific zones as described previously (see Figure 1-7). As a direct 
result of the 3D microenvironment, specific solute gradients exist from the boundary to 
the core of spheroids. Limitations in the diffusion potential of these solutes results in the 
formation of zones of proliferation, quiescence and necrosis within the spheroid, 
recapitulating the specific heterogeneity of tumours as observed in vivo [122, 246]. The 
implication that the 3D cellular microenvironment may affect the diffusive capabilities of 
nutrients and solutes within the spheroids also raises the same question for the ability of 
xenobiotics to penetrate into the entirety of the microtissue. This concern regarding drug 
penetration in 3D microtissue models has also been noted in various studies utilising 
tumour spheroids [247, 248]. Additionally the extracellular space between cells is 
permeated by a network of cross-linked proteins which make up the ECM. This matrix 
provides both structural and biochemical support to the surrounding cells in vivo and also 
in vitro. External forces exerted on these cellular structures and proteins within the 
network results in cellular migration and proliferation. The ECM is also continually 
remodelled by cells within the tissue, as multiple cell signals result in the production of 
matrix-degrading enzymes, whilst other signals result in the formation of new filaments 
[249]. These physical phenomena, and the continuous motile characteristics of cells and 
other constituent cellular elements within tissues (both in vivo and in vitro) makes 
mathematical modelling approaches to describe these characteristics difficult.   
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3D cell culture has been generally described as superior to 2D monolayer cell culture with 
respect to physiological relevance [250]. Specifically, 3D in vitro liver models are 
increasingly being acknowledged as an advanced platform for hepatotoxicity 
assessments due to the preservation of in vivo characteristics and liver-specific 
functionality [7]. Cells cultured in a 2D conformation are exposed to a nutrient-rich 
environment in which all cells experience the same oxygen tension and a homogenous 
amount of nutrients and growth factors from the medium during growth [250]. Waste 
products from these cells are also freely expelled into the culture medium. This cellular 
situation is certainly not representative of the in vivo situation. 2D cell cultures have 
previously been useful in determining drug action kinetics, and more recently at 
developing our understanding of chemical processes and kinetics of drug action at the 
single cell level [251]. However, the limitations of 2D cell culture systems have moved the 
research into exploring whether 3D cell culture platforms can provide more accurate in 
vitro tools that can bridge the gap between in vitro and in vivo.   
There have been numerous publications that demonstrate that spheroids display 
increased resistance to a number of xenobiotics when compared with monolayer 
cultures [250, 252]. This increased resistance to xenobiotics displayed by spheroid 
cultures is likely to be a result of the complex 3D microenvironment, including 
upregulated ECM and cytoskeletal components. The inherent physicochemical properties 
of xenobiotics may also affect the ability of specific compounds to penetrate the cultures 
effectively, as compounds with a higher propensity to adhere to cells may have increased 
binding affinity with the peripheral cells of the spheroid [189].   
Previously described mathematical models for drug penetration into tumours have 
provided insightful information in predicting therapeutic efficacy [253, 254]. The 
majority of research in this specific area has involved the modelling of cancer therapeutic 
drugs [187, 194, 255]. Mathematical modelling of transport properties in spheroid 
systems has described the delivery and movement of macromolecules in tumours, with 
most publications implicating the assumption of radial symmetry in order to facilitate 
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the modelling efforts [256]. A key conclusion from these previous works has been the 
demonstration of micro-architectural diffusional impediments to these molecules. 
However, relatively few investigations have attempted to model the penetration of 
larger molecules including nanoparticles and other xenobiotics. As these relatively 
smaller macromolecules have transport limitations within 3D microenvironments, it is 
clear that this effect may be more prominent for larger compounds.  
One notable publication that has implemented experimentally derived spheroid-specific 
(tumour) parameters into a mathematical diffusion model is that of Goodman et al. [245]. 
This publication provides a useful insight into the diffusion, penetration and transport 
properties of nanoparticles in a 3D spheroid system. The model parameterises spatial 
features in the spheroid microarchitecture including, the volume fraction of the 
accessible routes for paracellular diffusion, and the changing tortuosity of these routes 
with respect to spheroid radius. Other parameters, such as nanoparticle binding and 
accessible volume fraction were determined experimentally. This combined 
experimental and mathematical modelling approach has improved our understanding of 
the efficiency of nanoparticle delivery, and the effect of tumour architecture on 
nanoparticle transport. 
4.1.1 Background on porous media modelling  
Previously published models of porous media transport provide a useful basis for the 
derivation of a new mathematical framework for modelling paracellular solute transport. 
In general terms, porous media refers to a material or biomaterial that contains voids 
that are subsequently filled with a fluid. A porous medium is most often characterised by 
its porosity, which is defined as the fraction of the volume of pores over the total volume 
of the medium. For example, such porosity calculations for the in vivo liver have been 
explored by Bonfiglio et al. [257] and Siggers et al. [258]. Porous media may also be 
characterised by other features such as permeability, tensile strength etc. However, a key 
feature for my in silico modelling is tortuosity i.e. the directness of the paracellular path. 
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Tortuosity can be defined as the ratio of the length of the curved path to the Euclidian 
distance between the two ends of the path.  
Tortuosity has been utilised and described in far more detail with regards to chemical 
engineering [259] and in the field of medicine [260]. However, there have been some 
publications regarding the liver that utilise this parameter. Izadifar et al. [261] described 
a mechanistic modelling approach for drug elimination by the liver where the porosity, 
tortuosity and physicochemical properties were derived to describe the transient drug 
transfer and elimination across the liver following intravenous (IV) dosing. I want to be 
able to apply this method, and adapt it to investigate the transport and uptake of various 
molecules and xenobiotics in my experimental PRH spheroid model. 
My initial modelling will investigate the diffusivity of xenobiotics, of varying sizes and 
physicochemical properties, to determine whether or not they will penetrate the entirety 
of the spheroid. I will also analyse the heterogeneous microarchitecture of the 
experimental system and translate these physical properties into the model.  
4.1.2 Aims of mathematical modelling of solute diffusion in PRH spheroids 
The main aim of my mathematical modelling approach is to better understand the 
implications of the liver microtissue cellular microarchitecture on the diffusion of 
xenobiotics of varying sizes with different physicochemical properties. In particular, I aim 
to gain a more comprehensive understanding of how different compounds are 
transported into the 3D microtissue liver models.  
The experimental work in Chapter 2 has demonstrated the in-depth functional 
characterisation of my in vitro system and the mathematical modelling in Chapter 3 has 
provided prospective operating conditions for the recapitulation of in vivo oxygen 
gradients. The next step is to develop our understanding of how larger solutes (e.g. 
xenobiotics) are transported into the spheroid system, and how the microarchitecture of 
the spheroids impacts on the transport profiles of these molecules. I propose a 
mathematical model, based on porous media modelling, to investigate xenobiotic 
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penetration into PRH spheroids. This model incorporates experimentally derived 
parameters for radially dependent changes in spheroid microarchitecture, as 
represented by the volume fraction of paracellular space available for transport, and the 
tortuosity of the paracellular paths. These changes in microarchitecture have been 
correlated with my experimental spheroid growth characteristics to provide an in silico 
model that closely resembles my in vitro model. 
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4.2 Porous media modelling equations  
The mathematical equations I use for porous media modelling are derived from Fick’s law 
and the previously identified Laplacian symmetry equations. The principle equations 
were derived in previous work by Goodman et al. [245], namely; 
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Where 𝑟 is the radial coordinate (𝑟 = 0 is the centre of the spheroid and 𝑟 = 𝑅 is the 
outer spheroid boundary), 𝑡 is time, 𝜀 is the volumetric porosity of the spheroid (the 
volume fraction of paracellular space), 𝑐 is the molar concentration of xenobiotic (e.g. 
mol/m3),  𝑐/𝜀 is the concentration of the xenobiotic in the accessible paracellular volume, 
𝑘𝑢 is the passive diffusion rate of the xenobiotic into the cells, and, 𝐷 is the effective 
diffusion coefficient of the xenobiotic in the spheroid.  
In Goodman et al. [245] the effective diffusion coefficient is expressed by the following 
equation; 
 𝐷 = 𝐷0
𝐿(𝜆)
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Where 𝐷0 is the diffusion coefficient of the xenobiotic in the liquid medium, 𝐿(𝜆) is a 
factor responsible for hydrodynamic and steric reduction of the diffusion coefficient in 
the pore due to the size of the xenobiotic (𝛼) and that of the pore (𝑟𝑝), 𝜆 is the ratio of 
the particle size to pore radius, 𝜏(𝜀) is the tortuosity of the paracellular paths, 𝑘𝐵  is 
Boltzmann’s constant, 𝑇 is the absolute temperature (in Kelvin), 𝜇 is the viscosity of the 
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liquid medium, 𝛼  is the radius of the diffusing xenobiotic, and 𝑟𝑝  is the radius of the 
paracellular pores within the spheroid. The equations for 𝐿(𝜆)  and 𝜏(𝜖)  have been 
empirically defined by Saltzman [262], whereby transport rates of particles have been 
examined in multiple tissues. These equations are based on the idea that a spherical 
particle travels along the centre line of a cylindrical tube. Equation (4-3) describes how 
𝐿(𝜆) is a decreasing function of 𝜆 , and that the tortuosity,  𝜏(𝜖) , is a function of the 
volumetric porosity, 𝜀 (see Figure 4-2). 
4.3 Model parameterisation  
In the initial model by Goodman and colleagues, a number of the key variables, including 
volumetric porosity and pore radius, were determined via the use of brightfield 
microscopy image analysis (e.g. see Figure 4-1). In this example, spheroids are produced 
from monodispersed cells (FaDu human hypopharyngeal carcinoma cells) where they 
form into a 3D microtissue via self-reaggregation. FaDu spheroids were produced utilising 
the LOT as previously described (2.2.1 and 2.2.3). Spheroids were washed in PBS, fixed 
for 1 hour in 4% paraformaldehyde (PFA) and embedded in 2% agarose (low EEO) in 4% 
PFA before being subjected to routine histological processing and finally resin embedded. 
5µm sections were cut using a Leica RM2235 microtome (Leica microsystems) and 
stained with toluidine blue. These spheroids contain clear paracellular spaces that can be 
easily identified and dimensions quantified. FaDu spheroids were chosen for comparison 
with PRH spheroids as both microtissue models were produced utilising the same culture 
technique. This allows for direct comparison of cellular organisation between the 
proliferative tumour cell line and the non-proliferative PRH cells as all other culture and 
microtissue processing protocols were equivalent.  
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Figure 4-1 – A brightfield microscopy image of the edge of a fixed, stained section of a  
FaDu spheroid slice (5 μm) imaged at 100x magnification. Pores between cells show up 
as unstained areas in the microscope image and were measured with MetaMorph 
software to obtain an estimate of pore size.Dark blakc staining shows cell nuclei. 
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Goodman et al. [245] used these types of images (Figure 4-1) to calculate the volumetric 
porosity (𝜀), and the pore radius (𝑟𝑝) (for graphical representation of 𝜀 and 𝑟𝑝 see Figure 
4-2). 
 
Figure 4-2 – (A) shows the porosity, 𝜺, based on structural measurements of spheroid 
sections, as a function of the scaled radial position (where 0 is the centre of the spheroid, 
and 1 is the spheroid boundary). (B) shows the ratio of pore size, 𝒓𝒑, to spheroid radius, 
𝑹, as a function of scaled radial position [245]. 
 
For my PRH spheroids, the analysis of brightfield microscopy images of toluidine blue 
stained slices was ineffectual for determining these parameters. This was due to the 
much higher levels of ECM and cytoskeletal components within the PRH spheroids when 
compared to tumour spheroids. Standard cellular staining and image analysis could not 
elucidate the distinct paracellular spaces (as seen for the FaDu cell spheroids Figure 4-1), 
and similarly I was unable to determine the size of the pores or the tortuosity from the 
initial image analysis.  
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Figure 4-3 demonstrates the tight cell-cell interactions within the spheroid and the 
presence of large amounts of ECM.  
 
 
 
 
 
 
 
 
 
Figure 4-3 – 5 µm slice of a PRH spheroid stained with toluidine blue, demonstrating 
that paracellular spaces are not visible under this magnification using brightfield 
microscopy. Scale bar = 20 µm. 
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Therefore, the first parameter that I need to obtain is the size of the paracellular spaces 
between the cells (𝑟𝑝). In order to calculate this I utilise transition electron microscopy 
(TEM) images and ImageJ analysis from the experimental characterisation in Chapter 2 
(see 2.2.7). 
Figure 2-14 (B) shows the paracellular space between two adjacent hepatocytes. By 
magnifying the image, analysing the width of the space between the cells and comparing 
this to the known scale bar size, the average width of the paracellular spaces was 
determined. There were slight variations in the size of the paracellular pores but for my 
subsequent mathematical modelling I assume the average pore size for the entire 
spheroid. The average pore size (𝑟𝑝) from this analysis was taken to be 0.05 µm.  
Having determined the average size of the pores within the experimental model, I now 
want to calculate values for the volumetric porosity. In essence, this refers to the 
proportion of the spheroid that is composed of paracellular space. From my initial 
characterisation work in Chapter 2, brightfield images and histological analysis 
demonstrates spheroid compaction over the duration of the culture period and also 
cellular stratification on the periphery of the spheroid. I want to be able to assess what 
impact these changes may have on the diffusion and transport of xenobiotics, by 
quantifying how these observed variations impact on the values of volumetric porosity, 
and over the duration of the culture period.  
In order to determine the volumetric porosity I need to be able to visualise the 
paracellular spaces for the entire spheroid. Clearly, using TEM images to assess this is 
inappropriate due to the size of the spheroids relative to the scale of the TEM images, 
therefore I implement the use of a novel mathematical modelling approach in order to 
determine this parameter.   
One such method that may facilitate the derivation of the volumetric porosity ( 𝜀 ) 
parameter has been described in the literature, and is referred to as Voronoi tessellation 
(VT). VT is a mathematical description where cells within a tissue are regarded as tiles 
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tessellating space. This mathematical description is commonly used for estimating the 
morphology of cells in epithelial tissues [263] and, as hepatocytes are essentially 
specialised epithelial cells, the implementation of this mathematical technique to 
provide morphological estimates for PRH spheroid models seems appropriate. An 
example of the use of VT to define cellular morphologies was done in 1978 by Honda et 
al. [264], which describes cellular morphologies by Dirichlet domains (convex polygons) 
which cover a plane without leaving any gaps or overlaps. These Dirichlet domains were 
shown to accurately describe cellular patterns including monolayer cells, and epithelial 
cells in tissue.  
4.3.1 Voronoi tessellation  
VT will be implemented to determine the boundary of cells within my spheroids. A key 
constituent element to a VT is a set of discrete points around which the VT is organised. 
In my work, this set of points will be described by the individual cell nuclei. The theory of 
VT as applied to this problem is as follows.  
I suppose there are 𝑛 cell nuclei 𝑝1, … 𝑝𝑛. Modelling the slice of our spheroid as a planar 
region, 𝑝1, … 𝑝𝑛 are given as points in the ℝ
2 plane. This set of cell nuclei is then defined 
by, 
 𝑃 = {𝑝1, … 𝑝𝑛} 𝑖𝑠 𝑎 𝑠𝑒𝑡 𝑖𝑛 ℝ
2. (4-4) 
For point 𝑝𝑖, I associate its Voronoi region 𝑉(𝑝𝑖) where; 
 𝑉(𝑝𝑖) = {𝑞 ∈ ℝ
2: |𝑞 − 𝑝𝑖| ≤ |𝑞 − 𝑝𝑗|, ∀𝑗 ≤ 𝑛}. (4-5) 
The region 𝑉(𝑝𝑖)  is therefore the intersection of 𝑛 − 1  half-spaces. This half-space 
contains 𝑝𝑖 and is bounded by the bisector of 𝑝𝑖 and another point of 𝑃. For example, for 
𝑝𝑖 , 𝑝𝑗 ∈ 𝑃, this region is bounded by the bisector of 𝑝𝑖 and 𝑝𝑗, that is, the set of points 
which have the same distance to both 𝑝𝑖 and 𝑝𝑗 (see Figure 4-4). 
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Figure 4-4 – shows a schematic illustration of 𝒑𝒊  and 𝒑𝒋  where these points are 
separated by a bisector.  
 
𝐻(𝑝𝑖 , 𝑝𝑗)  denotes the closed halfspace bounded by the bisector of 𝑝𝑖  and 𝑝𝑗  that 
contains 𝑝𝑖 . In ℝ
2 , 𝐻(𝑝𝑖 , 𝑝𝑗) is a halfplane. The Voronoi Diagram 𝑉𝐷(𝑃) of a set 𝑃 =
{𝑝1 … 𝑝𝑛} of points in ℝ
2 is the subdivision of the plane caused by the Voronoi cells 𝑉(𝑝𝑖), 
for 𝑖 = 1, … , 𝑛. 
Voronoi can also be thought of in terms of another form of computations geometry called 
Delaunay triangulation. The premise of the approach is that for 𝑃 = {𝑝1 … 𝑝𝑛} in ℝ2, a 
triangulation of these points is a collection, Ƭ, of triangles. Every set in ℝ2, with 𝑛 ≥ 3 
points has a triangulation, unless all points in 𝑃  are collinear. Using this method, 
Delaunay triangulation connects all points in 𝑃 with straight lines. For an example, I take 
the simplest case where I have 3 points within the plane (see Figure 4-5). 
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Figure 4-5 – Voronoi diagram and Delaunay triangulation of 3 discrete points (P1, P2 
and P3). The blue lines describe the boundaries of the Voronoi cells which are bisectors 
of the Delaunay triangulation shown by the red dashed lines.  
 
Figure 4-5 demonstrates the simplest example of Voronoi diagram with accompanying 
Delaunay triangulation. The dashed red line shows the Delaunay triangulation of these 
points, where all the points are simply connected with each other. The blues lines show 
the bisectors between the points which converge towards each other to produce the 
Voronoi cells. For illustrative purposes Figure 4-6 shows the effect of increasing the 
number of points within the plane. 
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Figure 4-6 – Voronoi diagram and Delaunay triangulation of 20 randomly generated 
points. We can see now with a larger number of points that a number of Voronoi cells 
have been produced in the centre of the figure. These mathematically predicted cells have 
been reported to be a good estimation for epithelial cell membranes/boundaries in both 
monolayer and 3D culture [263].   
 
In this figure, we can see the interconnected points (Delaunay triangulation), again 
shown by the dashed red lines, with the bisecting blue lines to produce the Voronoi 
diagram. This approach to model epithelial cell boundaries has been found to be effective 
in capturing the morphological features of biological cells due to the natural cuboidal 
morphology of these biological cells, especially in 3D [263]. It is now accepted that these 
tessellations predict the observed morphological characteristics of epithelial cells with 
good accuracy. I therefore implement this same mathematical modelling approach to 
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distinguish the cell boundaries within IHC and histological images of our own spheroid 
slices.   
Firstly, I describe how I generate our Voronoi diagrams from my IHC and histology images. 
I utilise a publically available web-based application called WEBPLOTDIGITIZER, to extract 
the positions of the cell nuclei from the IHC images. The IHC images represent 2D slices 
of the 3D spheroids so that the cell nuclei represent points in the ℝ2 plane.  
The corresponding Voronoi tessellations can be generated using the Matlab Voronoi 
function. In some cases (i.e. cell nuclei near the cell boundary) the corresponding Voronoi 
cells are not closed. To close these cells, an additional tool was utilised called 
VoronoiLimit (https://uk.mathworks.com/matlabcentral/fileexchange/34428-
voronoilimit-varargin-) which constrains the Voronoi vertices to a given boundary domain. 
This means that I was able to limit the Voronoi tessellations to the region of ℝ2 space 
bounded by the spheroid boundaries. 
 
 
Figure 4-7 – (Left) Voronoi diagram for a day-11, 3000-cell spheroid. (Right) overlay of 
mathematically derived cell boundaries from VT and original microscopy image of IHC 
stained spheroid section (5 µm slice).  
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The left-hand image of Figure 4-7 shows the generated Voronoi diagram for an example 
spheroid slice. The right-hand image shows an overlay image of the IHC microscopy 
image and the generated Voronoi diagram. The large cell nuclei are visible in the right-
hand image and we can see that the computed cellular geometry provides a convincing 
representation of the cell-cell boundaries. I repeat this approach to all cell seeding 
densities, for days 3, 7, 11, 18 and 21 (in triplicate) (see Figure 4-8).  
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Figure 4-8 – Histology images for days 3, 7, 11, 18 and 21 with corresponding 
mathematically computed Voronoi diagrams. H&E stained histology samples show 
distinct nuclear staining in purple. Scale bars = 50 µm. 
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In order to determine how the volumetric porosity changes with regards to radius and 
time, the next step of analysis was to spatially categorise the Voronoi diagram and 
subsequently establish the volumetric porosity of separate annuli. Values for volumetric 
porosity (𝜀) can then be calculated for the separate annuli of decreasing radius and a 
function, 𝜀(𝑟), can be determined.  
 
Figure 4-9 – Separated annuli for a day-7, 4000-cell spheroid Voronoi tessellation. (Each 
annulus represented a thickness of 25 µm).  
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Figure 4-9 shows an example of the method utilised to partition the Voronoi diagram into 
separate annuli. For example, annulus 1 shows the outer most section of my day 7 
spheroids, where the radius of the annulus is 25 µm. From this outer most annulus, the 
inner edge was taken to be the outer most edge for the subsequent annuli section. This 
was repeated for the additional annuli of the Voronoi diagram with each annulus taken 
to be 25 µm. The method of partitioning the Voronoi images was implemented for all 
time points. 
ImageJ analysis was then utilised to produce a binary image of the different spheroid 
annuli. For each annuli image, the percentage of the area that is made up from 
paracellular lines was determined by using a threshold function, which quantified the 
area of the black lines. The % area of paracellular lines was converted to area (µm2). The 
width of the black lines (i.e. pixel width) produced from the VT was subsequently 
measured. This paracellular line area was then divided by this width and multiplied by 
the calculated pore size (0.05 µm) to give an estimate of area for the paracellular space 
in the annuli. 
This area value was then expressed as a fraction of the annulus area to give an estimate 
of volumetric porosity (𝜀) (see Table 6 for the full calculations). For each time point (day 
3, 7, 11, 18 and 21), 3 spheroids were analysed, and all of the normalised volumetric 
porosity values were plotted.  
 
 
 
 
 
 
 Mathematical modelling of xenobiotic transport through hepatocyte spheroids 
  
193 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6  - Table of volumetric porosity calculations as described in Figure 4-9 for 4000-cell spheroids at day 7 of culture. These values were 
calculated for 3 spheroids for each time point. Normalised radius is subsequently plotted against volumetric porosity values.
  DAY 7 DAY 7 DAY 7 DAY 7 
Annulus # 1 2 3 4 
X AXIS LENGTH (µm) 251.03 219.66 206.55 152.05 
Y AXIS LENGTH (µm) 263.1 228.97 207.59 156.51 
TOTAL AREA (µm2) 6.605x104 5.030x104 4.288x104 2.380x104 
Background area % 96.66% 96.72% 97.54% 97.83% 
VT area  % 3.34% 3.28% 2.46% 2.17% 
Total area of scale bar% 0.30% 0.40% 0.47% 0.84% 
VT area % - scale bar % 3.04% 2.88% 1.99% 1.33% 
Corrected area of VT (µm2) 2.01x103 1.45x103 8.53x102 3.17x102 
Width of line (average) (µm) 1.147 0.993 1.100 1.073 
Width of line(1) (µm) 1.01 0.96 1.12 1.04 
Width of line(2) (µm) 1.03 0.98 1.31 1.33 
Width of line(3) (µm) 1.4 1.04 0.87 0.85 
Total length of VT (µm) 1.751x103 1.458x103 7.757x102 2.949x102 
Circle diameter (average) (µm) 225.33 170.9933333 116.2433333 65.97333333 
Circle diameter (1) (µm) 238.19 181.77 128.98 73.9 
Circle diameter (2) (µm) 206.09 155.09 101.84 50.95 
Circle diameter (3) (µm) 231.71 176.12 117.91 73.07 
Area of circle [r] (µm2) 3.988x104 2.296x104 1.061x104 3.418x103 
Area of inner circle ([r-r] (µm2) 3.152x104 1.674x104 6.539x103 N/A 
Area of annulus [r] (µm2) 8.358x103 6.224x103 4.074x103 N/A 
Gap size (µm) 0.05 0.05 0.05 0.05 
Area of gaps (µm2) 87.54933956 72.91167009 38.78484175 14.74400754 
𝝐 0.010475147 0.011714565 0.009520109 0.004313093 
(%) 1.05% 1.17% 0.95% 0.43% 
Normalised radius(R-12.5)/R 0.944525807 0.703383186 0.460406219 0.073196349 
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In order to understand how the values for volumetric porosity change radially, these 
calculated porosity values were plotted against the normalised spheroid radius for all 
time points. Note that I use the mid-points of the annuli as the relevant radial points for 
the subsequent plot (Figure 4-10). Using non-linear regression analysis, a power function 
was fitted through the data for each time point.  
 
Figure 4-10 – Volumetric porosity values for day 3, 7, 11, 18 and 21 spheroids, plotted 
against normalised spheroid radius. Where 0 is the spheroid core and 1 is the spheroid 
boundary. Dark blue dots show day 3, yellow dots show day 7, grey dots show day 11, 
orange dots show day 18 and light blue dots show day 21. Non-linear regression analysis 
was used to fit power curves through the data points (the line colour corresponds to the 
data of that colour). R2 values for these lines were 0.75, 0.76, 0.86, 0.93 and 0.89 for days 
3, 7, 11, 18 and 21 respectively. (n=3 for each time point).  
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Figure 4-10 shows the relationship between volumetric porosity and normalised 
spheroid radius to take into account the observation of spheroid compaction. For all time 
points, the volumetric porosity (𝜀) increases as we move out radially from the spheroid 
centre. This relationship becomes more apparent for later time points as there is an 
increase in cellular stratification on the periphery of the spheroid. The nuclear staining 
as seen in Figure 2-9 demonstrates this relationship. However, utilising the Voronoi 
method and subsequent ImageJ analysis I have been able to quantify this relationship. I 
want to implement this data for volumetric porosity and how it depends against radius 
in my mathematical model. Table 7 shows the fitted 𝜀 versus 𝑟 curves for the different 
spheroids (shown in Figure 4-10).  
 
Table 7 – Calculated volumetric porosity values from power fits shown in Figure 4-10.  
Culture time (days) Calculated volumetric porosity (𝜺) 
3 0.0096 𝑟0.2889 
7 0.0107 𝑟0.3359 
11 0.0105 𝑟0.3493 
18 0.0114 𝑟0.5536 
21 0.0116 𝑟0.5103 
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I now need to be able to determine the values for tortuosity and again look at how these 
values change with respect to spheroid radius and culture time. Again, as I am unable to 
use my microscopy images and simply measure the path lengths, I will utilise the 
previously generated Voronoi diagrams to estimate the relevant values for tortuosity. 
In order to properly derive values for tortuosity, I need to know the positions of where 
the lines intersect, subsequently referred to as nodes, within the Voronoi diagrams. 
These nodes represent the points at which multiple cell boundaries meet. This is to 
enable me to determine the routes of the paracellular spaces and the lengths of these 
paracellular routes between these nodes.  
As part of the construction of the Voronoi diagram, the spatial (𝑥, 𝑦) ∈ ℝ2positions of 
the Voronoi nodes are calculated. From these, I calculate the lengths of all the edges of 
each Voronoi cell (i.e. the distances between connected Voronoi nodes). These Voronoi 
nodes and the associated edges therefore define a weighted, connected graph (e.g. see 
Figure 4-11). To calculate the tortuosity of this resulting network, I follow the following 
procedure; 
1. For a given node, identify all nearby nodes within a given Euclidean radius (I take 
this distance to be 0.2, relative to the normalised radius), that are not directly 
adjacent to the given node. 
2. Calculate the shortest graph path length between the selected node and all nodes 
within the given Euclidean radius. 
3. Calculate the corresponding Euclidean distance between these points. 
4. Divide the path lengths calculated in step 3 by the distance calculated in step 4 to 
give the individual tortuosities of the paths from the selected node to its 
adjacent/nearby nodes.  
5. Record the average of these individual tortuosities to give an estimate of the ‘local’ 
tortuosity of the tessellation structure at this radial position. 
6. Repeat for each Voronoi node. 
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Figure 4-11 – Weighted Voronoi to determine the tortuosity within PRH spheroids. Red 
circles denote the nodes where the Voronoi edges meet. The green lines represent the 
total path length between nodes 76 and 110, whilst the blue dashed line denotes the 
Euclidean distance between the two points.  
 
Figure 4-11 demonstrates this methodology. For example, the tortuosity is calculated by 
looking at a specific node, in this case uniquely identified by the number 76, and looking 
at the total path length between neighbouring nodes e.g. node 110. This is the 
cumulative sum of the straight-line distances between these nodes within a specified 
region (not including direct neighbours). The tortuosity is therefore calculated by the 
ratio of the total path length, to the Euclidian between the two points. For my model, 
these calculations were determined for every node of the Voronoi with a specified 
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neighbourhood range. These calculations were repeated for all of the original Voronoi 
diagrams as used for the volumetric tortuosity calculations (n=3). Again, in order to 
compare the contraction of the spheroids over the duration of the culture time, and the 
effect of the cellular stratification on the spheroid boundary, the values for tortuosity 
were normalised to experimental spheroid radius, providing us with the scaled radial 
distance for all time points (i.e. 𝑟/𝑅, where 𝑅 is the spheroid radius).  
 
Figure 4-12 – Calculated tortuosity values plotted against scaled spheroid radius. Red 
circles show the tortuosity values for day 3, blue for day 7, black for day 11, magenta for 
day 18 and green for day 21. Non-linear regression analysis was used to fit these data 
points. The bottom right-hand subplot shows the resulting quadratic fits. R2 values for the 
quadratic fits were 0.90, 0.81, 0.82, 0.8437 and 0.80 for days 3, 7, 11, 18 and 21 
respectively. (n=3 for each im point).  
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Figure 4-12 shows the tortuosity values from my calculations for each node within the 
Voronoi diagrams. The coloured circles describe the individual tortuosity calculations for 
each node within the Voronoi tessellation (n=3). The scaled radial distance takes into 
account the variations in the spheroid sizes and allows a comparison of the tortuosities 
to be made. The lines on the subplots represent quadratic fits through the data points. 
For all time points we can see that the tortuosity increases as you move out from the 
spheroid core (scaled radius of 0), to the spheroid boundary (scaled radius of 1). This 
relationship can be seen to generally increase with respect to culture time i.e. day 21 
spheroids have a greater tortuosity at the boundary than the day 3 spheroids, and also 
have a much smaller tortuosity at the spheroid core than those from day 3.  
The quadratic fits through the calculated tortuosity values have the following 
relationships, where 𝑟 is the scaled radial distance (see Table 8); 
 
Table 8 – Calculated tortuosity values from quadratic fits through the data points. For 
these values, 𝒓 represents the scaled radial distance.  
Culture time (days) Calculated tortuosity (𝜏) 
3 0.2293 𝑟2 + 1.0808 
7 0.3439 𝑟2 + 1.0998 
11 0.5469 𝑟2 + 1.0000 
18 0.3229 𝑟2 + 1.0640 
21 0.5787 𝑟2 + 1.0000 
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I have now been able to derive a number of the key parameters that are required for my 
mathematical model. From the TEM microscopy images I have been able to determine 
the average size of the paracellular gaps within the spheroid, namely ( 𝑟𝑝 ). By 
implementing the Voronoi tessellation method, I have been able to derive appropriate 
estimates for both the volumetric porosity, 𝜀(𝑟), and the tortuosity, 𝜏(𝑟), and how both 
these parameters change with respect to culture time. In the original model by Goodman 
et al. [245] they found tortuosity to be a function of volumetric porosity. I did not see this 
relationship and instead implement both 𝜀 and 𝜏 as functions of the scaled spheroid 
radius (𝑟). 
Finally, I need to describe the range of particle sizes that I want to investigate with regards 
diffusion within the model. For this, I develop a list of xenobiotics and a number of 
important characteristics for each of these including, the size of the particle, LogP, LogD7.4, 
etc.  
4.3.2 Physicochemical characteristics of chosen xenobiotics 
Here I will present a list of compounds chosen to investigate with regards to application 
to my spheroid model, and describe the methods by which I have generated the 
characteristics required for the mathematical model. As previously described by 
Goodman et al. [245], I require the size of the diffusing particle (namely, its radius, 𝛼, see 
(4-3)). In Chapter 3, I looked at the diffusion of oxygen, which is a relatively small diffusing 
particle. Goodman et al. [245] looked at the diffusion of nanoparticles with a size range 
of up to 200nm, predicting that particles greater than 100nm experience restricted 
transport. I want to be able to quantify the particle size from a list of applicable 
xenobiotics.  
It is important to note that I calculate the spherical radius of xenobiotics, where the 
spherical radius is calculated as, 
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 𝛼 =  √
3𝑀𝑤. 𝑛
4𝜋𝑁𝐴𝜌
3
 , (4-6) 
where 𝛼 is the spherical radius of the xenobiotic, 𝑀𝑤 is the molecular weight, 𝑛 is the 
number of moles, 𝑁𝐴 is Avogadro’s number, and 𝜌 is the density. 
An extensive list of over 270 compounds was compiled including specific physicochemical 
properties based on a list previously described by Separham et al. [265]. Although these 
compounds are not specific hepatotoxins, they have been selected due to the diversity 
in physicochemical parameters. Due to the mathematical modelling approach taken 
whereby I assume a spherical particle travels down the centre line of a cylinder 
(representing the paracellular space), the spherical radius of the compound is highlighted 
as a key parameter that will impact on transport potentials. Online databases such as 
www.drugbank.ca and the national chemical database services (cds.rsc.org) were used 
to obtain values for density, LogP, pKa, and molecular weight for each of the compounds. 
Structural files pertaining to each of the xenobiotics from the list were also sourced. The 
key information obtained from these searches were used to calculate xenobiotic-specific 
parameters (see Appendix). 
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Table 9 – Selected xenobiotics show the range of calculated spherical radii from 
equation (4-6). APAP is shown as a xenobiotic of interest. Fluorouracil has the smallest 
calculated spherical radius and vinblastine has the largest calculated spherical radius. 
Name of 
xenobiotic 
Density (g/cm3) Molecular weight 
(Da) 
Calculated 
spherical radius 
(nm) 
 
Fluorouracil 
 
1.557 
 
 
 
130.08 
 
 
0.321 
 
APAP 1.26 151.16256 
 
0.362 
 
Etomidate 
 
1.11 244.29 
 
0.444 
Methotrexate 
 
1.536 454.45 
 
0.490 
Diclofenac Sodium 
 
0.63 318.13 
 
0.585 
 
Vinblastine 
 
1.37 810.99 
 
0.617 
 
 
 
From Table 9 we can see that the size of the diffusing particles for my model will range 
from 0.321nm to 0.617nm. I can use this range within the model to see what effect 
varying these values have on xenobiotic transport. 
A key parameter that I need to calculate is the passive diffusion rate of these compounds 
from the paracellular space into the cell interiors (defined by 𝑘𝑢 in equation (4-1)). Such 
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passive diffusion has been shown to be related to LogD7.4 by Menochet et al. [266] with 
the following formula, 
 𝐿𝑜𝑔 𝑘𝑢 =  0.5977 × 𝐿𝑜𝑔𝐷7.4 − 0.0437. (4-7) 
These values for passive diffusion have the units; µl/min/106 cells so in order to convert 
this passive uptake rate to the required units (s-1), I implemented the following; 
 𝑉 =
4
3
𝜋𝑟3 = 2.5882 × 10−11 𝑚3 (4-8) 
Where 𝑟 is taken to be the average radius of 4000-cell spheroids for all time points (183.5 
µm). 𝑉, is the total volume of the spheroid. I correct this value by subtracting the average 
value for the volumetric porosity of the 4000-cell spheroid (𝜀 = 0.008307).  
 
1 − 𝜀 = 1 − 0.008307 = 0.9917 
∴ 𝑉𝑐𝑒𝑙𝑙𝑠 = 2.5882 × 10
−11 × 0.9917 = 2.5667 × 10−11𝑚3 
∴ 0.025667𝜇𝑙−14000𝑐𝑒𝑙𝑙𝑠 = 6.4167𝜇𝑙−1106𝑐𝑒𝑙𝑙𝑠, 
(4-9) 
where 0.9917 is the fraction of the spheroid that is made up of cells, and 𝑉𝑐𝑒𝑙𝑙𝑠 is the total 
volume occupied by the cells. The original 𝑘𝑢 values have the units µl/min/10
6 cells. I 
convert these values to rates (s-1) by calculating the volume per cell, dividing the 𝑉𝑐𝑒𝑙𝑙𝑠 
value by the known number of cells in the spheroid and then multiplying this value by 
106. This value represents the total volume of 106 cells (6.4167 µl/106 cells). As a 
comparison, Menochet et al. [266] described this value being 3.9 µl/106 cells. To obtain 
our passive uptake terms for the specific xenobiotics I rearrange the original equation 
(4-7) and divide this by 6.4167 µl/106 cells to cancel the units of µl and cells. Finally, I 
divide this value by 60 to convert the time from minutes to seconds (see equation (4-10)). 
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𝑘𝑢 =
1
60
10(0.5977×𝐿𝑜𝑔𝐷7.4−0.0437)
6.4167
  (4-10) 
Menochet et al. [267] looked at the simultaneous uptake and metabolism of compounds 
in rat hepatocytes and therefore the relationship described in (4-7) between LogD7.4 and 
passive diffusion is highly appropriate for the mathematical modelling of an experimental 
PRH spheroid. In order to calculate the values for 𝑘𝑢  I first use ACD/labs software 
(ACD/Structure Elucidator, version 15.01, Advanced Chemistry Development, Inc., 
Toronto, ON, Canada, www.acdlabs.com, 2015) which uses the corresponding structural 
SMILES (simplified molecular-input line-entry system) files to calculate the appropriate 
LogD7.4 values based on the pKa values of the compounds. SMILES files are a specific line 
notation which describes the structure of a chemical species using short ASCII strings. 
SMILES strings can subsequently be imported into molecule editing software for 
conversion back into 2D drawings or 3D models of the molecules. From these molecular 
structural files, various physicochemical properties can be predicted depending on the 
specific reactive groups of the chemical.  
pKa refers to the acid dissociation constant which is a quantitative measure of 
the strength of an acid in solution. In aqueous solution, the equilibrium of acid 
dissociation can be written as,   
 𝐻𝐴 + 𝐻2𝑂 ⇌  𝐴
− + 𝐻3𝑂
+,  
(4-11) 
where 𝐻𝐴 is a generic acid that dissociates into 𝐴− (conjugate base), and the hydrogen 
ion combines with a water molecule to produce a hydronium ion. 
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The concept of LogD is derived from an understanding of the partition coefficient which 
is itself is a constant. The partition coefficient is defined as the ratio of concentration of 
compound in aqueous phase to the concentration in an immiscible solvent. The LogP will 
vary according to the conditions under which it is measured and the choice of 
partitioning solvent were, 
 
𝑃𝑎𝑟𝑡𝑖𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡, 𝑃 =
[𝑂𝑟𝑔𝑎𝑛𝑖𝑐]
[𝐴𝑞𝑢𝑒𝑜𝑢𝑠]
 , (4-12) 
where [ ]= concentration.  
 
𝐿𝑜𝑔𝑃 = log 10 (𝑃𝑎𝑟𝑡𝑖𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡). (4-13) 
LogD is the log distribution coefficient at a certain pH. LogD at pH 7.4 (LogD7.4) is said to 
give an indication of the lipophilicity of a drug at the pH of blood plasma.  
 
𝐷𝑖𝑠𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡, 𝐷 =
[𝑈𝑛𝑖𝑜𝑛𝑖𝑠𝑒𝑑](𝑜)
[𝑈𝑛𝑖𝑜𝑛𝑖𝑠𝑒𝑑](𝑎𝑞) + [𝐼𝑜𝑛𝑖𝑠𝑒𝑑](𝑎𝑞)
 , (4-14) 
 
𝐿𝑜𝑔𝐷 = log 10 (𝐷𝑖𝑠𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡). (4-15) 
The LogD7.4 value refers to lipophilicity at pH 7.4 which is a measure of how well a 
compound dissolves in fats, and is therefore a key physicochemical characteristic when 
considering the transport and diffusion of the compound within my list. The passive 
diffusion rates for the xenobiotics introduced in Table 9 are derived from equation (4-7) 
and by utilising the ACD/labs generated LogD7.4 values (see Table 10).  
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Table 10 – Previously selected xenobiotics and calculated passive diffusion rates. These 
rates have been calculated using equation (4-7) and ACD/labs generated LogD7.4 values.  
Name of xenobiotic Passive diffusion rate 𝒌𝒖 (1/s) 
 
Fluorouracil 
 
1.0708x10-6 
 
APAP 
 
0.0038 
 
Etomidate 
 
 
0.2086 
 
Methotrexate 
 
 
2.7676x10-6 
 
Diclofenac Sodium 
 
 
0.0087 
 
Vinblastine 
 
 
0.3770 
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4.4 Xenobiotic transport simulations  
The principle equation used for the modelling of xenobiotic transport is described by the 
following equation; 
 𝜕𝑐
𝜕𝑡 
=
1
𝑟2
𝜕
𝜕𝑟
 [𝐷𝜀𝑟2
𝜕
𝜕𝑟
 (
𝑐
𝜀
)] − 𝑘𝑢
𝑐
𝜀
 ,       (4-16) 
I use the initial condition,  
 𝑐(𝑟, 0) = 0, (4-17) 
 I also use the boundary conditions, 
 𝜕𝑐
𝜕𝑟
= 0 , at 𝑟 = 0,  
 𝑐 = 0, at 𝑟 = 𝑅, 
(4-18) 
(4-19) 
 
where 𝑐 is the molar concentration of the xenobiotic in the spheroid volume. I will look 
at normal dose ranges for known compounds e.g. 50mM for APAP. 𝑘𝑢 is the calculated 
passive diffusion rate based on LogD7.4, 𝐷 is the effective diffusion coefficient expressed 
by equation (4-2). In this case the diffusion coefficients of each xenobiotic will be 
compound specific.  Recall that in Goodman et al. [245], the diffusion coefficient was 
calculated using the following formula: 
 
𝐷 = 𝐷0
𝐿(𝜆)
𝜏(𝜀)
, 𝐷0 =
𝑘𝐵𝑇
6𝜋𝜇𝛼
 ,  
where the researchers describe tortuosity as being a function of the volumetric porosity, 
𝜏(𝜀). I did not observe this relationship within my spheroid model and instead explicitly 
calculated tortuosity as a function of spheroid radius, 𝜏(𝑟) . Similarly with volumetric 
porosity, 𝜀, I explicitly calculated tortuosity as a function of spheroid radius 𝜀(𝑟). 
Where 𝐷0 is the diffusion coefficient in unbounded liquid medium (in this case I assume 
it to be culture medium), 𝜏(𝑟) is the calculated tortuosity, 𝑘𝐵 is Boltzmann’s constant, 𝑇 
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is the absolute temperature (in Kelvin), 𝜇 is the viscosity of the liquid (water), 𝛼 is the 
calculated spherical radius of the diffusing xenobiotic as shown in Table 9, 𝑟𝑝  is the 
calculated radius of the pores within the spheroid (0.05 µm), 𝜆 = 𝛼/𝑟𝑝, and 𝐿(𝜆), as 
described above, is the factor responsible for hydrodynamic and steric reduction of the 
diffusion coefficient in the pore. 
The spheroid radius if fixed for my simulations and the PDE is solved for, 
 𝑟 ∈ [0, 𝑅] 𝑎𝑛𝑑, 𝑡 ∈ [0,3] (𝑚𝑖𝑛𝑢𝑡𝑒𝑠),  
where 𝑅 is the spheroid radius. For these simulations I assume that the radius of the 
spheroid and spatial features don’t vary in this short three minute time frame, and only 
the concentration of the xenobiotic varies. 
I will show the results for the 4000-cell spheroids (days 3, 7, 11, 18 and 21). The results 
for the remaining spheroids are similar.  
I will now describe the initial simulation results were I use APAP as an example xenobiotic. 
These steady state simulations will show the paracellular transport of the xenobiotic 
where there is no passive uptake term for the cells, and I will compare this to the same 
simulation where I have both the paracellular transport as well as a passive uptake term. 
I will also look at the effect of the spatially varying porosity and tortuosity (Table 7 and 
Table 8).  
The key aim of my simulations is to quantify how long it takes for the initial dose 
concentration to accumulate in the centre of the spheroid, assuming that I have a 
constant source of xenobiotic at the boundary (i.e. the media). By simulating for both 
paracellular transport and passive uptake, I can better discern the effect that the specific 
lipophilicity of the xenobiotic has on its transport within the microtissue. Also I will look 
at how the spatially varying volumetric porosity and tortuosity effects the transport of 
the xenobiotics and if the observed stratification effects xenobiotic penetration into the 
microtissue.  
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4.5 Simulation results  
4.5.1 Transport of APAP 
In this section, I show the in silico predicted transport profiles for APAP, and how 
variations in the volumetric porosity (𝜀 ) and tortuosity (𝜏 ) effect this transport. I will 
utilise the explicitly calculated values for volumetric porosity and tortuosity that change 
with respect to radius, 𝜀(𝑟), 𝜏(𝑟) , and I will also investigate the effect of these 
parameters in the cases where; 
o 𝜀 is constant and 𝜏(𝑟), 
o 𝜀(𝑟) and 𝜏 is constant,  
o 𝜀 is constant and 𝜏 is constant. 
For the simulations where 𝜀  is constant I will use the mean 𝜀(𝑟)  over all sample 
considered (i.e. 0.008307). For the simulations where 𝜏  is constant I will utilise the 
corresponding mean tortuosity value, 𝜏 = 1.272.  
I solve the reaction diffusion equation (4-16) utilising the Matlab pdepe solver which 
solves PDEs using finite differences on the spatial derivatives to generate a system of 
coupled ODEs, which are then solved using an in-built Matlab ODE solver (ODE15s). (See 
3.2.1 for numerical methods). 
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Figure 4-13 - APAP transport where we assume paracellular transport only (i.e. 𝒌𝒖 =
𝟎) where we have; top left where 𝜺(𝒓) and 𝝉(𝒓), top right where 𝜺 is a constant term 
and 𝝉(𝒓), bottom left where 𝜺(𝒓) and 𝝉 is a constant, and bottom right where 𝜺 and 𝝉 
are both constant terms. The y axis represents time (minutes), the x axis describes the 
scaled radial distance from the spheroid core to the boundary, and the colour bar 
represents concentration of the xenobiotic. All cases use the spatial profiles and radius 
corresponding to that of a day 3 spheroid with 4000 cells.  
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Figure 4-13 demonstrates the transport profile for APAP when we assume paracellular 
transport with no uptake into the cells (i.e. 𝑘𝑢 = 0 ). I have solved the PDE with the 
previously described variations in ε and τ to see if these radially coupled values cause 
changes in the transport profiles of APAP. I.e. I test the effect of the aggregation of the 
cells at the spheroid boundary. The results from this simulation show that there is no 
discernible difference when we have ε(𝑟) and τ(r), or when we utilise constant values 
for these, i.e. when we assume paracellular transport only (𝑘𝑢 = 0), my simulations show 
that APAP will accumulate in the core of the spheroids within 2 minutes of dosing at 
50mM at day 3.  
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Figure 4-14 APAP transport where we assume paracellular transport and passive 
uptake where we have; top left 𝜺(𝒓) and 𝝉(𝒓), top right 𝜺 is a constant term and 𝝉(𝒓), 
bottom left 𝜺(𝒓) and 𝝉 is a constant, and bottom right 𝜺 and 𝝉 are both constant terms.  
The y axis represents time (minutes), the x axis describes the scaled radial distance from 
the spheroid core to the boundary, and the colour bar represents concentration of the 
xenobiotic. In each case, I take 𝒌𝒖 = 0.0038 (s
-1). 
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Figure 4-14 shows the same transport profiles for APAP as Figure 4-13, however, with the 
implementation of the passive uptake term as calculated from equation (4-10) and given 
in Table 10 (𝑘𝑢 = 0.0038 𝑠
−1 for APAP). From these results we can see that when I 
incorporate passive uptake into the cells, the transport profiles for APAP are distinctly 
different to paracellular transport only. Initially, when we assume paracellular transport 
only, APAP fully accumulates in the core at the same concentration as the initial dose 
within approximately 2 minutes. However, Figure 4-14 shows that when we include 
paracellular transport of APAP into the cells, APAP does not fully penetrate the spheroid, 
independent of the spatial effects of 𝜀 and/or 𝜏, and is instead rapidly taken up by the 
cells on the periphery of the spheroid.  
These simulations were also repeated for APAP at day 7, 11, 18 and 21 (data not shown). 
However, there was no discernible difference between these transport profiles and that 
of the original simulations at day 3 (Figure 4-14). Therefore, for all other subsequent 
simulations I will look at day 3 as we do not observe any difference between transport 
profiles as culture time increases.   
From these initial simulations I therefore conclude that, for a diffusing particle of this size 
(0.362nm), the discrete radial changes in spheroid microarchitecture (𝜀(𝑟) and 𝜏(𝑟) ) 
makes little difference to the transport profiles. What can clearly be seen from the 
simulations is that when we only assume paracellular transport, APAP accumulates in the 
spheroid core rapidly. However, when we incorporate the calculated passive uptake term, 
very little of the drug penetrates to the centre of the spheroid. 
I will now look at vinblastine, a chemotherapeutic drug commonly used to treat breast 
cancer. This xenobiotic had the largest calculated spherical radius in my list of compounds, 
and therefore I can investigate the effect of a larger diffusing particle within the model 
structure.  
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4.5.2 Transport of vinblastine  
These subsequent simulations will show the transport of vinblastine with both transport 
scenarios, where we have paracellular transport only and both paracellular diffusion with 
passive uptake. I will again investigate the effects of changing the values for 𝜀 and 𝜏, to 
see if changes in the microarchitecture of the mathematical spheroid model may impede 
the transport of this xenobiotic. In this instance I will implement a therapeutic dose of 
vinblastine  (10-6mol/l) as previously described [268]. 
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Figure 4-15 - Vinblastine transport where we assume; top left where we have 
paracellular transport only and 𝜺(𝒓) and 𝝉(𝒓) ; top right we have both paracellular 
transport and passive uptake, with 𝜺(𝒓)  and 𝝉(𝒓) ; bottom left where we have 
paracellular transport only and 𝜺,𝝉 are both constants; and, bottom right we have both 
paracellular transport and passive uptake and 𝜺,𝝉 are both constant terms. In this case 
we take 𝒌𝒖 = 𝟎. 𝟑𝟕𝟕𝟎 (s
-1). 
 
Figure 4-15 demonstrates the transport profiles for vinblastine. The simulations show the 
difference between transport via paracellular routes only, versus combined paracellular 
transport and passive uptake of the xenobiotic. When we assume paracellular transport 
only, the simulations show that vinblastine will almost fully accumulate in the core of the 
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spheroids of dosing at 10-6mol/l at day 3. Also, there is no discernible difference between 
the transport profiles for vinblastine when we assume spatially dependent or constant 
values for 𝜀 and 𝜏. When we look at the same simulations but include passive uptake, we 
instead see that vinblastine is not transported to the spheroid interior and instead the 
simulations suggest that the dose of the drug is taken up by the cells on the periphery of 
the spheroid. Again, by varying ε and τ , we see no changes in this result. From these 
simulations and the previous result for APAP, I conclude that for the transport of small 
molecule xenobiotics, the spatial variations in volumetric porosity and tortuosity makes 
little difference to the drug transport profiles.  
As a comparison, I will now look at the transport profiles of fluorouracil, another 
chemotherapeutic drug commonly used to treat colorectal cancer. This xenobiotic had 
the smallest calculated spherical radius in my list of compounds. The previous simulations 
with the largest xenobiotic vinblastine, showed that spatial variations in 𝜀 and 𝜏 had no 
effect on its transport profile. As I am now looking at the smallest xenobiotic from my list, 
I can postulate that radial changes in 𝜀  and 𝜏  will similarly have little effect on the 
resulting transport profiles for fluorouracil. Interestingly, when compared to APAP and 
vinblastine, fluorouracil has a much smaller passive uptake rate as calculated as a 
function of its LogD7.4 (1.0708 x10-6 s-1). This is because, fluorouracil has a relatively low 
lipophilicity when compared to APAP and vinblastine. I therefore expect to see more 
penetrance of this xenobiotic into the core of the spheroid, as it will be less likely to 
diffuse across the cell membranes (i.e. lower 𝑘𝑢).    
4.5.3 Transport of fluorouracil  
Figure 4-16 shows the transport of fluorouracil where I will again compare the cases of 
paracellular transport only, versus the combined transport of fluorouracil with passive 
uptake. For completeness, I will again investigate the spatial effects of 𝜀 and 𝜏. Fang et al. 
[269] describe an optimised dose of fluorouracil of between 28-38mg/L/h. In line with 
this, I use a therapeutic dose of 33mg/L/h.  
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Figure 4-16 - Fluorouracil transport where we assume; top left, we have paracellular 
transport only with 𝜺(𝒓) and 𝝉(𝒓); top right, we have both paracellular transport and 
passive uptake with 𝜺(𝒓) and 𝝉(𝒓); bottom left, we have paracellular transport only 
and 𝜺 and 𝝉 are both constants; and bottom right, we have both paracellular transport 
and passive uptake and 𝜺 and 𝝉 are both constant terms. In this case, we take 𝒌𝒖 =
 1.0708x10-6 (s-1). 
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Figure 4-16 demonstrates the transport profiles for fluorouracil. These simulations show 
the similarity between transport profiles when I assume paracellular transport only (i.e. 
𝑘𝑢=0), compared with paracellular transport coupled with passive uptake in to the cells 
(i.e. 𝑘𝑢=1.0708x10
-6 s-1). This result is completely different for the simulations for APAP 
and vinblastine where the rapid rate of passive uptake into the cells is predicted to 
impede the transport of the xenobiotic into the spheroid core. The result for fluorouracil 
demonstrates the importance of the lipophilicity (LogD7.4) of the compound, and how 
this physicochemical property will affect the potential transport within my in vitro model. 
Xenobiotics that have a low LogD7.4 values are less likely to be taken up into the cells as 
they have a relatively low lipophilicity. These simulations may help to determine what 
the likely penetration profiles will be, based on physicochemical properties of the 
xenobiotic and calculated values for cellular passive uptake. The simulations for 
fluorouracil, where 𝜀 and 𝜏 are taken to be constant values, show that the inclusion of 
these spatial changes do not appear to affect the transport of this small molecule 
xenobiotic as I have demonstrated above.   
The results from all of my simulations so far have demonstrated that the spatial variations 
in 𝜀  and 𝜏  do not appear to impact on the subsequent transport profiles of these 
compounds considered. For these simulations, I have looked at both the smallest and 
largest xenobiotics from my list (0.321-0.617nm), compounds with different LogD7.4 
values, and subsequently different cellular uptake rates (Table 10). I can conclude that 
for xenobiotics that fall into this size range, the major impactor on spheroid penetration 
is lipophilicity. Where xenobiotics are highly lipophilic (e.g. such as vinblastine), they are 
more likely to be transported by passive diffusion into the cells and therefore appear not 
to accumulate in the centre of the microtissue. Conversely, if the xenobiotic has a 
relatively low lipophilicity (e.g. such as fluorouracil), they are more likely to be 
transported via the paracellular routes and therefore are predicted to accumulate in the 
spheroid core.  
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To further investigate the effects of LogD7.4, I now look at the transport profiles of 
fluorouracil again. I run the simulations for day 3 only, and I again look at paracellular 
transport only (𝑘𝑢 = 0) versus combined transport with passive uptake (𝑘𝑢 ≠ 0). I use 
the same therapeutic dose of 33mg/L/h. However, for these simulations I now choose 3 
limiting values for LogD7.4, namely;  
1. LogD7.4 = -5, as a value representative for low lipophilicity (similar to the original 
value -5.59), 
2. LogD7.4 = 5, as a value representative for high lipophilicity  (similar to that of 
felodipine 4.83), 
3. LogD7.4 = 0.74, as the average LogD7.4 value from my list of approximately 270 
compounds. 
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Figure 4-17 - Fluorouracil transport for day 3 where we assume only paracellular 
transport for the top left simulation; we assume both paracellular transport and 
passive uptake for top right simulations with a LogD7.4 = -5; we assume both 
paracellular transport and passive uptake for bottom right simulation with a LogD7.4 = 
0.74; we assume both paracellular transport and passive uptake for bottom left 
simulations with a LogD7.4 = 5. In all simulations, 𝜺 and 𝝉 are assumed to be spatially 
varying, as described above.   
 
Figure 4-17 shows the transport profiles for fluorouracil on day 3 where I vary the values 
of the LogD7.4 parameter to account for high, low or mean (calculated) lipophilicity. Here 
I have used 𝜀(𝑟) and 𝜏(𝑟) as with my initial simulations in Figure 4-16 to include the 
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spatial variations in spheroid microarchitecture. The results show that changing the 
LogD7.4 has a profound effect on the predicted transport profiles. When we look at 
implementing the calculated mean value for LogD7.4 (i.e. 0.74), the compound is now 
readily taken up by the cells. There is some penetrance of the xenobiotic into the, but 
only to around 50 µm. When we use a relatively high value for LogD7.4 (i.e. 5), we see that 
none of the xenobiotic is transported into the spheroid core as all of the initial dose is 
taken up into the periphery cells. These simulations further support the idea that the 
xenobiotic LogD7.4 is a key parameter when determining the spheroid transport profile, 
as this value dramatically affects the ability of the compound to be taken up passively by 
the cells.  
4.5.4 Transport of larger particles 
So far, I have looked at particles that range between 0.321nm and 0.617nm. I will now 
finally investigate the profiles of larger particles, similar to those investigated by 
Goodman et al. [245]. The size of the pores within the mathematical model are 0.05 µm, 
and therefore, particles of this size will not be transported through the paracellular 
spaces. Goodman et al. [245], identify the size of the pores within their tumour spheroid 
non-necrotic regions as being 1.23 µm, 25 times larger than the pores in my spheroid 
model. The researchers also describe transport being impeded when the diffusing 
particles are 100-200nm. If we consider the same particle to pore size ration, this is 
equivalent to a particle of size 4nm diffusing in my system. As this is a hypothetical, I 
assume paracellular transport only with no given logD7.4 (𝑘𝑢 = 0). As a comparison, the 
dose of the 4nm particle is assumed to be the same as that of APAP (50mM). I will look 
at day 3 and day 21 profiles to see if the compaction of the spheroids over time, impedes 
the transport of this larger particle. I select the appropriate calculated 𝜀(𝑟), 𝜏(𝑟) profiles 
for these respective (day3 and 21) spheroids. 
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Figure 4-18 – Transport profile for 4nm particle for day 3 and day 21 where we assume 
only paracellular transport (𝒌𝒖 = 𝟎), where 𝜺(𝒓) and 𝝉(𝒓) as described in Table 7 and 
Table 8.  
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Figure 4-18 shows the transport of a 4nm particle. We can see that for paracellular 
transport of the particle on day 3, we do not get full penetrance of the particle. Instead, 
approximately 10 mM concentration accumulates in the spheroid core under steady state 
conditions. However for the same simulation on day 21, approximately 20 mM 
concentration reaches the core of the spheroid. These simulations indicate that the 
spheroidal compaction may impact on the transport profiles for larger particles. To 
investigate this more thoroughly, I now look at the transport profiles of a range of particle 
sizes (0.1 nm – 10 nm) for day 3, 7, 11, 18 and 21 spheroids to take into account the 
compaction as described previously. I will look at the concentration of the accumulated 
particle in the spheroid core under steady state conditions, and determine the proportion 
of the initial particle dose that penetrates to the core of the spheroids.  
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Figure 4-19 shows the percentage of the initial dose concentration (50 mM) that 
accumulates in the spheroid core under steady state conditions. Red circles represent 
spheroids at day 3, green squares represent spheroids at day 7, purple triangles represent 
spheroids at day 11, orange stars represent spheroids at day 18 and the black diamonds 
represent spheroids at day 21. In all cases, 𝒌𝒖 = 𝟎. For these simulations, spheroid radii 
are as follows; Day 3, 𝑹 = 209 µm; day 7, 𝑹 = 198 µm; day 11, 𝑹 = 186.7 µm, day 18, 𝑹 = 
166.7 µm; day 21, 𝑹 = 158 µm.  
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Figure 4-19 shows the transport profiles for hypothetical particles of varying sizes with 
no specific LogD7.4 (i.e. no cellular passive uptake, where 𝑘𝑢 = 0). The percentage of the 
initial particle dose concentration that accumulates in the centre of the spheroids under 
steady state conditions is plotted against particle size. For these simulations, 𝑅 varies as 
previously described for 4000-cell spheroids (Figure 2-4), and the volumetric porosity 
and tortuosity also vary with respect to spheroid radius, 𝜀(𝑟), 𝜏(𝑟). From these results 
we can see that the compaction of the spheroids makes little difference when looking at 
the commonly used small molecule xenobiotics (0.321 - 0.617 nm). However, if we take 
a particle size of 2 nm for example, the PDE model predicts that at day 3, approximately 
60% of the initial 50 mM dose will accumulate in the spheroid core. Compare that to day 
18 and 21, and the PDE model predicts that approximately 80-85% of the initial 50 mM 
dose will accumulate in the spheroid core. This same trend can be seen for particles of 
between 3 nm and 6 nm. For example, for a 3 nm particle the model predicts that 
approximately 30% of the initial 50 mM dose concentration will penetrate to the spheroid 
core at day 3, and at day 18 and 21, the model predicts that approximately 60% of the 
initial 50 mM dose will penetrate to the spheroid core. The difference in predicted 
particle penetrance for varying culture times significantly reduces when we look at the 
particles of 6 nm or greater, and also for particles of 1 nm or smaller.  
This result suggest that if we assume paracellular transport only and no passive uptake 
(i.e. 𝑘𝑢 = 0), the compaction of the spheroids and/or the spatially varying values for 𝜀 
and 𝜏, significantly affect the transport profiles of these particles. In order to determine 
if this result is predominantly due to spheroid compaction, or due to spatial variations in 
𝜀(𝑟), 𝜏(𝑟), we will use the PDE model to simulate the same transport scenarios as seen 
in Figure 4-19. However, we will use a fixed spheroid radius of 183.7 µm (representative 
of the mean value for 4000-cell spheroids over the culture period) (see Figure 4-20).  
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Figure 4-20 shows the percentage of the initial dose concentration (50mM) that 
accumulates in the spheroid core under steady state conditions. Red circles represent 
spheroids at day3, green squares represent spheroids at day 7, purple triangles represent 
spheroids at day 11, orange stars represent spheroids at day 18 and the black diamonds 
represent spheroids at day 21. In all cases, 𝒌𝒖 = 𝟎. For these simulations, the spheroid 
radii for all time points are fixed at, 𝑹 = 183.7 µm. 
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Figure 4-20 shows the transport profiles for hypothetical particles of varying sizes (0.1 -
10 nm) with no specific LogD7.4 and no passive uptake rate, ( 𝑘𝑢 = 0). The percentage of 
the initial particle dose concentration that accumulates in the centre of the spheroids 
under steady state conditions is again plotted against particle size. For these simulations, 
𝑅 is fixed at the mean value of 185.7 µm for 4000-cell spheroids. For these simulations, 
volumetric porosity and tortuosity are the only parameters that vary (𝜀(𝑟), 𝜏(𝑟) ), as 
described in Table 7 and Table 8.  
These results show that, when we assume the spheroid radius is constant for all time 
points, and where porosity and tortuosity are both functions of spheroid radius, there is 
little difference between the transport profiles when we vary the size of the particle. If 
we take the 2 nm particle for example, the model predicts that approximately 70-75% of 
the initial dose concentration will accumulate in the spheroid core for all time points. This 
trend is observed for all of the particle sizes and therefore confirms that, whilst there 
may be slight variation in the % dose accumulation in the spheroid cores due to spatial 
variations in 𝜀 and 𝜏, it is the compaction of the spheroids that impacts on the transport 
profiles with the most significance.  
4.6 Chapter discussion 
The aim of this chapter was to better understand the effects of cellular microarchitecture 
variations on the transport of xenobiotics. Previous studies that have investigated similar 
transport profiles of larger nanoparticles within tumour spheroids [187, 245] have 
provided some insight into the dynamics of transport within spheroid systems. However, 
an understanding of how small molecule xenobiotics are transported within liver 
spheroids has not been undertaken previously. 
There are currently no studies that investigate the impact of spheroid volumetric porosity 
or tortuosity on the potential transport profiles of xenobiotics. Additionally, there are no 
studies that explore the effects of passive uptake rates, based on lipophilicity, as a means 
of assessing modes of xenobiotic transport. 
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Initially, I identified changes in the microarchitecture of the experimental system 
(specifically ε and τ) (see Figure 2-6 and Figure 2-9), where we see stratification of cells 
on the boundary of the spheroid producing an encapsulated model. Additionally there 
was cellular reorganisation and distribution, where we have more cells distributed at the 
periphery and fewer cells populating the spheroid core. I hypothesised that these micro-
architectural features in the experimental model could impede the transport of 
xenobiotics.  
I have previously described a mathematical diffusion model of oxygen. As oxygen is a 
small diffusing particle, it is known to readily and rapidly cross the cell membrane. 
However, for larger particles such as drugs and other compounds, they can be 
transported between cells, as well as into cells via passive uptake. I also wanted to be 
understand the importance of the xenobiotic-specific physicochemical characteristics, 
such as lipophilicity and what effect variations in these parameters may have had on 
transport into the microtissue.  
Goodman et al. [245] previously described a mathematical model for nanoparticle 
diffusion into tumour spheroids. They explored the effect of the increasing particle size 
on transport profiles, whilst also considering the changing microarchitecture within the 
experimental system. They concluded that the size of the particle, particle binding rate 
and the porosity of the tissue, were key parameters to take into account when designing 
nanoparticles as carriers for drugs. Ward et al. [187] looked at the potential for spheroid 
cellular death as a result of modelling the penetrance of compounds with varying initial 
dose concentrations. Clearly this kind of modelling is extremely useful for developing an 
understanding of drug action on tumours. However, this approach has not yet been 
translated to an in vitro liver system.  
I have developed a mathematical model based on porous media modelling, specifically 
applied to my experimental PRH spheroid, to investigate the effect of particle size, 
porosity and tortuosity, and physicochemical properties on the penetrance of xenobiotics 
into the in vitro liver system. I was able to develop this model and incorporate 
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experimentally derived parameters for tortuosity and volumetric porosity and identify 
that these two parameters vary spatially against spheroid radius. A number of 
xenobiotics were considered in order to comprehensively determine the effects of the 
microtissue architecture on transport profiles. Additionally the intrinsic xenobiotic 
physicochemical characteristics were also investigated as a means to discern the likely 
transport profiles.  
In particular, I analysed the transport profiles of APAP, vinblastine and fluorouracil to see 
if the varying sizes of these commonly utilised xenobiotics effected the transport profile 
characteristics. I chose APAP initially as this drug has been intensively investigated in 
terms of its pharmacology and toxicology and therefore I could benchmark my findings 
against the current literature. Vinblastine and fluorouracil were chosen as these were 
the smallest and largest xenobiotics from my list of commonly used small molecule 
compounds. Additionally, they both had distinctly different physicochemical properties 
based on their LogD7.4 values and therefore the subsequent calculated cellular passive 
uptake rates were also different, providing a good comparison. 
My results shown in Figure 4-13 describe, firstly, the transport profiles of APAP for 
paracellular diffusion only and, secondly, with the additional assumption of passive 
uptake. The effect of passive uptake of APAP significantly effects the initial prediction of 
xenobiotic penetration. When assuming passive uptake, little APAP is transported to the 
spheroid core. This is an interesting point to discuss because toxicity caused by APAP 
overdose, for example, is experienced by hepatocytes within the pericentral zone of the 
sinusoid. If we look at the simulations where we assume passive uptake of APAP, none of 
the drug penetrates the entirety of the spheroid body. Therefore, the pericentral-like 
hepatocytes within the spheroid core may not be exposed to the drug and manifestations 
of known toxicity may not be captured accurately in this in vitro system.   
I also investigated the effect of varying the values for both tortuosity and porosity to see 
if these radially coupled functions affect compound transport profiles. Figure 4-13, 
Figure 4-14, Figure 4-15, and Figure 4-16 show the results when assuming that these 
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parameters are constant or functions of the spheroid radius. My results demonstrated 
that when considering the range of small molecule compounds from my list of 
xenobiotics (0.321 nm - 0.617 nm), we do not see an effect from these spatial variations 
in these micro-architectural features. 
Figure 4-16 describes the transport profiles for fluorouracil. These simulations 
demonstrate the difference in transport profiles for xenobiotics that are highly lipophilic 
(such as APAP) versus those that have a low lipophilicity.  I was able to show that the 
transport of fluorouracil was dominated by the paracellular route due to its low LogD7.4, 
and subsequently low cellular uptake. I therefore conclude that the favoured transport 
route of xenobiotics within my in vitro model is determined mostly by its lipophilicity. 
When xenobiotics have high LogD7.4 values, (i.e. highly lipophilic), calculated passive 
uptake rates are high which leads to more transport by passive uptake. This passive 
uptake into cells means that the xenobiotics will therefore not accumulate as readily in 
the centre of my spheroids. On the other hand, when xenobiotics have a relatively low 
LogD7.4, (i.e. low lipophilicity), these low LogD7.4 values result in subsequently calculated 
low passive uptake rates and therefore are more likely to be transported via the 
paracellular routes. 
4.7 Conclusion  
The results from my mathematical modelling have shown that the transport profiles of 
xenobiotics in my spheroid system are dependent on the specific physicochemical 
parameters as well as particle size. I have shown that spatial variations in volumetric 
porosity and tortuosity have little impact on the transport of larger molecules (see Figure 
4-20), or that of commonly used small molecule compounds. I have also demonstrated 
that the size of the spheroids i.e. spheroidal compaction effects the transport profiles of 
larger molecules (see Figure 4-19).  
A limitation of my in silico model system is that I did not include active transporter 
kinetics or other routes for xenobiotic transport, such as the bile canaliculi or cellular 
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endocytosis. If I was to include these other modes of cellular transport, I could potentially 
develop a more comprehensive model to assess the transport of these compounds. 
Within my model, cellular passive uptake refers to the movement of compounds down 
the concentration gradient, and therefore this process does not require cellular energy. 
In contrast, active transport requires the expenditure of ATP in order to pump molecules 
against the concentration gradient. Thus, the transport of molecules occurs from a low 
concentration to high concentration, or up the concentration gradient. The addition of 
this type of transport in my in silico system may well impact on the transport properties 
of certain xenobiotics. However, active transport seems to be limited to xenobiotics that 
are structurally similar to endogenous substances. Despite this, there are some drug 
compounds that have been shown to be absorbed via active transport mechanisms, 
namely equilibrative nucleoside transporters, which include s-adneo-sylmethionine, 
fludarabine, arabinosylcytosine and azidothymidine [270]. I can therefore assert that, the 
specific physicochemical properties of xenobiotics will determine their likely transport 
profiles. Additional experimental work to try and elucidate some of the key transport 
parameters would therefore further strengthen my modelling efforts.  
My initial aim for this chapter was to develop a mathematical model to assess xenobiotic 
transport and penetration into a PRH spheroid. I have used novel mathematical 
techniques to derive parameters that would be extremely difficult to achieve 
experimentally. I have demonstrated that the changes in 𝜏 and 𝜀 with respect to culture 
time have little affect the transport profiles of the compounds that are commonly tested 
in these systems. From experimental observations of cellular reorganisation, I 
hypothesised that the uptake and transport of drugs may have been impeded by the 
spatial variations in microarchitecture. However, my mathematical modelling 
demonstrates that these features do not affect the xenobiotic transport profiles. 
Furthermore, the most sensitive parameters regarding transport into the microtissue is 
the lipophilicity of the molecule and the compaction of the spheroid. 
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Chapter 5: Concluding discussion  
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Our understanding of xenobiotic safety is continually developing due to improvements in 
the predictive capabilities of both experimental in vitro and in silico platforms. However, 
xenobiotic safety still remains a complicated area of research due to the wide variation 
in population susceptibility and also due to our limited understanding in the 
pharmacology of some novel xenobiotics. To elucidate this unknown pharmacology and 
toxicological potential, there is a requirement of more representative in vitro and in silico 
liver models. The implementation of the 3R’s has also driven the process of accelerated 
in vitro model development and optimisation, leading to the progression of microtissue 
and fluid-flow, systems such as bioreactor technologies, microfluidic devices and 3D 
spheroid models. The literature has demonstrated that these more complex in vitro 
models are able to recapitulate more of the intricate physiological aspects of the liver as 
seen in vivo and therefore are considered more representative when compared to 
classical 2D and sandwich culture models [43, 54, 76, 81, 109, 250]. Despite the major 
developments in 3D and more complex in vitro systems, it is clear that the requirement 
of animal studies for toxicological investigations remains within the process of research 
and development. As a result, researchers are continually advancing methods by which 
the number of animals used in these studies is in compliance with the 3R’s principles. 
The incorporation of more refined and representative 3D in vitro liver models that are 
able to successfully capture appropriate toxicity endpoints at early stage investigations, 
will inevitably facilitate the reduction of many potential compounds reaching later stage 
testing in animal trials.     
Hepatocytes within the liver sinusoid are exposed to multiple solute gradients such as; 
oxygen, nutrients, hormones, and metabolites. These gradients are caused by successive 
cellular uptake along the sinusoid which reduces the concentrations of these solutes for 
subsequent cells. The variation in the cellular exposure to these solutes results in 
zonation, whereby cells along the sinusoid have varying levels of metabolic competence 
and gene expression. Recent in vitro and in silico models have attempted to replicate the 
oxygen gradients as seen in vivo, as the literature has reported that specific oxygen 
tensions are a key physiological characteristic that modulates liver zonation [12, 13, 118, 
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120]. It may be the case that the replication of these appropriate in vivo-like oxygen 
gradients results in appropriate zonation within the in vitro model.  
In order for these systems to be utilised in industry for hepatotoxicity assessments, a 
comprehensive programme of evaluation and validation is required to demonstrate that 
these models add value with regards to exhibiting the relevant and appropriate 
experimental end points. Of the vast number of 3D models, microfluidic devices and 
bioreactor platforms available, spheroids in particular have been investigated with 
intensity over the last decade. The implementation of such relatively simplistic 
experimental methodologies for the production of a highly functional and representative 
high-throughput system illustrates the potential for the application of this model.  
5.1 Chapter summaries  
Chapter 2 in this thesis details the extensive experimental characterisation of a primary 
isolated rat hepatocyte spheroid model. My aim was to implement a method by which 
to produce a spheroid model that is relatively simple in terms of culture and laboratory 
manipulation, and also and cost-effective. Additionally I wanted to develop an in vitro 
model that would circumvent other limitations that have previously been described, 
such as the formation of necrosis. Size controllability of spheroids was an area initially 
highlighted as a limitation of numerous spheroid production techniques. Commercially 
available systems, like that of Insphero, utilise the hanging-drop method to produce size 
controllable spheroids, however, they are extremely expensive when compared to other 
systems [7].  
I have implemented the application of the liquid-overlay technique (LOT) as a culture 
platform for PRH, as a means to produce size controllable cost-effective spheroids based 
on the initial seeding density of the cells. This novel combination of the LOT methos and 
culturing PRH results in the formation of viable and reproducible spheroids. This is 
advantageous when compared with hepatic-derived cell lines, which tend to proliferate 
abundantly when cultured with the LOT. This proliferation results in spheroids that 
rapidly increase in size, resulting in the inability of oxygen to diffuse through the entirety 
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of the microtissue, culminating in the formation of centralised necrotic zones [230]. The 
formation of necrosis subsequently affects gene expression and the expression of 
metabolising enzymes and, as a consequence, the system is no longer representative of 
a healthy liver [271]. This brings in to question the appropriateness of such cell systems 
as tool for reliable hepatotoxicity investigations. By comparison, my PRH spheroid model 
shows no signs of central necrosis and the fact that these spheroids actually compact 
during the culture time, means that it is much more likely that oxygen will be able to 
penetrate the entirety of the microtissue.  
Experimental characterisation has demonstrated the structural and functional 
polarisation of the hepatocytes within the spheroid via immunofluorescent analysis, and 
also confirmed the functionality of the apical membrane transport MRP2 via incubation 
with CMFDA. The demonstration of CMFDA transport via MRP2 is a key output from this 
research as this has never been carried out with primary isolated hepatocytes previously.  
Interestingly, histological analysis of my PRH spheroid model has shown that the cells at 
the periphery of the spheroid seem to become distinctly different in morphology when 
compared with the more centralised hepatocytes. Only one other paper within the 
literature makes comment of the formation of a similar feature and identifies this to be 
the mesothelial lining of the liver in vivo, namely the Glisson’s capsule [42]. 
Immunohistochemical analysis has confirmed that these peripheral cells are likely to be 
mesothelial and therefore the formation of this in vivo-like feature further strengthens 
my assertion that this spheroid model is representative of the in vitro liver. 
My objective for Chapter 3 was to develop a mathematical model of oxygen diffusion, 
utilising experimental derived parameters, with the aim of establishing a prediction for 
optimal spheroid size before the onset of necrosis. To appropriately model this, I 
highlighted the need for model-specific parameters due to the extensive variability of 
OCR vales in the literature. Appropriate oxygen delivery to cells is a critical component 
in vivo and consequently it is just as important a consideration for in vitro cell models. 
However, many cell culture protocols do not take into account the fundamental 
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properties of oxygen diffusion [179]. Many of the previously described culture models 
are used by a number of research laboratories and they are dependent on oxygen 
exchange at the air-medium interface [179]. Oxygen then travels by diffusion through 
the culture medium to the underlying cells. Distances from the air-medium interface to 
the cells vary between in vitro devices. For example, in my spheroid system, oxygen has 
to diffuse over 3.5mm from the air-medium interface to the top of the spheroid. 
Information regarding the determination of oxygen tensions experienced at the cell 
surface are extremely limited and this is often an overlooked feature [179].  
My mathematical model was able to predict the oxygen tensions experienced by the cells 
at the spheroid boundary as well as the spheroid core and I subsequently used this to 
propose optimised operating conditions in order to recapitulate sinusoidal oxygen 
tensions. The optimisation of these operating conditions was firstly based on the size of 
the spheroids at specific times of the culture period, as a result of the initial cell seeding 
densities, and secondly on experimentally derived oxygen consumption rates (OCR).  
Previous modelling approaches for oxygen diffusion within 3D microtissue models have 
utilised average OCR values for all cells within the spheroid [178]. However, after 
scrutinizing the experimental results from Seahorse analysis, I was able to demonstrate 
that OCR is a function of the spheroid radius. It is important to note that this relationship 
has previously been reported in the literature with tumour spheroids [231]. By 
incorporating this radius dependent OCR rate, I demonstrate that larger spheroids 
actually consume less oxygen than smaller ones, and this means that there is a higher 
oxygen potential to diffuse further into the spheroid core. My in vitro and in silico results 
demonstrate that when attempting to optimise a spheroid model, the specific OCR of the 
cells and the size stability of the spheroids over the course of the culture period are the 
important characteristics to determine. Size stability in particular will be dependent on 
the proliferative characteristics of the cells.  
Chapter 4 describes the construction of a mathematical model, based on porous media 
modelling, to predict the diffusion of xenobiotics that vary in size and lipophilicity. The 
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key aim of this work was to improve our understanding of how xenobiotics are 
potentially transported within my spheroid model, and also to discern the effects of 
microarchitectural variations on the transport profiles of these xenobiotics. I 
incorporated experimental model-specific features including variations in cellular 
microarchitecture into my in silico model. My mathematical model incorporates solute 
transport route characteristics, namely tortuosity and pore fraction properties, in order 
to understand if changes in the microarchitecture of the experimental model would 
impact on the transport potential of xenobiotics. I have previously described a number 
of other publications that had investigated the transport potential of nanoparticles and 
other solutes in tumour spheroid models. Goodman et al. [245] investigated the diffusion, 
penetration and transport properties of nanoparticles in a tumour spheroid model and 
used experimental parameters for changes in the spheroid microarchitecture including, 
the volume fraction and tortuosity. Binding affinity and accessible volume fraction were 
also determined experimentally. Although this particular publication provided good 
insight into the potential transport profiles of nanoparticles in tumour spheroids, a more 
comprehensive understanding of how xenobiotics are transported within liver spheroids 
was required. 
I was able to demonstrate that the transport profiles for small molecule xenobiotics were 
unchanged when I implemented my radially coupled terms for volumetric porosity and 
tortuosity. I was able to conclude that for the size of particles I was interested in, the 
subtle temporal changes in the cellular microarchitecture did not impact on their 
transport potential. I was, however, able to show that the most sensitive parameter that 
effected the transport profiles for the xenobiotics of interest, was the calculated LogD7.4 
values, which is a measure of particle lipophilicity. In particular, my findings 
demonstrated that for a wide range of dosing regimen, not all of the compounds 
penetrate the entirety of the spheroid due to uptake into peripheral cells.  
I have demonstrated that microarchitectural changes within my spheroid model, do not 
affect the transport profiles of xenobiotics despite the concern from experimental 
observations. I have also shown that for my model the most sensitive parameter is the 
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lipophilicity/ LogD7.4 value of the molecule for commonly used small molecule 
xenobiotics. Furthermore, when I consider larger molecules, I have been able to highlight 
that spheroidal compaction significantly effects the transport profiles of these particles.   
These kinds of studies would be extremely difficult and costly to undertake 
experimentally, and therefore the mathematical modelling approaches taken in this 
research demonstrate the added value and appropriateness of my reciprocal in vitro and 
in silico modelling approach. Additionally, these results show that mathematical 
modelling with verifiable and model-specific parameters provides a more accurate model 
than those previously described in the literature.    
5.2 Key research outputs 
The overall aim of this research was develop a 3D microtissue model, suitable for repeat-
dose hepatotoxicity testing. My extensive experimental characterisation and in silico 
modelling demonstrates that this system may be well placed as in vitro platform to assess 
hepatotoxicity after repeat-dose exposure to xenobiotics. I have been able to produce a 
novel in vitro liver spheroid model that can be cultured for extended periods (up to 31 
days) that remain devoid of central regions of necrosis. Additionally, these spheroids 
display structural and functional polarisation of transporters with CMFDA transport via 
MRP2. The formation of the potential mesothelial lining surrounding the PRH spheroids 
is also something that has rarely been mentioned in the literature and strengthens the 
apparent in vivo-like morphology of my microtissue model.  
 I have also implemented numerous novel mathematical techniques and computational 
modelling approaches to allow for better utilisation of experimental results. The 
proposed optimised operating conditions for the recapitulation of sinusoidal oxygen 
gradients is perhaps the most impactful result from my research. Not only has the 
experimental characterisation shown that the PRH spheroids can be utilised for long-
term investigations, but also that it may be possible to maintain healthy oxygen gradients 
for the duration of the culture period. Additionally, I have implemented mathematical 
models to derive microarchitectural properties of an experimental model, in way that 
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has never been utilised before for in vitro liver models. I concluded from my xenobiotic 
transport modelling that microarchitectural properties of the model would not affect the 
transport properties of selected compounds, further enhancing the utility of 
mathematical modelling in order to address concerns that would have been extremely 
difficult and costly to address experimentally.  
5.3 Future work  
In order to fully determine the application of my in vitro and in silco models, additional 
experimental work would help strengthen the conclusions from my research. In particular, 
further insight into the oxygen tensions experienced by spheroids in the culture set-up 
would help validate the mathematical modelling approaches. The use of an oxygen 
probe/dye could potentially be used to demonstrate the oxen gradients within the 
spheroids. However, it is important to state that the mathematical modelling approach 
was taken because experimental determination of these parameters is extremely difficult 
to achieve. Seahorse analysis was chosen to determine spheroid OCR as this is considered 
an appropriate means of analysis when compared with other techniques such as 
immunofluorescent dyes etc.  
A better understanding of the mechanisms driving the PRH spheroidal compaction during 
the culture period may also be warranted, however, numerous publications have 
previously focussed on, and attributed this compaction to the upregulation of key ECM 
and cytoskeletal components. A quantitative analysis of the spheroidal compaction along 
with improved cellular viability analysis may facilitate the mathematical modelling 
findings with regards to OCR values over culture time. 
Finally, considering the characterisation work that has been undertaken and the 
complimentary mathematical modelling alongside this experimental work, I believe that 
the outlook for future work would be in testing compounds with known hepatotoxic 
potential utilising the PRH spheroid model. As I have demonstrated that this model is 
amenable in the laboratory and both cost-effective with high-throughput potential, it 
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may prove beneficial within the early compound screening tools already utilised across 
industry as well as academia.  
5.4 Concluding statement  
Hepatic-derived spheroid models have recently been incorporated into a number of 
industry sectors as tools for early-stage hepatotoxicity investigations. Although theses 
spheroid models may be superior in predictive capabilities when compared with other 
more simplistic cultures and testing platforms, I suggest that the implementation of a 
primary cell line spheroid model that remains devoid of necrosis would be a further 
improvement to the battery of tools already utilised. In terms of the literature, although 
primary spheroid models have been developed and characterised for many years, there 
have been no investigations that have been able to detail experimental operating 
conditions for the maintenance of healthy liver oxygen gradients, and none that have 
critically evaluated size-dependent OCR analysis of spheroids I can conclude that using a 
combined research approach, both the in vitro and in silico modelling facilitates the 
development of these systems in a reciprocal fashion. I have shown that mathematical 
modelling of oxygen diffusion  within my spheroid model, has allowed for the prediction 
of incubator oxygen levels required to recapitulate in vivo liver oxygen gradients for as 
long as possible. The maintenance of these in vivo-like gradients may therefore facilitate 
repeat-dose toxicological studies as the model is more representative of the in vivo organ. 
This research demonstrates that a combined quantitative systems pharmacology 
approach will pave the way for the development of more representative in vitro systems 
to be used for repeat-dose, and long-term toxicological investigations.   
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Chapter 6: Appendix  
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6.1 Appendix  
Appendix shows the full list of xenobiotic compounds described in Chapter 4. I describe 
a number of key physicochemical parameters that were required for the modelling of 
xenobiotic transport. Xenobiotics are shown from smallest calculated radius to largest.  
This list of compounds is based on a list previously described by Separham et al [265]. 
Online databases including www.drugbank.ca, the national chemical database services 
(cds.rsc.org) etc. were used to obtain values for density and molecular weight. The 
calculated spherical radius was determined by implementing equation (4-6). LogD7.4 
values were determined via computational analysis using ACD/labs software which uses 
structural SMILES files to calculate the appropriate LogD7.4 values based on pKa values. 
The passive uptake rates of these compounds were calculated by implementing equation 
(4-10).  
Name of 
xenobiotic   
Density 
(g/cm3) 
Molecular 
weight 
(Da) 
 Spherical 
Radius (cm) 
LogD7.4 Passive 
uptake rate 
(s-1) 
Fluorouracil 1.557 130.08 3.21E-08 -5.59 1.07076E-06 
Benzyl alcohol 1.047 108.14 3.45E-08 1.03 0.009693219 
Ancitabine  2.01 225.20 3.54E-08 -3.25 2.68109E-05 
Creatinolfosfate 1.65 197.13 3.62E-08 -6.29 4.08605E-07 
APAP 1.26 151.16256 3.62E-08 0.34 0.003750205 
Sulfanilamide 1.427 172.20 3.63E-08 -0.72 0.000871953 
Dacarbazine 1.486 182.18 3.65E-08 -0.28 0.001597648 
Norfenefrine 1.249 153.18 3.65E-08 -1.92 0.000167206 
Penicillamine 1.204 149.21 3.66E-08 -1.58 0.000266975 
Mizoribine 2.06 259.22 3.68E-08 -0.9 0.000680624 
Acetylcysteine  1.294 163.19 3.68E-08 -2.73 5.48423E-05 
Thiotepa  1.5 189.22 3.68E-08 0.52 0.004804421 
Aciclovir  1.77 225.21 3.70E-08 -5.85 7.48673E-07 
Aminocaproic acid  1.03 131.17 3.70E-08 -2.61 6.46904E-05 
Vidarabine 2.08 267.24 3.71E-08 -1.02 0.00057701 
 Appendix 
  
243 
 
Name of 
xenobiotic   
Density 
(g/cm3) 
Molecular 
weight 
(Da) 
 Spherical 
Radius (cm) 
LogD7.4 Passive 
uptake rate 
(s-1) 
Flopropione 1.372 182.18 3.75E-08 2.32 0.057213829 
Triaziquone 1.727 231.25 3.76E-08 -1.79 0.000199965 
Minoxidil 1.521 209.25 3.79E-08 0.35 0.003802174 
Tegafur 1.45 200.17 3.80E-08 -0.96 0.000626679 
Tranexamic acid 1.096 157.21 3.85E-08 -2.18 0.00011691 
Chlorothiazide 2.04 295.72 3.86E-08 -0.37 0.001411523 
Amrinone  1.277 187.20 3.87E-08 -0.55 0.001101798 
Chlorazanil 1.483 221.65 3.90E-08 0.77 0.006777445 
Bemegride  1.024 155.20 3.92E-08 1.53 0.019289369 
Ethinamate 1.1 167.21 3.92E-08 -0.77 0.000813969 
Caffeine 1.23 194.19 3.97E-08 -0.13 0.001963975 
Mephenesin 1.152 182.22 3.97E-08 1.21 0.012418067 
Cinoxacin 1.64 262.22 3.99E-08 -3.38 2.24187E-05 
Diprophylline 1.57 254.25 4.00E-08 -1.1 0.000516853 
Proxyphylline 1.46 238.24 4.01E-08 -0.2 0.001783598 
Sulfathiazole 1.561 255.31 4.02E-08 -0.33 0.001491406 
Carbromal 1.445 237.10 4.02E-08 -1.87 0.000179117 
Cyclobutyrol 1.128 186.25 4.03E-08 -1.23 0.000432181 
Guaifenesin 1.195 198.22 4.04E-08 0.57 0.005146666 
Baclofen  1.285 213.66 4.04E-08 -0.94 0.000644168 
Sulfadiazine 1.496 250.27 4.05E-08 -0.84 0.000739212 
Doxofylline 1.59 266.26 4.05E-08 -0.7 0.000896287 
Captopril 1.272 217.28 4.08E-08 -3.18 2.95224E-05 
Nikethamide 1.042 178.23 4.08E-08 0.33 0.003698946 
Sulfamethizole 1.562 270.32 4.09E-08 -1.17 0.000469384 
Nalidixic acid  1.331 232.24 4.11E-08 -0.37 0.001411523 
Glyconiazide 1.679 295.25 4.12E-08 -1.52 0.000289957 
 Orciprenaline 1.199 211.26 4.12E-08 -1.77 0.000205546 
Trifluridine 1.646 296.20 4.15E-08 -0.22 0.001735174 
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Name of 
xenobiotic 
Density 
(g/cm3) 
Molecular 
weight 
(Da) 
 Spherical 
Radius (cm) 
LogD7.4 Passive 
uptake rate 
(s-1) 
Busulfan 1.35 246.29 4.17E-08 -0.52 0.001148241 
Mexiletine 0.979 179.26 4.17E-08 0.96 0.008802966 
Sulfamerazine 1.439 264.30 4.18E-08 -0.02 0.002284983 
Imipenem 1.62 299.34 4.18E-08 -5.28 1.64052E-06 
Lofexidine 1.39 259.14 4.20E-08 1.73 0.025401421 
Epirizole 1.25 234.26 4.20E-08 1.4 0.016129356 
Propofol 0.948 178.27 4.21E-08 4.16 0.719894763 
Meticrane 1.464 275.34 4.21E-08 -0.15 0.001910654 
Phenobarbital 1.234 232.24 4.21E-08 -3.11 3.2508E-05 
Methyprylon 0.969 183.25 4.22E-08 0.23 0.003223354 
Dichlorophen 1.419 269.13 4.22E-08 4.61 1.337315919 
Sulfaethidole 1.499 284.35 4.22E-08 -0.66 0.000947011 
Sulfalene 1.465 280.30 4.23E-08 -0.13 0.001963975 
Meprobamate 1.139 218.25 4.24E-08 0.7 0.006154985 
Ranimustine 1.69 327.72 4.25E-08 0.58 0.005217987 
Bamethan  1.079 209.29 4.25E-08 -0.65 0.000960134 
Chlorphenesin 
carbamate 
1.365 265.09 4.25E-08 1.41 0.016352871 
Ozagrel 1.17 228.25 4.26E-08 -1.09 0.000524015 
Cyclophosphamide 1.33 261.09 4.27E-08 0.23 0.003223354 
Ifosfamide 1.326 261.09 4.27E-08 0.23 0.003223354 
Beclamide  1.145 225.72 4.28E-08 0.91 0.008217581 
Aminophenazone 1.17 231.30 4.28E-08 0.76 0.006684809 
Morphine 1.44 285.34 4.28E-08 -0.4 0.001354431 
Cimetidine 1.27 252.34 4.29E-08 -0.25 0.001664991 
Phenylbutazone 1.542 308.38 4.30E-08 0.85 0.007566273 
Khellin 1.301 260.25 4.30E-08 1.78 0.027210907 
Etamivan 1.115 223.27 4.30E-08 1.45 0.01727834 
Mefenamic acid 1.203 241.29 4.30E-08 2.37 0.061289491 
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uptake rate 
(s-1) 
Flufenamic acid 1.396 281.23 4.31E-08 2.57 0.080709752 
Suprofen 1.29 260.31 4.31E-08 -0.77 0.000813969 
Piromidic acid  1.4 288.31 4.34E-08 -2 0.000149774 
Furosemide 1.606 330.74 4.34E-08 -0.03 0.002253751 
Chlorpropamide 1.334 276.74 4.35E-08 0.94 0.008563968 
Salbutamol 1.152 239.31 4.35E-08 -2.12 0.000126973 
Chloramphenicol 1.547 323.13 4.36E-08 0.82 0.007260241 
Ibudilast 1.09 230.31 4.38E-08 3.34 0.232892238 
Ketoprofen 1.198 254.29 4.38E-08 -0.26 0.001642234 
Pentoxifylline 1.31 278.31 4.38E-08 0.32 0.003648388 
Carbuterol 1.248 267.33 4.40E-08 -1.99 0.00015185 
Mitomycin 1.56 334.33 4.40E-08 -2.73 5.48423E-05 
Tazanolast 1.343 289.29 4.40E-08 0.35 0.003802174 
Pindolol 1.152 248.32 4.41E-08 -0.21 0.001759219 
Trichlormethiazide 1.748 380.65 4.42E-08 0.13 0.002808911 
Methylphenidate 1.07 233.31 4.42E-08 0.47 0.004484934 
Flumazenil 1.39 303.29 4.42E-08 0.67 0.005906035 
Procaine 1.077 236.31 4.43E-08 0.52 0.004804421 
Pipemidic acid 1.38 303.32 4.43E-08 -2.72 5.56023E-05 
Etomidate 1.11 244.29 4.44E-08 3.26 0.208611869 
Secobarbital 1.079 238.28 4.44E-08 2.04 0.038917507 
Carbutamide 1.226 271.33 4.44E-08 0.31 0.003598521 
Procainamide 1.06 235.37 4.45E-08 -0.8 0.000781047 
Bendazac  1.27 282.30 4.45E-08 -0.62 0.001000606 
Azosemide  1.661 370.83 4.46E-08 1.3 0.014055523 
Viloxazine 1.061 237.30 4.46E-08 0 0.002348751 
Benzoctamine  1.114 249.36 4.46E-08 1.29 0.013863408 
Nalorphine 1.38 311.38 4.47E-08 0.65 0.005745688 
Sulfaphenazole 1.39 314.36 4.48E-08 0.98 0.009048634 
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Ketobemidone 1.092 247.34 4.48E-08 1.18 0.011915795 
Ciprofloxacin 1.461 331.35 4.48E-08 -1.29 0.000397928 
Clorexolone 1.447 328.81 4.48E-08 0.71 0.006240279 
Riboflavin 1.65 376.37 4.49E-08  0.002348751 
Lidocaine 1.026 234.34 4.49E-08 2.31 0.056431814 
Chlordiazepoxide 1.3 299.75 4.51E-08 2.16 0.045905954 
Melphalan 1.32 305.20 4.51E-08 -0.7 0.000896287 
Indobufen 1.275 295.34 4.51E-08 0.42 0.004186692 
Azapropazone  1.29 300.36 4.52E-08 -0.75 0.000836685 
Iopanoic acid 2.426 570.94 4.54E-08 1.42 0.016579484 
Atenolol  1.125 266.34 4.54E-08 -1.99 0.00015185 
Norfloxacin 1.344 319.34 4.55E-08 -1.61 0.000256177 
Ajmaline  1.373 326.44 4.55E-08 0.08 0.002622123 
Aztreonam  1.83 435.43 4.55E-08 -5.47 1.26304E-06 
Ethylmorphine 1.31 313.40 4.56E-08 0.8 0.007063127 
Gliclazide 1.35 323.41 4.56E-08 -0.18 0.001833374 
Trofosfamide 1.35 323.59 4.56E-08 1.77 0.02683898 
Oxaprozin 1.222 293.32 4.57E-08 1.13 0.011123412 
Ampicillin  1.45 349.40 4.57E-08 -1.91 0.000169524 
Midazolam 1.35 325.77 4.57E-08 3.92 0.517393555 
Atropine  1.194 289.37 4.58E-08 -0.94 0.000644168 
Pipradrol 1.103 267.37 4.58E-08 1.01 0.00943005 
Nortriptyline 1.084 263.38 4.58E-08 3.17 0.184308776 
Prothipendyl 1.168 285.41 4.59E-08 0.91 0.008217581 
Dextromethorphan 1.11 271.40 4.59E-08 2.39 0.062999922 
Propentofylline 1.25 306.36 4.60E-08 1.38 0.015691448 
Pilsicainide 1.11 272.39 4.60E-08 0.53 0.004870999 
Pimobendan 1.36 334.38 4.60E-08 1.81 0.028357897 
Zimeldine 1.286 317.23 4.61E-08 4 0.577613074 
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Clozapine 1.319 326.83 4.61E-08 1.96 0.034860131 
Doxepin 1.122 279.38 4.62E-08 2.09 0.041689819 
Diphenhydramine 1.025 255.36 4.62E-08 2.29 0.054899705 
Chloropyramine 1.158 289.81 4.63E-08 1.53 0.019289369 
Promazine 1.133 284.42 4.63E-08 2.67 0.092618131 
Perlapine 1.16 291.40 4.64E-08 1.48 0.018006654 
Thenalidine 1.14 286.43 4.64E-08 3.01 0.147881557 
Zopiclone 1.54 388.81 4.64E-08 -0.41 0.001335919 
Iocetamic acid 2.416 613.96 4.65E-08 0.18 0.003009006 
Desipramine 1.047 266.69 4.66E-08 1.43 0.016809238 
Protirelin 1.421 362.38 4.66E-08 -5.56 1.1159E-06 
Piretanide 1.415 362.40 4.67E-08 -1.01 0.000585006 
Maprotiline 1.081 277.41 4.67E-08 1.65 0.022753175 
Nipradilol 1.27 326.35 4.67E-08 0.17 0.002967878 
Benzthiazide 1.66 431.93 4.69E-08 0.94 0.008563968 
Nadolol 1.189 309.41 4.69E-08 -0.81 0.000770371 
Dibenzepin 1.134 295.37 4.69E-08 0.55 0.005006936 
Zotepine 1.27 331.86 4.70E-08 5.24 3.182621662 
Griseofulvin 1.35 352.77 4.70E-08 3.53 0.30249487 
Fleroxacin 1.409 369.34 4.70E-08 -0.59 0.001042783 
Tetracaine 1.004 264.37 4.71E-08 2.61 0.085277412 
Methylergometrine 1.28 339.44 4.72E-08 1.39 0.015908895 
Nizatidine 1.249 331.45 4.72E-08 0.98 0.009048634 
Ranitidine 1.184 314.40 4.72E-08 0.23 0.003223354 
Rebamipide 1.394 370.79 4.72E-08 -0.68 0.0009213 
 Quinidine 1.218 324.42 4.73E-08 1.6 0.021240122 
Salazosulfapyridine 1.488 398.39 4.74E-08 0.03 0.002447755 
Imipramine 1.041 280.41 4.74E-08 2.79 0.10924964 
Mefruside 1.417 382.88 4.75E-08 1.76 0.026472138 
 Appendix 
  
248 
 
Name of 
xenobiotic 
Density 
(g/cm3) 
Molecular 
weight 
(Da) 
 Spherical 
Radius (cm) 
LogD7.4 Passive 
uptake rate 
(s-1) 
Tetracycline 1.644 444.43 4.75E-08 -4.26 6.67782E-06 
Doxycycline 1.639 444.44 4.76E-08 -3.36 2.30444E-05 
Tetroxoprim 1.232 334.38 4.76E-08 0.34 0.003750205 
Quazepam 1.42 386.79 4.76E-08 4.06 0.627334272 
Vinpocetine 1.28 350.46 4.77E-08 4.54 1.214492996 
Dimetindene 1.065 292.42 4.78E-08 1.95 0.034383653 
Pentazocine 1.036 285.43 4.78E-08 3 0.14586027 
Oxyphenbutazone 1.241 342.38 4.78E-08 0.45 0.004363169 
Sulpiride 1.236 341.43 4.78E-08 -1.39 0.000346764 
Periciazine 1.32 365.49 4.79E-08 2.5 0.073297138 
Trazodone 1.33 371.87 4.80E-08 1.49 0.018256184 
Oxytetracycline 1.645 460.43 4.81E-08 -4.43 5.28477E-06 
Etofenamate 1.317 369.34 4.81E-08 4.15 0.71005504 
Chlortetracycline 1.704 478.89 4.81E-08 -2.75 5.33534E-05 
Nitrendipine 1.28 360.37 4.82E-08 3.5 0.290259882 
Floctafenine 1.437 406.36 4.82E-08 3.63 0.347126696 
Penbutolol 1.03 291.43 4.82E-08 2 0.036832993 
Binedaline 1.03 293.41 4.83E-08 2.26 0.052679181 
Miconazole 1.451 416.13 4.84E-08 5.86 7.470660738 
Chloroquine 1.111 319.18 4.85E-08 1.86 0.030377989 
Terbinafine 1.007 291.43 4.86E-08 6.49 17.7791099 
Bifonazole 1.07 310.40 4.86E-08 4.78 1.689829994 
Budipine 1.009 293.45 4.87E-08 1.92 0.03299294 
Piperidolate 1.11 323.43 4.87E-08 3.77 0.420887487 
Fencarbamide 1.127 328.47 4.87E-08 2.97 0.139960671 
Papaverine 1.161 339.39 4.88E-08 3.71 0.387528828 
Clebopride 1.27 373.88 4.89E-08 1.99 0.03632955 
Perazine 1.149 339.50 4.89E-08 3.43 0.263601583 
Bentiromide  1.367 404.42 4.90E-08 0.61 0.005437935 
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Methotrexate 1.536 454.45 4.90E-08 -4.9 2.76762E-06 
Adiphenine  1.052 311.42 4.90E-08 3.14 0.176854052 
Isradipine 1.249 371.39 4.90E-08 3.59 0.328533768 
Risperidone 1.38 410.49 4.90E-08 2.1 0.042267544 
Nilvadipine 1.29 385.38 4.91E-08 1.72 0.025054227 
Fosfestrol 1.433 428.32 4.91E-08 -2.36 9.12568E-05 
Kanamycin 1.62 484.50 4.91E-08 -6.84 1.91677E-07 
Bufetolol 1.081 323.43 4.91E-08 -0.5 0.001180285 
Thioridazine 1.237 370.57 4.92E-08 3.72 0.392899082 
Felodipine 1.277 384.26 4.92E-08 4.83 1.81020606 
Haloperidol 1.239 375.87 4.94E-08 2.18 0.04718707 
Azelastine  1.25 381.90 4.95E-08 1.81 0.028357897 
Dinoprost 1.153 354.49 4.96E-08 -0.47 0.001230037 
Urapidil 1.26 387.48 4.96E-08 1.87 0.030798957 
Tobramycin 1.52 467.52 4.96E-08 -8.72 1.44176E-08 
Benperidol  1.24 381.45 4.96E-08 3.06 0.15841599 
Propanidid 1.087 337.42 4.97E-08 2.3 0.055660489 
Fluanisone 1.146 356.44 4.98E-08 3.14 0.176854052 
Bevantolol 1.11 345.44 4.98E-08 1.77 0.02683898 
Bromperidol 1.336 420.32 5.00E-08 2.36 0.060451769 
Nemonapride 1.23 387.91 5.00E-08 2.02 0.037860907 
Vesnarinone 1.246 395.46 5.01E-08 1.71 0.024711779 
Domperidone 1.341 425.92 5.01E-08 1.75 0.026110309 
Pipamperone 1.174 375.49 5.02E-08 1.45 0.01727834 
Opipramol 1.129 363.55 5.04E-08 3.23 0.20017416 
isoldipine 1.205 388.42 5.04E-08 4.38 0.974457751 
Perphenazine 1.253 403.97 5.04E-08 4 0.577613074 
Sisomicin 1.387 447.53 5.04E-08 -7.55 7.21443E-08 
Trifluperidol 1.26 409.42 5.05E-08 2.29 0.054899705 
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Moracizine 1.315 427.52 5.05E-08 2.29 0.054899705 
Carvedilol 1.25 406.48 5.05E-08 3.09 0.165093515 
Plaunotol 0.936 306.45 5.06E-08 5.75 6.421138159 
Talinolol 1.11 363.50 5.06E-08 1.03 0.009693219 
Cinnarizine 1.125 368.52 5.06E-08 4.46 1.087875045 
Glisoxepide 1.37 449.52 5.07E-08 -1.63 0.000249222 
Nicergoline 1.47 484.39 5.07E-08 4.3 0.872864869 
Sulforidazine 1.221 402.57 5.08E-08 2.16 0.045905954 
Tofisopam 1.15 382.46 5.09E-08 2.03 0.038385572 
Cloricromen 1.189 395.88 5.09E-08 1.83 0.029149292 
Nimodipine 1.25 418.45 5.10E-08 3.85 0.469874649 
Doxorubicin 1.61 543.53 5.12E-08 1.11 0.010821414 
Budesonide 1.27 430.54 5.12E-08 3.14 0.176854052 
Daunorubicin 1.554 527.53 5.13E-08 1.23 0.012764624 
Dehydrocholic 1.172 402.53 5.15E-08 -0.86 0.000719143 
Suxibuzone 1.265 438.48 5.16E-08 0.17 0.002967878 
Chenodeoxycholic 
acid  
1.129 392.58 5.17E-08 2.05 0.039456814 
Pivampicillin 1.33 463.55 5.17E-08 1.8 0.027970293 
Netilmicin 1.32 461.56 5.18E-08 -6.84 1.91677E-07 
Dextromoramide 1.121 392.54 5.18E-08 3.68 0.371854477 
Etodroxizine 1.175 418.96 5.21E-08 1.59 0.020949806 
Thioproperazine 1.237 446.63 5.23E-08 2.56 0.079606589 
Oxatomide 1.175 426.56 5.24E-08 3.29 0.217405243 
Buprenorphine 1.26 467.65 5.28E-08 2.46 0.069371169 
Acarbose  1.7 631.58 5.28E-08 -4.18 7.45506E-06 
Piritramide 1.15 430.59 5.30E-08 3.8 0.438628669 
Dipyridamole 1.347 504.63 5.30E-08 -1.24 0.000426274 
Pimozide 1.224 461.55 5.31E-08 2.91 0.128867681 
 Appendix 
  
251 
 
Name of 
xenobiotic 
Density 
(g/cm3) 
Molecular 
weight 
(Da) 
 Spherical 
Radius (cm) 
LogD7.4 Passive 
uptake rate 
(s-1) 
Etoposide 1.555 588.56 5.31E-08 0.3 0.003549335 
Astemizole  1.2 458.58 5.33E-08 4.41 1.015532939 
Ketoconazole 1.38 531.44 5.35E-08 3.43 0.263601583 
Convallatoxin 1.41 550.65 5.37E-08 0.81 0.007161006 
Carpipramine 1.143 446.64 5.37E-08 2.46 0.069371169 
Calcitriol 1.063 416.64 5.38E-08 6.12 10.68466757 
Sofalcone 1.149 450.53 5.38E-08 3.03 0.152008549 
Ergotamine 1.47 581.67 5.39E-08 3.63 0.347126696 
Proscillaridin 1.33 530.66 5.41E-08 3.9 0.503346455 
Loperamide 1.187 477.04 5.42E-08 3.73 0.398343756 
Meproscillarin 1.29 544.69 5.51E-08 3.09 0.165093515 
Mupirocin 1.183 500.63 5.52E-08 0.85 0.007566273 
Verapamil 1.058 454.61 5.54E-08 2.33 0.058006681 
Pantethine 1.277 554.72 5.56E-08 -1.4 0.000342024 
Deserpidine 1.32 578.66 5.58E-08 3.72 0.392899082 
Gefarnate 0.9 400.64 5.61E-08 10.53 4619.74511 
Reserpine 1.329 608.69 5.66E-08 3.82 0.450869663 
Iotroxic acid 2.648 1215.82 5.67E-08 -2.41 8.51883E-05 
Iocarmic acid 2.57 1253.87 5.78E-08 -4.27 6.58655E-06 
Ioxaglic acid 2.545 1268.89 5.83E-08 -4.04 9.03918E-06 
Itraconazole 1.4 705.64 5.85E-08 4.29 0.860934307 
Diclofenac Sodium 0.63 318.13 5.85E-08 0.95 0.008682644 
Hexobendine 1.147 592.69 5.90E-08 3.52 0.298360286 
Inositol nicotinate 1.5 810.73 5.98E-08 6.37 15.07252505 
Oleandomycin 1.21 687.87 6.09E-08 0.48 0.004547084 
Vincristine 1.406 824.97 6.15E-08 2.27 0.053409193 
Vinblastine 1.37 810.99 6.17E-08 3.69 0.377007521 
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